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Abstract 
 
 
Omega-3 fatty acids are one of the two main families of long chain polyunsaturated 
fatty acids.  Polyunsaturated fatty acids are in general considered to be one of the 
most essential nutrients for humans. The human body is not capable of synthesizing 
omega-3 or omega-6 fatty acids efficiently.  Thus, it must be obtained through diet or 
supplementation.  The main omega-3 fatty acids in the mammalian body are α-
linolenic acid (ALA), docosahexenoic acid (DHA) and eicosapentaenoic acid (EPA).  
Central nervous tissues of vertebrates are characterized by high concentration of 
omega-3 fatty acids.  Moreover, in the human brain, DHA is considered as the main 
structural omega-3 fatty acid, which comprises about 40% of the PUFAs in total.  DHA 
deficiency is related with many disorders such as depression, inability to concentrate, 
excessive mood swings, anxiety, cardiovascular disease, type 2 diabetes, dry skin and 
so on.  Animal model studies have shown a link between omega-3 rich diet and the 
neuronal cell survival.  Like DHA, zinc is the most abundant trace metal in the human 
brain.  There are much scientific evidence linking zinc, especially excess amounts of 
free zinc, to cellular death.  Neurodegenerative diseases such as Alzheimer’s disease 
is characterised by the altered zinc metabolism.  Studies conducted with rats have 
shown increased expression of ZnT3 zinc transporter levels and increased 
hippocampal levels of zinc when treated with a DHA deficient diet.   
 
ii
Therefore, this study was designed to explore the concept of “Omega-3 fatty acids 
and zinc in neuronal cell homeostasis and survival” in a holistic context.  The main 
focus of the research was to investigate possible link between zinc, DHA, apoptosis 
and cell survival.  The research also investigates many aspects of “omega-3 fatty acids 
and its benefits at the cellular level”.  The project attempts to gauge omega-3 effects 
on neurodegenerative conditions such as Alzheimer’s disease.  This study describes 
various factors which are responsible for neurodegeneration and a possible link 
between free zinc availability at the cellular level to neurodegeneration.  To elucidate 
the link between DHA, zinc and brain cell death, we cultured human neuronal M17, 
SY5Y and NT2 cells in DHA-deficient or DHA-enriched culture medium.  Exposure of 
cells to DHA-deficient medium reduced the levels of active caspase-3 and increased 
the levels of Bcl-2, relative to levels in DHA treated cells, confirming the adverse 
effects of DHA deficiency in promoting neuronal cell death.  To investigate the role of 
zinc in DHA-induced apoptotic cell death, we grew cells in DHA-deficient and DHA-
enriched culture medium and measured zinc uptake using zinc fluorophores.  In DHA 
treated cells, zinc fluorescence signalling was almost invisible compared to the strong 
fluorescence labelling which could be seen with the DHA deficient cells.  Furthermore, 
in DHA-treated cells, ZnT3 mRNA and protein levels were significantly down-
regulated compared to levels in DHA-deficient cells.  Previous studies have shown 
free zinc can mediate brain cell death through apoptosis.  In conclusion, observations 
reported by this this study suggests that DHA acts as a neuro-protective compound 
trough a reduction in free cellular zinc levels that in turn protect cells from apoptosis. 
 
iii
Despite the increasing demand, neuroscience research is limited due to the high cost 
associated with the research and lack of a suitable in vitro model that can mimic the 
structural and functional characteristics of human mature neurons.  Many research 
uses cheaper and readily available substitutes such as animal models or rodent 
neurons or other different immortalized human cells such as neuroblastoma cells.  
Though, these alternatives have been widely used in common practice, the 
resemblance to the actual physiological conditions can vary substantially.  Second 
component of this study was to address this issue and was focused in developing a 
better human cell culture model for neurobiology research.  Human neuroblastoma 
cell lines M17 and SY5Y, along with human tetra carcinoma cell line NT2, were used 
in this study and differentiated using retinoic acid.  Past studies have shown that M17 
cells are resistant to retinoic acid and continued to proliferate under the normal 
conditions when treated with retinoic acid.  However, during this study, cells were 
grown on a 3D structure instead of the conventional 2D method and then treated 
with retinoic acid.  With the combination of these improved methods, we managed 
to differentiate all the three cell lines and cellular differentiation was tested with 
neuronal specific markers using immunocytochemistry and Western blotting 
techniques.   
 
 
In conclusion, the current study provides two key significant contributions towards 
the advancement of neuroscience research.  Firstly by elucidating a possible link 
between free zinc availability, DHA levels and apoptosis, thus suggesting a possible 
neuroprotective pathway following DHA treatment at the cellular level.  Secondly 
iv
thist study was able to develop a better cell culture model to generate terminally 
differentiated neuronal cells.  The current method provides an economical, effective 
and simple method of differentiating neuronally committed cells into primary 
neuronal cells. 
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CHAPTER 1: Literature Review 
 
 
1.1 Omega -3 (ω-3) Fatty Acids 
 
Fatty acids (FAs) in general are naturally occurring molecules consisting of a 
hydrocarbon chain of varying length, with a carboxyl group (COOH) and a methyl 
(CH3) group at either end.  Fatty acids are classified according to the number of 
carbon atoms and the number and the type of bond between the carbons.  Saturated 
FAs only have single bonds between carbon-carbon atoms, which are fully saturated 
with hydrogen atoms. In contrast, unsaturated FAs have at least one or more 
unsaturated carbons. Monounsaturated FAs contain a single carbon-carbon double 
bond, while polyunsaturated FAs contain at least two or more double bonds. The 
most common confirmation for these double bonds are in cis, however the trans 
confirmation is also present as intermediates in the bio-hydrogenation of FAs in some 
plant lipids (Christy et al., 2003). 
 
Polyunsaturated fatty acids (PUFAs) in general are considered to be one of the most 
essential nutrients for humans and are well known to be important as a structural 
and functional component of the mammalian body.  Omega-3 and omega-6 are the 
two main families of PUFAs.  High concentration of PUFAs can be found in the human 
central nervous system (Salem et al., 1976) and eyes (Benolken et al., 1973).  A huge 
20% of the dry matter of the brain (Logan, 2004) and 6% of the dry matter of the 
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cerebral cortex is made up of PUFAs (Svennerholm, 1968).  Many biochemical 
processes especially in early postnatal development, such as cellular differentiation, 
active synaptogenesis, and photoreceptor membrane biogenesis are extensively 
dependent on PUFAs (Longo et al., 2003).  However, despite of all these essentialities, 
mammals cannot synthesize PUFAs de novo, and must attain it through their dietary 
sources.   
 
Both Omega-3 and omega-6 are very important in many biochemical functions, but 
still metabolically and functionally distinct and have opposing physiological effects 
(Simopoulos, 2002). As an example, at high concentrations, omega-6 FAs can increase 
the formation of prostaglandins and thereby increase inflammatory processes.  In 
contrast, the reverse process can be seen with increased omega-3 in the body.  Many 
other factors such as thromboxane A2 (TXA2), leukotriene B4 (LTB4), IL-1, IL-6, 
tumour necrosis factor (TNF), and C-reactive protein, which are related to varies 
health conditions have been shown to increase with high omega-6 FAs, but decrease 
with omega-3 FAs (Simopoulos, 2002).  
 
In recent years, evidence supporting the essential nature of PUFA’s for better health 
has increased.  As a result, the recommended level of dietary PUFA intake has gone 
through extreme scientific scrutiny over the last few years.  As an example, over the 
last few years the recommended levels for two main omega-3 FAs (eicosapentaenoic 
acid and docosahexaenoic acid) have increased four-fold from 0.15 to 0.6 g/day (Kris-
Etherton et al., 2000).  The essential nature of FAs are well documented in a study 
performed with rats, where rats on a fat-free diet showed no growth or reproduction 
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(Holman, 1971). Both linoleic acid (omega-6 fatty acid) and α-linolenic acid (omega-3 
fatty acid) have been classified as essential for humans (Burr and Burr, 1930).  More 
recently, arachidonic acid and docosahexaenoic acid have also been recognised for 
their importance in human development (Connor et al., 1992).  Docosahexaenoic acid 
(DHA) is one of the major omega-3 FAs in the mammalian body along with α-linolenic 
acid and eicosapentaenoic acid (EPA).  Two of the major omega-6 PUFAs in the human 
body are linolenic acid and arachidonic acid (ARA) (Simopoulos, 2002; Solfrizzi et al., 
2005).   Linolenic (18:2n6) and α-linolenic (18:2n3) acids can be metabolized into 
longer chain polyunsaturated versions such as ARA (20:4n6) and DHA (22:6n3), 
respectively. However, it has been reported that this biosynthesis or inter-conversion 
does not provide an adequate amount for optimal neural development (Salem et al., 
1996), indicating the importance for sufficient dietary intake.  In fact, no more than 
0.2% of C-18 PUFA is effectively biosynthesised into C-22 PUFA (Pawlosky et al., 
2001). Furthermore, this very low inter-conversion rate of omega-3 has been linked 
to three other major factors: high omega-6 to omega-3 ratio, excess amounts of trans 
FAs in the diet, and enzyme cofactor deficiencies such as zinc deficiency (Hobbeln, 
2001).   
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1.2 Docosahexenoic acid (DHA) 
 
Docosahexaenoic acid (DHA) is a carboxylic acid with a 22-carbon chain with six cis 
carbon-carbon double bonds (Figure 1.1).  DHA is the longest and most unsaturated 
fatty acid.  Its third carbon from the omega end contains the first double bond, hence 
the fatty acid nomenclature 22:6 (n-3).  The trivial name of DHA is cervonic acid and 
its systematic name is all-cis-docosa-4,7,10,13,16,19-hexaenoic acid.  DHA is one of 
the main omega-3 FAs and its well conserved throughout the mammalian species 
despite dietary differences (Neuringer et al., 1988).  DHA is commonly found in the 
phospholipids of biological membranes and it is a primary structural component of 
membrane phospholipids at synapses, in retinal photoreceptors (Lukiw et al., 2005), 
and also in testis and sperm (Neuringer et al., 1988).  In adult rats’ brain, DHA 
comprises approximately 17% of the total FA weight and in the retina it’s as high as 
33% (Hamano et al., 1996).  DHA is believed to have played a major role in the 
evolution of the modern human, and in particular the well-developed brain (Crawford 
et al., 1999).   
 
The effects of dietary FAs and their deficiencies have been well studied and 
documented.  Furthermore, a potential protective effect from coronary heart disease 
(McLennan PL, 1992), and a critical role in  immune response, gene expression, and 
intercellular communication have also been linked to PUFA levels (Hobbeln, 2001).  
Mainly, omega-3 FAs are known to be vital in prevention of fatal ventricular 
arrhythmias (Nair et al., 1997).   
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Figure 1.1: DHA Structure 
DHA's structure is a carboxylic acid with a 22-carbon chain and six cis double bonds 
with the first double bond located at the third carbon from the omega end. 
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Omega-3 FAs are also known to reduce thrombus formation propensity by decreasing 
the platelet aggregation, blood viscosity and fibrinogen levels (Simopoulos, 1991).  
Many brain related disorders such as depression (Hibbeln, 1998), bipolar (Stoll, 1999) 
and unipolar (Nemets et al., 2002) disorders, impairments in learning ability 
(Yamamoto et al., 1987), schizoaffective disorders (Fenton et al., 2001), dementia 
(Sandra Kalmijn, 1997) and Alzheimer’s disease (Conquer et al., 2000) have all been 
linked to omega-3 deficiency, suggesting its importance in cognitive functions and 
health.  Furthermore, conditions such as vision impairment, diabetes, arthritis, cancer 
proliferation (Connor, 2000), dermatitis, growth retardation, and reproductive failure 
(Holman, 1971) have also been shown to correlate with omega-3 deficiency.        
 
 
1.3 Zinc and life 
 
1.3.1 Zinc 
 
Zinc is a trace element indispensable for life and is the second most abundant trace 
element in the body (Weiss et al., 2000).  Zinc is known to be related to growth, 
development, differentiation, immune response, receptor activity (Vallee and 
Falchuk, 1993), gene expression, DNA synthesis, enzymatic catalysis, hormonal 
storage and release, tissue repair, neurotransmission, memory, the visual process 
(Chai et al., 1999) and many other cellular functions too numerous to list.  The 
indispensability of zinc to the body can be discussed in many other aspects;  including 
as a component of over 300 different enzymes (Wallwork, 1987), as an integral 
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component of a metallithioneins (Kagi et al., 1961), or  a gene regulatory protein 
(Hanas et al., 1983).  Approximately 3% of all proteins contain zinc binding motifs 
(Frederickson et al., 2005a).  The broad functional capability of zinc is thought to be 
due to its usually stable chemical and physical properties (Vallee and Auld, 1990).  
Zinc is thought to have three different functions in enzymes: catalytic, coactive and 
structural (Vallee and Auld, 1992).  Indeed, it is the only metal that can be found in 
all six different subclasses of enzymes (Cai and Chou, 2005; Vallee and Falchuk, 1993).  
In the mammalian body zinc is mainly localised in the brain where it is at around 
150μM in concentration (Wallwork, 1987).  However, free zinc in the mammalian 
brain is calculated to be around 10 to 20nM (Frederickson et al., 2005a), and the rest 
exist as either protein, enzymes or nucleotide bound (Vallee and Falchuk, 1993).  The 
brain and zinc relationship is thought to be mediated through glutamate receptors 
(Smart et al., 1994), and zinc is known to inhibit both inhibitory and excitatory 
receptors (Frederickson et al., 2005a).  Vesicular localization of zinc in presynaptic 
terminals is a characteristic feature of brain zinc and its release is dependent on 
neural activity (Weiss et al., 2000).   
 
Moreover, high zinc concentration is linked with neurodegenerative disorders such 
as Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS) (Weiss et al., 
2000).  The relationship between zinc and AD has been interpreted in several ways.  
One of the studies has proposed that β-amyloid has greater propensity to form 
insoluble amyloid in the presence of high physiological zinc levels (Bush et al., 1994b).  
Insoluble amyloid is thought to promote plaque formation, which is a main 
pathological feature of AD (Hyman, 2005).  Further studies have shown that chelation 
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of zinc ions can deform and disaggregate the plaque (Cherny et al., 2001; Stoltenberg 
et al., 2005a).  In AD, the most prominent injuries can be found in hippocampal 
pyramidal neurons, acetylcholine containing neurons in the basal forebrain, and in 
somatostatin-containing neurons in the forebrain (Weiss et al., 2000).  All these 
neurons are known to favour rapid and direct entry of zinc in high concentrations (Yin 
HZ, 1994), allowing frequent exposure  to zinc in high dosages.  This is thought to 
promote neuronal cell damage through oxidative stress and mitochondrial 
dysfunction (Weiss et al., 2000). 
 
 
1.3.2 Zinc in the brain 
 
In the mammalian body, the highest concentration of zinc is found in the adult brain, 
which is about 150μM (Wallwork, 1987).  However, free zinc in the mammalian brain 
is thought to be around 10 to 20nM (Frederickson et al., 2005b) and the rest exists 
bound to either proteins, enzymes or nucleotides (Vallee and Falchuk, 1993).  A major 
role for zinc in the brain is to regulate glutamate receptors (Smart et al., 1994), where 
zinc is able to increase the activity of  both inhibitory and excitatory types of receptors 
(Frederickson et al., 2005b).  In the central nervous system, zinc has an additional role 
as a neurosecretory product or cofactor.  Vesicular localization of zinc in presynaptic 
terminals is a characteristic feature of brain-zinc and its release is dependent on 
neural activity (Weiss et al., 2000).   
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1.3.3 Alterations of zinc metabolism  
 
The importance of zinc for the human body is readily identified by studying the wide 
range of pathological effects of zinc deficiency.  Anorexia, embryonic and postnatal 
growth retardation, alopecia, skin lesions, difficulties in wound healing, increased 
haemorrhage tendency and severe reproductive abnormalities, emotional instability, 
irritability and depression are just some of the many diseases linked to an altered zinc 
metabolism in the body (Ackland and Michalczyk, 2006; Aggett, 1983; Halsted, 1972; 
Smart et al., 1994; Vallee and Falchuk, 1993; Wallwork, 1987).  Proper development 
and function of the central nervous system is also dependent on zinc levels.  Growth 
retardation and impaired development of CNS tissues have been associated with low 
levels of zinc (Dreostl, 1983).  Peripheral neuropathy, spina bifida, hydrocephalus, 
anencephalus (Hurley, 1981), epilepsy and Pick's disease (Frederickson, 1989), have 
also been linked to zinc deficiency. 
 
In addition to zinc deficiency causing much damage to the body, excessive amounts 
of zinc can also lead to significant adverse effects.  Neurotoxicity and neuro-
degeneration are widely seen with exposure to excessive amounts of zinc.  Using 
mouse neuronal cells, it has been shown that 24 hour exposure to 40μM of zinc was 
sufficient to degenerate cells (Sheline et al., 2000b). The translocation of zinc from 
presynaptic to postsynaptic neurons is the main mechanism suspected to be involved 
in neurotoxicity (Weiss et al., 2000).  This zinc translocation is responsible for inducing 
the cell injuries encountered in conditions such as brain trauma (Suh, 2000), epilepsy 
and transient global ischemia (Weiss et al., 2000).  Using an intraventricular injection 
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of metal chelator, it has been shown that edetate calcium disodium (CaEDTA) blocked 
the postsynaptic accumulation of zinc, and thereby markedly reduced the neuronal 
death (Koh et al., 1996; Suh, 2000).  Excessive zinc is also capable of inhibiting Ca2+ 
and Na+ voltage gated channels (Akaike, 1989; Ravindran et al., 1991; Winegar and 
Lansman, 1990). Moreover, prolonged exposure to higher concentrations of zinc has 
been shown to induce cell necrosis (McGowan et al., 1994).  Another mechanism 
through which zinc toxicity may work is by inhibiting glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), resulting in a decrease production of ATP in neuronal cells, 
and ultimately cell death (Sheline et al., 2000b).  Furthermore, increased levels of zinc 
have been found to up-regulate cellular levels of reactive oxygen species (ROS) (Kim 
et al., 1999a). Elevated ROS levels can be directly detrimental to cell survival by 
damaging key macromolecules such as nucleic acids, proteins and lipids, and 
subsequently cause rapid cell death.  In a recent study, cultured mouse cortical and 
cerebellar granule cells died via apoptosis in response to high zinc concentrations 
(Kim et al., 1999c; Manev et al., 1997).   
 
 
1.4 Zinc transporters 
 
As described above, deficient or excessive amounts of zinc in the body can be 
extremely catastrophic to the integrity of biochemical and biological systems.  Thus, 
this indicates the necessity of an appropriate and sophisticated homeostatic 
mechanism.  Primarily, this is done by the gastrointestinal system by controlling the 
absorption, execration and the distribution of zinc (Krebs, 2000), though the 
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hydrophilic and high charge molecular characteristics of zinc are not favourable for 
passive diffusion across cell membranes (McMahon and Cousins, 1998).  Thus, most 
if not in all zinc movement across cell membranes are known to occur via inter-
membrane zinc transporter proteins (Kambe et al., 2004b).  These transporters are 
mainly categorized under two metal–transporter families; Zip (ZRT, IRT – like 
proteins) and CDF/ ZincT (Cation diffusion facilitator) (Kambe et al., 2004b). Both 
families are also known as SLC (Solute Linked Carrier) gene families: ZincT (SLC30) and 
Zip (SLC39) (Liuzzi and Cousins, 2004b).   
 
The SLC 30 family facilitates zinc efflux from the cytosol to the extracellular matrix or 
into the lumen of intracellular compartments, thus decreasing intracellular zinc 
availability.  Conversely, the SLC39 family facilitates the opposite mechanism: Zinc 
influx to the cytosol, either from the extracellular matrix or from intracellular 
compartments.  ZincT1 was the first mammalian zinc transporter to be identified, in 
an experiment with rat kidney cDNA (Findley, 1995).  Since then, more than 100 
different members of at least 9 known zinc transporters, and around 86 members of 
15 known Zip transporters have been identified in human cells (Liuzzi and Cousins, 
2004b). In addition, a “Nramp” family of metal-ion transporter, divalent cation 
transporter1 (DCT1), is also suspected to be involved in zinc transportation (Gunshin 
H, 1997).  Apart from the recent rapid enhancement in the knowledge of these 
transporters, the exact molecular mechanism of zinc metabolism is yet to be 
understood. 
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1.4.1 SLC30 (ZnT) family 
 
Members of the SLC30 family are putative facilitators of zinc efflux from the cytosol 
to the extracellular environment or into luminal compartments such as secretory 
granules, endosomes and synaptic vesicles, thus decreasing the intracellular zinc 
availability (Figure 1.2).  The predicted protein structure of this family consists of six 
membrane-spanning domains, a large intracellular loop, and the amino and carboxyl 
termini are both localized to the cytoplasmic side (Figure 1.3).  Between the IV and V 
transmembrane domains, there is a histidine rich intracellular loop, which is common 
for this family.  The predicted protein sizes are around 40 to 60 kDa (Palmiter, 1995b) 
for this family.  The ZnT1 gene cloned from a rat kidney cDNA library was the first 
mammalian zinc transporter to be identified (Palmiter, 1995b).   More than 100 
different members have now been identified in the ZnT family (Gaither, 2001), and 
out of these at least 9 are known to be present in human cells.    
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Figure 1.2: Putative cellular localization of the different human zinc transporters. 
Arrows indicate the direction of zinc (Zn2+) transport by the appropriate putative zinc 
transporters (i.e. Zip1- Zip4 and ZnT1- ZnT7). 
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Figure 1.3: Predicted structure of the SLC30 family members.  
Key amino acid residues highlighted include leucine (L) on the amino or N-terminal 
(NH2) half and the histidine (H) rich loop on the carboxyl or C-terminal half of the 
molecule.  Arrow indicates the direction of zinc movement from the membrane by 
the putative zinc transporters.      
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1.4.2 SLC39 (ZIP) family 
 
Members of the SLC39 family facilitate zinc influx into the cytosol, either from the 
extracellular environment or from intracellular compartments (Figure 1.2).  The 
identification of this transporter family was a result of gene alignment of known ZRT1, 
IRT1-like protein transporters in plants, yeast and human GenBank sequences 
(Gaither and Eide, 2000).  Most members of this family contain eight trans-membrane 
domains and a long cytoplasmic histidine rich loop between domains III and IV.  This 
loop is thought to facilitate zinc transportation by binding to zinc molecules.  In the 
ZIP family, both the amino and carboxyl termini are on the extracellular or luminal 
side (Eide, 2004). Predicted protein sizes for this family are around 30 to 40 kDa (Eide, 
2004). Currently, about 86 ZIP family members have been identified and 15 of these 
are known be present in human cells (Liuzzi and Cousins, 2004a).  
 
 In addition to these two families, the “Nramp” family metal-ion transporters, 
divalent cation transporter1 (DCT1) (Gunshin H, 1997), metallithioneins, ATP-binding 
cassette (ABC) transporters (Dean, 2001), P-type ATPases (Thelwell et al., 1998) and 
iron regulated-like proteins (IRT1) (Smith et al., 2006) are also suspected to be 
involved in zinc transportation across organisms.  Despite the recent rapid increase 
in knowledge of these transporters, many aspects of the molecular mechanisms of 
zinc metabolism are yet to be understood. 
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Figure 1.4: Predicted structure of the SLC39 family members.  
The amino acid residue highlighted on the diagram is histidine (H), which is rich in the 
loop between domains III and IV of the molecule.  Arrow indicates the direction of 
zinc movement from the membrane by the putative zinc transporters.      
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1.5 Alzheimer’s disease (AD)   
 
1.5.1 History and pathology of AD 
 
AD is a neurodegenerative disorder that was first described by the German physician, 
Alois Alzheimer and his colleagues in 1906 (Rainulf, 1995).  Studies done on Augusta 
Deter, a patient who showed distinct behavioural changes, lead to this remarkable 
discovery.  As described by Dr. Alzheimer, AD is characterised by a progressive pre-
senile dementia with general cortical atrophy (Rainulf, 1995).  Gradually increasing 
memory loss is the first symptom in many cases, and from then onwards the brain 
deterioration becomes more rapid until the patient loses their ability to perform 
almost all of the cognitive functions.  Finally, the brain stops functioning due to 
significant neuronal loss, resulting in death (Shapiro et al., 1985). The pathological 
changes of AD includes β-amyloid plaque formation, dystrophic neurites associated 
with plaques and neuro-fibrillary tangles within nerve cell bodies (Vickers et al., 
2000).  AD is known to be the most prevalent cause of progressive dementia, 
accountable for 50 - 70% of cases (Katzman, 1986).  Within 100 years of its discovery, 
much research was conducted to find a cure or a specific cause for the disease, 
however most of these studies failed to make the target, though a few made 
significant contributions (Gracious et al., 2010; Kuratko and Salem, 2009; Lien, 2009; 
Sadli et al., 2012; Shahdat et al., 2009; Suphioglu et al., 2010b).   
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1.5.2 The future of Alzheimer’s disease 
 
AD has been classified as a chronic brain disorder known to have a staggering impact 
on both the health and economic prospect of the world.  More than 1 in 10 people 
over the age of 65 and almost half the population over 85 years is believed to suffer 
from AD (Wall, 2007).  Another study has estimated more than 26 million people 
worldwide suffer from AD at present.  Forecasts predict this number will more than 
quadruple by 2050 from 26 million to 106 million and an estimated huge increase in 
cost of 400% from 12.6 million to 62.8 million in Asia by 2050.  In USA alone, the 
incidence of AD is projected to rise from 5 million to 16 million. The forecast for other 
regions are: Africa, 1.3 million cases today and 6.3 million by 2050; Europe, from 7.2 
million to 16.5 million; Latin America and the Caribbean, 2 million to 10.8 million; 
Oceania, from 200,000 to 800,000 (Wall, 2007).  In USA, it’s considered to be the 
fourth leading cause of death and third most expensive disease (Evans et al., 1989).  
In addition to the huge monetary cost, the emotional and psychological impact 
associated with AD for both patients and their families are even more devastating.  
Therefore, AD is considered a significant health threat to the world, and since no 
effective cure exists, mental health research has become a national priority for many 
countries around the globe.   
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1.5.3 Predicted mechanisms for Alzheimer’s disease 
 
In the process of identifying the cause for AD, several mechanisms have been 
suggested.  These include the amyloid cascade hypothesis (Zlokovic et al., 2005), 
neurovascular hypothesis (Zlokovic, 2005), and dysregulated protein hypothesis 
(Xiao, 2005).  Also, processes such as phosphorylation of microtubule-associated 
protein τ (tau protein), oxidative stress, metal ion deregulation, inflammation and 
dysregulation of the cell cycle (Webber et al., 2005) have been identified as 
mechanisms by which the disease develops.  In addition to the above mechanisms, 
genetic links have been proposed to some cases of AD (de la Torre, 2005; Erçelen, 
2005).  However, none of these hypotheses have been proven conclusively. Despite 
its different mechanisms, the pathological features of AD have been well 
documented and the most prominent is the formation of senile plaques.  Amyloid 
beta (Aβ) is primarily responsible for the formation of these senile plaques.  This 
plaque is then thought to trigger a cascade of reactions resulting in neurotoxicity 
(Patel, 2003).  Fragmentation of the transmembrane protein APP (amyloid precursor 
protein) by the enzymes α, β and γ secretase produces Aβ.  The enzymatic cleavage 
of APP by α- secretase followed by γ is non-amyloidogenic. In contrast, β and γ 
cleavage produces β-amyloid by the amyloidogenic pathway (Wolozin, 2001).  The 
neurofibrillary tangles present in AD plaques also consist of tau protein (Robert 
Adalberta, 2007).  Hyper-phosphorylation of this tau protein has been listed as a 
causative factor in AD, along with many other candidates.  
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1.5.4 Omega-3 FA and Alzheimer’s disease 
 
The absence of omega-3 FA in the diet has been linked with the onset of AD.  
Epidemiology evidence suggests increased dietary omega-3 consumption can reduce 
or delay the risk of AD.  A recent experiment in rats has shown an increase in zinc 
transporter 3 (ZnT3) expression levels with reduced consumption of omega-3 FA.  
From this observation, the authors suggest this alteration can explain the link 
between consumption of FA with the reduced risk of dementia and AD (Jayasooriya 
et al., 2005a).  Another study suggests that omega-3 FA can decrease β-amyloid 
production, its accumulation and potential downstream toxicity, and therefore 
reduce the onset of AD (Lim et al., 2005).  In the same study, a DHA-enriched diet has 
been shown to reduce the β-amyloid production in transgenic mice by approximately 
70% and decrease the accumulation of plaques by approximately 40 to 50%.  
Moreover, this study also demonstrated that both α and β APP C-terminal fragment 
products and full length APP production was decreased due to DHA.  Short term 
administration of DHA into rats was shown to increase the transcription of a gene 
responsible for scavenging the β – amyloid proteins (Puskas et al., 2003).      
 
 
 
1.5.5 Zinc and Alzheimer’s disease 
 
The relationship between zinc and AD has been interpreted in several ways.  The 
presence of zinc in neurofibrillary tangles has been well documented and studied.  
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One study has proposed that β-amyloid has a greater propensity to form insoluble 
amyloid in the presence of high physiological zinc levels.  Insoluble amyloid is thought 
to promote the plaque formation, the main pathological feature of AD (Hyman, 
2005).  In addition, in vitro studies conducted with zinc and β-amyloid (Aβ) has shown 
that zinc can precipitate soluble Aβ into protease resistant amyloid aggregates (Bush 
et al., 1994b; Bush, 1994b).  Zinc chelation from post-mortem AD brains was shown 
to increase the solubility of Aβ proteins (Cherny R. A., 1997).  Another study 
performed using Tg2576 transgenic mice have shown the release of zinc during 
synaptic transmission to stimulate cerebral Aβ deposition (Bush, 2003).  Further 
studies have revealed that chelation of zinc ions can cause the plaque to deform and 
disaggregate (Cherny et al., 2001; Stoltenberg et al., 2005b).  These studies 
conducted using human AD brains and transgenic Tg2576 mice brains have exhibited 
high level of zinc and a link between excess amounts of zinc and the formation of 
amyloid plaques (Huang et al., 2000). Moreover, ZnT-3 knockout transgenic Tg2576 
mice have demonstrated substantially reduced levels of insoluble Aβ and reduced 
amyloid plaque formation (Lee, 2002).  These findings confirm the link between high 
levels of cytoplasmic zinc and AD.        
 
In AD, the most noticeable damage can be found in hippocampal pyramidal neurons, 
acetylcholine containing neurons in the basal forebrain and in somatostatin-
containing neurons in the forebrain (Weiss et al., 2000).  These neurons are highly 
permeable to zinc (Yin HZ, 1994), leaving neurons exposed to frequent and high 
fluctuations in zinc.  This is thought to promote neuronal cell damage through 
oxidative stress and mitochondrial dysfunction (Weiss et al., 2000).  Zinc has also 
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been shown to specifically inhibit the α-secretase cleavage of APP, which is the non-
amyloidogenic pathway, thereby increasing the propensity for AD (Roberts et al., 
1994).  In addition, a specific and saturable binding site for zinc (KA = 750 nmol/L) has 
been identified within the cysteine-rich region on the ectodomain of amyloid 
precursor proteins (Bush, 1994a).  Zinc is well conserved throughout all members of 
the APP super-family (Bush et al., 1993), and considered as being one of the most 
conspicuous metals available at physiological pH levels to precipitate Aβ (Bush et al., 
1994b).  On the other hand, metals such as copper tend to be more active in acidosis 
conditions (Atwood, 1998).  A series of studies conducted with early and late AD 
brains have shown significantly elevated levels of ZnT-1, ZnT-4 and ZnT-6 proteins 
(Lovell et al., 2006; Lovell et al., 2005; Smith et al., 2006).   These findings further 
strengthen the link between altered zinc levels in the brain and development of AD.        
 
Recently, a link between DHA dietary levels and zinc homeostasis has been revealed 
for the first time.  A study using rats has shown that dietary deprivation of DHA levels 
caused abnormal zinc metabolism via overexpression of ZnT-3 (Jayasooriya et al., 
2005a), suggesting a possible relationship between zinc levels and omega-3 
consumption in AD cases.  In summary, the studies mentioned above highlight links 
between zinc metabolism and AD; dietary omega-3 FA levels with the onset of AD; 
and also an association between DHA levels and zinc metabolism (Figure 1.5).  Thus, 
these findings suggest a possible synergistic effect, which may be present in AD.       
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Figure 1.5: Summary of key findings from literature to establish a possible link 
between DHA, zinc and AD.   
The figure indicates all the major findings from literature to establish a possible link 
between DHA, zinc and AD.  The project was based on these major findings and the 
fourth point forms the basis of the hypothesis, the increase in DHA affects zinc 
transporter expression levels in human neuronal cell cultures. 
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1.5.6 Hypothesis of the study 
 
The study is based on the hypothesis that the manipulation of DHA levels available to 
human neuronal cells will influence the zinc homeostasis through altering the zinc 
transporter expression levels.  The link between DHA levels and zinc will be examined 
using cultured human neuronal cells (SY5Y and M17), the human tetracarcinoma cell 
line (NT2) and the human skin cell line (HaCaT) as the control. 
 
 
1.5.7 Aims of the study 
  
The aims of this project are outlined as follows: 
 
x To investigate the changes in gene expression levels of zinc transporters in 
neuronal cells in response to different concentrations of omega-3 FAs and zinc 
availability using quantitative PCR (QPCR); 
x To determine the changes in levels of zinc transporter proteins with different 
doses of omega-3 and zinc levels using SDS-PAGE and immunoblotting, and 
thereby confirm the PCR results; 
x To assess the free zinc availability following DHA treatment in human cells using 
M17 and NT2.  Thus, to determine the effect of DHA on cell survival and 
homeostasis; 
x Assess the importance of these zinc transporters on cell survival and apoptosis by 
using different levels of DHA and zinc;Develop a better cell culture model for 
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neuronal research by differentiating human cell lines to display more neuronal 
properties.  
 
 
1.5.8 Project outline 
 
Four different cell lines: HaCaT, SY5Y, M17 and NT2 will be used in this study. HaCaT 
is a skin cell line, which will be used as the control cell line.  SY5Y and M17 cell lines 
are both derived from human bone marrow neuroblastoma and both exhibit 
epithelial and neuroblast morphologies (Biedler et al., 1978; Ciccarone et al., 1989).  
NT2 cells are neuronally committed human teratocarcinoma cell line (Andrews, 
1984).  The experimental plan will be to culture these four cell lines to a fully 
confluent stage and treat with 12 different treatment regimens for 4 days. Cell-
specific media supplemented with different concentrations of DHA (0, 5, 10, 20 & 40 
μg/ml) with or without zinc will be used.  All the different cell samples will be 
collected and then total RNA and total protein will be isolated.  cDNA will be 
synthesised through reverse transcription of RNA, which will be used in QPCR to 
measure any up-regulation or down-regulation of zinc transporter genes using gene 
specific primers (hZnT1 - hZnT7 & hZIP1 - hZIP4).  After this initial step, all results will 
be analysed to choose 1 zinc transporter for further studies in this project.  
 
 In the second half of the project, DHA effects on human cells will be investigated.  
Excessive amount of free zinc is considered as a biomarker for neurodegeneration.  
Thus, DHA effect on labile zinc will be assessed following DHA treatments (20 μg/ml).  
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Linoleic acid will be used to compare the specificity of the results obtained using DHA.  
The purpose of this part of the study is to analyse any neuroprotective properties 
DHA may have thus to identify a possible pathway for neuroprotection through 
omega-3 FAs. 
 
Third part of the project is to develop a methodology to differentiate human neuronal 
cells to give more neuronal properties so that it can be used in neuronal research.  RA 
will be used as the differentiation agent.  Traditional monolayer method of cell 
differentiation will be tested against the novel 3D differentiation to evaluate the pros 
and cons of each method.    
 
 
1.5.9 Significance of the study 
 
 The experiments are planned to established the effects of DHA and zinc on zinc 
transporter expression levels and ultimately on neuronal cell survival.  In conclusion, 
this study is intended to elucidate the link between dietary omega-3 FA levels and AD 
onset.  In the future, it may be possible that these results will assist in finding a 
prevention or therapeutic treatment for this debilitating disease.     
 
 
In addition, by establishing a method to differentiate human cells to give more 
neuronal properties will greatly benefit neurobiology research in general.  A cost and 
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time efficient method for cell differentiation translates to improved productivity and 
affordability in the research area in general. 
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CHAPTER 2.1: Introduction 
 
 
2.1 DHA effect on zinc transporters and cell survival 
 
The hydrophilic and high charge atomic nature of zinc is not very compatible with 
passive diffusion across the cell membrane (McMahon, 1998).  Thus, in most if not in 
all these cases, zinc movement is known to be mediated by intra-membrane proteins 
termed zinc transporters (Kambe et al., 2004a). These transporters can be 
categorized into two main metal transporter families, ZnT (Zinc transporters) family 
and ZIP (ZRT, IRT – like proteins) family.  Members of the ZnT family are putative 
facilitators of zinc efflux from the cytosol to the extracellular environment or into 
luminal compartments such as secretory granules, endosomes and synaptic vesicles,   
thus decreasing intracellular zinc availability (Kambe et al., 2004a).  ZIP transporters 
facilitate zinc influx into the cytosol, either from the extracellular environment or 
from intracellular compartments (Liuzzi and Cousins, 2004a).  In addition to these two 
main families, the “Nramp” family metal-ion transporters, divalent cation 
transporter1 (DCT1) (Gunshin H, 1997), metallithioneins, ATP-binding cassette (ABC) 
transporters (Dean, 2001), P-type ATPases (Thelwell et al., 1998), and iron regulated-
like proteins (IRT1) (Smith et al., 2006) are also supposed to be involved in zinc 
transportation across organisms.   
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DHA is an omega-3 PUFA found predominantly in marine and plant oils.  Mammals 
cannot produce adequate amounts of omega-3 FAs through biosynthesis or inter-
conversion (Salem et al., 1996).  Thus, sufficient dietary intake is vital for many 
biological processes such as brain development, brain function and vision (Connor et 
al., 1990; Gamoh et al., 2001; Ikemoto et al., 2001; Kyle et al., 1999; Mitchell et al., 
1998; Suzuki et al., 1998).  Effects of DHA deficiency are well studied and 
documented.  Hearing and vision impairments (Bourre, 2004),  depression (Logan, 
2004), deficits in learning ability, cystic fibrosis, unipolar depression and 
cardiovascular diseases (Horrocks and Yeo, 1999) are just some disorders known to 
be associated with DHA deficiency.  Neurodegenerative disorders such as AD and 
Parkinson are also linked with DHA deficiency (Bousquet et al., 2011; Bousquet et al., 
2008; Calon and Cole, 2007).  Studies done with rats have shown a link between zinc 
homeostasis and DHA intake.  DHA deficient rats have shown a decrease in plasma 
zinc levels and modified brain zinc distribution (Jayasooriya et al., 2005b).  More 
importantly, DHA deficient rats also exhibit increased ZnT3 zinc transporter 
expression levels (Jayasooriya et al., 2005b).    
 
Both labile Zn2+ levels in a cellular system and DHA availability are linked with 
neuronal cell death.  Increased free zinc levels are associated with 
neurodegeneration (Mocchegiani et al., 2005).  When cortical neurons were exposed 
to zinc, cells displayed widespread degeneration within 15 minutes (Koh and Choi, 
1994).  DHA on the other hand had a protective effect on serum-starved rodent 
neural cells (Kim et al., 2000). 
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Though, a possible link between DHA and zinc is widely discussed the molecular basic 
of this link remains unknown.  Hence, this study intends to establish the effects of 
DHA and zinc on zinc transporter expression levels and zinc metabolism, specifically 
in relation to cell death through apoptosis. 
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CHAPTER 2.2: Materials & Methods 
 
 
2.2.1 Cell culture and treatments 
 
2.2.1.1 Cell line and cell culture 
 
The human neuroblastoma cell lines BE(2)-M17, SH-SY5Y, human teratocarcinoma 
cell line NT2 and human skin (keratinocyte) cell line HaCaT, which were used in these 
experimental studies, were obtained from Professor Leigh Ackland, Centre for 
Cellular and Molecular Biology, Deakin University, (VIC, Australia).   
 
HaCaT, the skin cell line was used as a control cell line to validate the neuronal 
specificity of the results obtained from this study.  HaCaT cells were originally isolated 
from a melanoma of a sixty two year old male patient, and display an aneuploid 
karyotype with distinctive stable marker chromosomes indicating monoclonal origin 
(Boukamp, 1988).   HaCaT cells were grown in Dulbecco’s Modified Eagle’s Medium 
(DMEM) with 10% heat inactivated foetal bovine serum (FBS).   SH-SY5Y is a thrice-
cloned sub line originally derived from a bone marrow biopsy from a four year old 
female in 1970 (Biedler et al., 1978).   This cell lines was grown in Roswell Park 
Memorial institute 1640 (RPMI) medium supplemented with 20% heat inactivated 
FBS. BE(2)-M17 is a twice cloned cell line, which originated from a bone marrow of a 
two year old male patient with disseminated neuroblastoma (Ciccarone et al., 1989). 
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These cells were cultured in OPTI-MEM (modified Eagles Minimum Essential 
Medium) with 2.5% heat inactivated FBS.  The Ntera 2/D1 (NT2) is a neuronally 
committed human teratocarcinoma cell line and was grown in Dulbecco's modified 
Eagle medium (DMEM) with 10% heat inactivated FBS. 
 
All four cell lines were grown as monolayers in 75 cm2 Nunc® EasYFlasks™ (Invitrogen, 
Melbourne, Australia) and incubated at 37ºC in a humidified atmosphere of 5% CO2.   
When monolayers reached confluence, cells were rinsed once with phosphate-
buffered saline (PBS), then rinsed again with 0.05% Trypsin 
/ethylenediaminetetraacetic acid (EDTA) solution (Sigma-Aldrich, Sydney, Australia), 
and finally incubated with Trypsin/EDTA at 37ºC for approximately 5 minutes (min) 
for cells to be detached from the flask and from each other, and viewed under light 
microscopy (Olympus CK40).  Suspension was pipetted up and down, to further break 
up cells, and divided into fresh media containing flasks, according to divisional needs 
(Table 2.1). 
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Table 2.1: Cell culture media and divisional needs. 
RPMI (Roswell Park Memorial Institute 1640 medium), was supplemented with 20% 
of heat inactivated foetal bovine serum (FBS).  DMEM (Dulbecco's Modified Eagle's 
Medium), was supplemented with heat inactivated FBS at 20%.  OPTIMEM is a 
modified MEM (Eagle’s) media, supplemented with 2.5% heat inactivated FBS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell 
line
Media %  
FBS
Passages 
(per 
week)
Feeds     
(per 
week)
%
Trypsin
Proportion of cells 
to split in new 
flask
HaCat DMEM 10 1 1 0.05 1:20
SY5Y RPMI 20 1 - 0.025 1:20
M17 OPTI-MEM 2.5 1 - 0.025 1:20
NT2 DMEM 10 1 - 0.025 1:20
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2.2.1.2 Omega-3 fatty acid (DHA) and zinc treatments 
 
Cells were treated with five different doses of DHA and with or without Zinc (Figure 
2.1) therefore, for each cell line 10 flasks were used.  First of all, 4 flasks from each 
cell lines were grown to confluence, and then harvested into 50 mL Falcon tubes and 
diluted with five times the volume of appropriate media.  Then 50 μL of this cell 
suspension was combined with equal volume of trypan blue and cells per a unit 
volume were counted using a haemocytometer under light microscope using Hoskins, 
Meynell and Sanders (1956) method.  Following that, for each cell line 10 flasks were 
seeded with one million of cells and allowed to grow to confluence (approximately 2 
to 3 days).  While waiting, DHA and with or without zinc containing stock solutions of 
media were made according to Table 2.2.  The stock solutions were incubated at 37ºC 
overnight on an orbital rotator.  This was to allow DHA to conjugate with proteins in 
the media to ensure maximum delivery into the cells.  These stock solutions were 
then used to make each treatment regime (Table 2.3) and were refrigerated until 
further use. 
 
When cells were about 100% confluent, old media was replaced by 20 mL of 
appropriate media and left for two days before harvesting.   
 
 
 
 
 
Chapter 2.2: Materials & Methods 
35 | P a g e  
Figure 2.1: Cell culture treatment regimes. 
Cells from each cell line were grown to 100% confluence and then treated with 
different doses of DHA (0, 2.5, 5, 10, 20 and 40μg/mL) and with or without zinc 
treatments for two days.  This treatment was repeated for twice and then cells were 
harvested for further studies.  The cell specific media which cells were grown in are 
indicated in the figure as well: (HaCaT – DMEM, SY5Y – RPMI, M17 – OPTI MEM).   
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Table 2.2: Stock solutions for DHA treatments 
Stock solutions for DHA treatments were prepared according to the table prior 
dividing to each treatment regimes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Volume 
(mL)
DHA stock  
(μg/mL)
ZnCl2
(μM)
DMEM 90 160 -
90 160 10
RPMI 45 80 -
45 80 5
OPTI-MEM 45 80 -
45 80 5
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Table 2.3: Different DHA regimes 
The treatment regime indicated in the table is for one cell line.  As it shows each cell 
line had 10 different treatment regimes, therefore altogether 40 regimes for 4 cell 
lines.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment 
Number
DHA
(μg/mL) Zn
1 0 -
2 2.5 -
3 5 -
4 10 -
5 20 -
6 0 +
7 2.5 +
8 5 +
9 10 +
10 20 +
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2.2.1.3 Harvesting of cells 
 
Cells were harvested using the method stated in “cell line and cell culture” (2.1.1) 
section described above.  Then, each of the cell-trypsin solutions was poured into 15 
mL Falcon tubes and diluted with five times the volume of appropriate media.  Cell 
count was performed using 50 μL of cell suspension and trypan blue.  Rest of the 
samples were then centrifuged for 5 mins at 1,000 X g.  The pellet was resuspended 
in 3 mL of PBS, pipetted up and down to homogenise, and separated into three 1 mL 
aliquots.  These aliquots were centrifuged for 5 mins at 16,000 X g, the supernatant 
was discarded and the cell pellets drained and stored at -80° C. 
 
 
2.2.2 Quantification of zinc transporter gene levels 
 
2.2.2.1 Total RNA isolation 
 
Total RNA isolation was performed from cell pellets from all the four cell lines using 
Silica Membrane RNeasy Mini Kit (QIAGEN, Doncaster, VIC) following the 
manufacturer’s instructions.    During the whole process, extreme care was taken to 
prevent any contamination (i.e. RNase contamination) with the use of gloves, 
goggles, aerosol barrier tips, dedicated RNA bench and pipettes.   
 
In brief, cells were first disrupted by adding 350 μL of reducing agent β- 
mercaptoethanol (β-ME) and buffer RLT mix (10 μL of β-ME for every 1 mL of RLT).  
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Samples were first mixed thoroughly by pipetting up and down.  Then, the samples 
were homogenized using 21G (gauge) needles with an RNase free syringe.    After 
that, 350 μl of 70% ethanol was added to each sample and mixed by pipetting.   Whole 
mixture from each sample was then transferred to RNeasy silica gel membrane mini 
columns, which were placed in 2 mL collection tubes.    Tubes were centrifuged at 
10,000 X g for 15 seconds (s) and the flow through was discarded.   Then 350 μl of 
buffer RW1 was added to the columns and again spun for 15 s at 10,000 X g.  The flow 
through was again discarded and then this was followed by another centrifugation 
for 15 s at 10,000 X g.  The flow through was discarded.  An additional step of on-
column DNase-I digestion was carried out according to the instructions listed in the 
same protocol to ensure the removal of all contaminating DNA.  First, DNase stock 
solution was prepared by adding 550 μL of RNase free water to DNase-I powder.  
Then, 10 μL of this DNase stock solution and 70 μL RDD buffer was delivered directly 
onto each RNeasy silica membrane and incubated at room temperature for 15 mins.  
After the incubation, 350 μL of buffer RW1 was added to each tube and centrifuged 
for 15 s at 10,000 X g, and the flow through was discarded.  500 μL of RPE solution 
was added to the columns and then centrifuged for 2 mins at 10,000 X g, the flow 
through was discarded.  The columns were centrifuged for a further 1 min at 10,000 
X g to dry.  The RNeasy columns were then transferred to a new 1.5 mL collection 
tube and 50 μL of RNase free water was delivered to the membrane.  The tubes were 
centrifuged for 1 min at 10,000 X g to elute RNA.  RNA concentrations and quality 
were estimated using a DU 530 Life Science UV spectrophotometer (Beckman, 
Melbourne, Australia) at 260/280 wavelengths. Total RNA was standardised to 5,000 
ng/μL for cDNA synthesis. 
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2.2.2.2 cDNA synthesis 
 
Total RNA was reverse transcribed to cDNA using StrataScript Reverse Transcriptase 
kit (Stratagene, La Jolla, California) following the manufacturer’s instructions.  In 
brief, into nuclease-free microcentrifuge tubes, 10 μg of total RNA from each sample, 
3 μL of 100 ng/μL random primers and diethylpyrocarbonate (DEPC) treated water to 
a final volume of 50 μL were added.  Then the tubes were placed into heat block set 
at 65ºC for 5 min, and then allowed to cool to room temperature.  Subsequently into 
each tube, 5 μL of 10× StrataScript buffer, 1 μL of 40 U/μL RNase Block (ribonuclease 
inhibitor), 2 μL of 100 mM dNTP mix and 1-2 μL of 50 U/μL StratScript reverse 
transcriptase were added.  The tubes were mixed gently by inversion and then 
incubated for 1 h at 42ºC, followed by 5 min at 90ºC.  The transcribed cDNA was then 
frozen away at -20ºC until needed.     
 
 
 
2.2.2.3 Quantitative PCR (Q-PCR) 
 
Reverse transcribed cDNA from each cell line and treatment were used in real time 
PCR.   Amplification reactions were performed with 1 × SYBR Green PCR Master Mix 
(Applied Biosystem, Warrington, UK), 3 μM of forward and reverse primers for Znt 1-
7, Zip 1-4 and GAPDH (Table 2.4) and 20ng cDNA from each sample.   Samples were 
analysed in triplicate in 20μl total volume per well using GeneAmp 5700 Sequence 
Detection System (PE Biosystems, Foster City, CA).   GAPDH was the internal control 
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used to normalize RNA quantities and efficiency of reverse transcription.  
Amplification was performed as follows: One cycle at 50°C for 2 minutes and 95°C for 
10 minutes, 45 cycles at 95°C for 15 minutes and 60°C for 60 s.  Incorporation of SYBR 
green dye into double stranded DNA produce fluorescence which would be then 
automatically detected and recorded after the elongation phase of each repetitive 
cycle.   The specificity of each reaction was determined by analysis of the melting 
point dissociation curve produced at the end of each PCR.   The abundance of each 
mRNA was measured as the cycle threshold (Ct) value, which is the cycle number 
when fluorescence level exceeds the threshold value.   The Ct values were 
automatically recorded after each reaction.   The Ct value of GAPDH was subtracted 
from the Ct value of the target gene to produce ∆Ct for each sample.   The relative 
RNA expression level of each sample was calculated using the equation 2-∆∆Ct, 
where ∆∆Ct is a difference between the treated ∆Ct and control ∆Ct.   Two types of 
PCR controls were performed to assure correct and acuate results.   First one was a 
“no-amplification control”, in which water replaced the volume of the primers.   The 
other one was a “no-template control”, which was with no cDNA.  Also all the reaction 
mixtures were prepared in bulk (master mixtures) in order to minimize pipetting 
steps therefore reducing the risk of DNA contamination and also for better accuracy.   
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Table 2.4: List of QPCR primers 
All the forward and reverse primers used in QPCR analysis of human zinc transporters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Transporter Forward primer Reverse primer
hZnT1 hZnT1-1 (20-mer) CTGGTGAACGCCATCTTCCT hZnT1-2 (19-mer) CAATCTCGTGCGGCTCGAT
hZnT2 hZnT2-1 (19-mer) GCGCTGTGGCTGTGAACAT hZnT2-2 (20-mer) GGGTTCTCCTCCTGCTGGTT
hZnT3 hZnT3-1 (18-mer) TTTGGCTGGCACCGTTCA hZnT3-2 (18-mer) GCGGACGAAGGCCAGGTA
hZnT4 hZnT4-1 (22-mer) AACCAGTCTGGTCACCGTCACTh hZnT4-2 (20-mer) CTATCCTGCCCATGGTTACG
hZnT5 hZnT5-1 (22-mer) CATGGAGCTTCTCAAGGAAGCT hZnT5-2 (23-mer) ACACCCCTCATGTTAGCATTCAT
hZnT6 hZnT6-1 (23-mer) TCCTTTTTTGGCAAGTTGTTACG hZnT6-2 (25-mer) AAGCAGGAAGCCAGTACATATCAAG
hZnT7 hZnT7-1 (19-mer) TTGCCCCTGTCCATCAAAG hZnT7-2 (22-mer) AGACCTAAACCAGCCCGAGATC
hZIP1 hZIP1-1 (22-mer) GCCCTGAGCCTAGTAAGCTGTT hZIP1-2 (23-mer) TCATCTATGGCAGCCAGGTAGTC
hZIP2 hZIP2-1 (18-mer) ATGGAGTCGCTGGCATTG hZIP2-2 (23-mer) GGCTGTGGAGTTCGAAGATATGA
hZIP3 hZIP3-1 (19-mer) GAGCCTCGGCCACATCAGC hZIP3-2 (20-mer) CTGATCCTGACCTTCCGCAA
hZIP4 hZIP4-1 (18-mer) TCAGGAGCGGGTCTTGCT hZIP4-2 (19-mer) TGCTGTGCTGCTGGAACAC
GAPDH GAPDH-1 (18-mer) CCACCCATGGCAAATTCC GAPDH-2 (21-mer) TGGGATTTCCATTGATGACAA
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2.2.3 Quantification of zinc transporter protein levels 
 
2.2.3.1 Total protein isolation 
 
Cell pellets harvested as described in section 2.1.3 above, were re-suspended in 500P 
Lysis buffer (1% sodium dodecyl sulfate (SDS) in 10 mM Tris-hydrochloric acid (HCl), 
at a pH of 6.8).  One Mini EDTA-free protease inhibitor cocktail tablet (Roche Applied 
Science, Castle Hill, NSW, Australia) was added for every 10 mL of lysis buffer prior to 
pipetting onto pellet, to prevent protein degradation.  Cells were placed on ice and 
homogenized by passaging through a Terumo 21G needle for approximately 10 times.  
Cell samples were then sonicated (40% power output, 30% duty cycle) thrice for 15 s 
with 30 s break between each sonication, using a Microson ultrasonic cell disrupter 
(Misonix Incorporated, New York, USA).  The homogenate was centrifuged at 16,000 
X g at room temperature for 10 mins, and the supernatant was collected and 
transferred to a new tube. 
 
 
 
2.2.3.2 Total protein quantification 
 
The supernatant was quantified using the Pierce BCA Protein Assay Reagent Kit 
(Perbio, Rockford, USA), according to the manufacturer’s Microplate Procedure 
instructions, adapted from Smith et al. (Smith, 1985).  Changes from this protocol 
included, reading the samples at a wavelength of 595 nm, instead of the specified 
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562 nm, and only using 10 μL of each unknown sample, hence the sample to working 
reagent ratio was 1:20 (v/v), which minimises the effects of interfering substances. 
Absorbance readings were obtained by Labsystems Multiscan Plate Reader and 
Genesis Lite 3.03 computer Software.  A standard curve was constructed using 
Microsoft Excel 2007 computer software, from the absorbance of the known bovine 
serum albumin (BSA) standards, a trendline was added and a linear equation 
calculated. The protein concentration for each sample was then calculated using this 
equation. 
 
 
 
2.2.4 Gel electrophoresis of proteins 
 
2.2.4.1 Preparing the gels 
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) technique 
was used to separate proteins according to their size.  12% SDS-Acrylamide gel 
mixture was prepared according to Table 2.5 and poured into upright gel cassettes 
(Invitrogen, Melbourne, Australia).  First, three quarters of the cassettes were poured 
with the resolving gel mixture and the top quarter was filled with deionised water 
(dH2O) and left to set for about 1 hour (hr).  Once set, the water layer was displaced 
with the stacking gel mixture up to the top.  A comb was then inserted, into each 
cassette and the gel left to set for another 1 hr.  Then the gels were sealed in airtight 
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plastic bags, with a small volume of 1× running buffer (6 g Tris, 29 g Glycine, 2 g SDS 
and dH2O water up to 2 L) to prevent dehydration and stored at 4oC until further use. 
 
 
 
2.2.4.2 Protein loading 
 
An aliquot of 40 μg of protein was loaded to each well, combined with 3.3 μL of 6× 
loading buffer and milliQ water to a total volume of 15 μL.  Before loading, each 
sample was boiled for 10 mins, allowed to cool to room temperature, and 
centrifuged for 15 s at 1,000 X g.  The samples were separated, along with 5 μL of 
Pageruler Prestained Protein Ladder Plus (Fermentas from Quantum Scientific, QLD, 
Australia) using the XCell Surelock Mini-Cell (Invitrogen, Melbourne, Australia) 
system and following the manufactures instructions.  Tanks were connected to a 
PowerPac300 (BIORAD, Gladesville, New South Wales) and protein electrophoresis 
was performed for 90 mins at 125 volts (V) in 1 × running buffer.  For each sample, 5 
gels were prepared since there were 5 zinc transporter specific antibodies available 
(hZnT1, 3 & 4, hZIP 1 & 3). 
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Table 2.5: SDS-Acrylamide gel mixture 
12% SDS- Acrylamide gel were prepared following the tabulated volumes and 
guidelines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Component 12% Resolving Gel (1.5 mm thick)
4% Stacking Gel (1.5 mm 
thick)
Milli Q 2.6 mL 2.3 mL
0.5M Tris, pH 6.8 - 1.0 mL
1.5M Tris, pH 8.8 1.9 mL -
10% SDS 77.1 μl 38.6 μl
30% Acrylamide 3.1 mL 0.5 mL
10% APS 50.3 μl 25.6 μl
TEMED 5.5 μl 6.2 μl
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2.2.4.3 Nitrocellulose membrane transfer 
 
Following electrophoretic separation, proteins were transferred to nitrocellulose 
blotting membrane (Pall, Life Sciences, Pensacola, Florida, USA) in 1× Novex Tris–
glycine transfer buffer (Invitrogen) and 10% methanol for 120 mins at 25 V using an 
XCell Surelock Mini Cell (Invitrogen, Melbourne, Australia).  Upon completion of the 
transfer, membranes were stained briefly with 1× Ponceau red (0.2 (w/v) Ponceau 
stain, 3% (w/v) trichloroacetic acid and 3% (w/v_ sulfosalicylic acid) to confirm the 
integrity of protein transfer.  Ponceau red was removed with a brief wash in 0.1 NaOH 
followed by rinsing in dH2O.   
 
 
2.2.4.4 Membrane protein detection 
 
To detect specific protein bands, membranes were blocked for 12 hrs in 5% (w/v) 
skim milk powder in Tris buffered saline (TBS) (50 mM Tris-HCL (pH 7.5), 150 mM 
NaCl) at 4ºC with gentle agitation.  Antibodies were then diluted appropriately (Table 
2.6) in 0.1% skim milk in TBS.  Membranes were then incubated with primary 
antibodies for 2 hrs in sealed bags on an orbital rotator.  Following that, membranes 
were given 2×5 mins washes in 2× TBS, then 2×10 min washes with 1× TBS (with 0.1% 
(v/v) Tween-20 (Sigma-Aldrich, St. Louis, USA) with gentle agitation.  The membranes 
were then incubated with horseradish peroxidase (HRP) conjugated anti-sheep 
secondary antibody (1 in 2,000 diluted in 0.1% skim milk in TBS) for 1hr at room 
temperature, again in sealed bags and on an orbital rotator.  After incubation, 
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membranes were given 4×10 mins washes in TBST prior to the exposure.  Proteins 
were detected using a chemiluminescence kit according to the manufacturer’s 
instructions (Roche Applied Science, Castle Hill, NSW, Australia). Membranes were 
developed using a Fujifilm Luminescent Image Analyser LAS-3000.  Densitometry to 
quantify results was performed using Fujifilm Multi Gauge V2.3 computer software.  
Then the membranes were stripped for 5-10 mins (depending on band intensity) at 
room temperature, using 1 mL of Re-Blot Plus-Strong (Chemicon International, 
Temecula, CA, USA) diluted 1:10 in Milli Q water.  In order to show equal protein 
loading, all membranes were re-probed for β-actin. Membranes were re-blocked for 
30 min in 5% (w/v) skim milk powder in TBS and incubated with β-actin primary and 
then anti-mouse secondary and exposed, then quantified following the same 
procedure as mentioned above.  
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Table 2.6: Antibodies used in the study. 
Dilution factors and the source of the antibodies used in the study and there 
secondary antibodies and the dilution factors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3ULPDU\
$QWLERG\ 6RXUFH 'LOXWLRQ 6SHFLILFW\ 6XSSOLHU 6HFRQGDU\$QWLERG\DQWL,J* 'LOXWLRQ
hZnT3 6KHHS  SRO\FORQDO $FNODQG/DE +53VKHHS 
%FO 0RXVH  PRQRFORQDO 0LOOLSRUH9LFWRULD$XVWUDOLD +530RXVH 
&DVSDVH 5DEELW  SRO\FORQDO 0LOOLSRUH9LFWRULD$XVWUDOLD +535DEELW 
ȕDFWLQ 0RXVH -DQ PRQRFORQDO 6LPD$OGULFK6W/RXLV86$ +530RXVH 
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CHAPTER 2.3: Results 
 
 
2.3.1 Zinc transporters and their expression pattern in neuronal cells 
 
2.3.1.1 Basal zinc transporter levels in human neuronal cells 
 
The expression level of zinc transporters (Zip1-4 & ZnT1-7) was tested using QPCR on 
two different human neuronal cell lines (M17, SY5Y) and a neuronally committed 
human tetra carcinoma cell line (NT2).  Human skin cell line HaCaT was used to test 
the neuronal specificity of the each transporter.  Results obtained from QPCR was 
normalised using GAPDH as the internal control.  The expression levels of these 
transporters are shown, relative to expression of hZnT3 (Figure 2.2).  The four cell 
lines expressed all the transporters tested.   
 
 
2.3.1.2 Relative zinc transporter levels in human cell lines 
 
In HaCaT cells (Figure 2.3A) the most highly expressed zinc transporters were hZnT6 
and hZnT7.   In M17 cells (Figure 2.3B), Zip3 and hZnT2 expression was very low 
compared to hZnT3 expression.  All the other transporters were about 5 to 10 fold 
higher in their expression level compared to hZnT3 levels. 
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hZnT1 was the most expressed transporter in SY5Y cells (Figure 2.3C).  hZip1, hZnT4, 
hZnT6 & hZnT7 also showed high expression levels in SY5Y cells, whilst the expression 
of the remaining transporters were very similar to the hZnT3 level with the exception 
of hZip3.  hZip3 expression was about 27 fold lower than hZnT3 levels in SY5Y cells.    
 
NT2 cells (Figure 2.3D) exhibited a very interesting expression pattern in comparison 
to other cell lines.  Apart from hZnT1 & hZnT7, all the other transporter expression 
levels were lower than hZnT3.  Of these two transporters, only hZnT1 had a 
considerable fold difference (approximately 50 fold lower) compared to ZnT3 levels. 
 
 
2.3.2 Effects of DHA and zinc on zinc transporter expression levels  
 
Real time PCR (QPCR) was performed to test the mRNA levels of zinc transporters 
hZnT1 to hZnT7 and hZIP1 to hZIP4 following DHA treatment.  The cDNA used in QPCR 
was obtained from cells which were subjected to different doses of DHA (0, 2.5, 10, 
20 & 40 μg/mL) in the presence (5 μM) or absence of zinc.  Therefore, for each cell 
line there were 10 different treatment regimes, totalling 40 for all the four cell lines.  
The cycle threshold (Ct) values obtained were used in calculating the fold difference 
and then plotted against the DHA dose.  However, Ct values which were above 30 
were not included in further calculations to ensure specificity and accuracy of the 
results.  Each experiment was repeated three times with independent sets of cells 
and only the results which are most consistent with the other two experiments are 
presented here.  In literature, an increase or decrease of more than two-fold 
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difference is considered significant (Bubner et al., 2004) and the rest is considered as 
non-specific.  Therefore, the changes below two fold difference, is presented with 
grey shading in the figures presented.  
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Figure 2.2: Expression levels of zinc transporters mRNA levels relative to ZnT3. 
Fold-difference of mRNA levels of the different putative zinc influx (Zip1-Zip4) and 
efflux (ZnT1-ZnT7) transporters measured relative to that of ZnT3 in M17, SY5Y, NT2 
& HaCaT cells.  Relative mRNA expression level is indicated according to the zinc 
transporter. 
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Figure 2.3: Relative zinc transporter mRNA levels in HaCaT, M17, SY5Y and NT2 cells 
compared to ZnT3 levels. 
Fold-difference of mRNA levels of the different putative zinc influx (Zip1-Zip4) and 
efflux (ZnT1-ZnT7) transporters measured relative to that of ZnT3 in M17, SY5Y, NT2 
& HaCaT cells.  Relative mRNA expression level is indicated according to the cell line. 
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2.3.2.1 hZnT1 
 
In HaCaT cells, without zinc, the cell response to DHA doses was not significant with 
only a slight increase in hZnT1 expression levels observed, and no obvious DHA dose 
dependent pattern was seen (Figure 2.4A).   However, in the presence of zinc the 
increase was more dose dependent except for the maximum dose, and reaching 
significance at the 20 μg/mL DHA dose (Figure 2.4B).   
 
SY5Y and M17 cells reacted in a contrasting pattern to HaCaT cells, suggesting that 
the hZnT1 expression change due to DHA is more neuronal cell specific.   In SY5Y cells 
with no zinc (Figure 2.4A), a downregulation could be seen in response to many DHA 
doses, and when in the presence zinc (Figure 2.4B) this downregulation was even 
more pronounced, being consistent across all three independent experiment sets.  
Even though a downregulation pattern could be seen with M17 cells, dose 
dependency and the consistency was lacking in comparison to SY5Y cells.  Both with 
(Figure 2.4A) and without (Figure 2.4B) zinc treatment, hZnT1 expression reached 
significance at a very limited number of doses.  
 
From the four cell lines, NT2 cells showed the most promising downregulation 
pattern in the presence of DHA treatment with no zinc (Figure 2.4A).  hZnT1 
expression at all four DHA doses reached beyond the significance threshold, and the 
changes were consistent across the triplicates.   However, when zinc was present 
(Figure 2.4B), the reaction was not consistent in response to DHA.  Downregulation 
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was most commonly seen as a response to DHA treatment with the neuronal cell lines 
and the tetra-carcinoma cell line. 
 
 
 
2.3.2.2 hZnT2 
 
The expression level of hZnT2 in all four cell lines showed a significant decrease with 
different DHA doses in the absence of zinc (Figure 2.5A).   In SY5Y cells, hZnT2 
expression was decreased with the increase in DHA dose, apart from at the DHA 40 
μg/mL dosage.   HaCaT cells showed a similar pattern of hZnT2 downregulation, 
although to a much lower extent than in SY5Y cells.  Similarly, M17 cells showed 
significant downregulation of hZnT2 at DHA 10 μg/mL dosage, but this was much 
lower than what was seen with SY5Y cells.  A dose dependent pattern was also not 
visible in SY5Y cells.  Though the levels were much lower than in SY5Y cells, NT2 cells 
showed a consistent dose dependent downregulation when treated with DHA in the 
absence of zinc. 
 
In the presence of zinc (Figure 2.5B), the downregulation of hZnT2 was more 
pronounced and higher for HaCaT cells when compared with no zinc treatment.   
However, in NT2 cells the downregulation became much less consistent and less dose 
dependent, while in SY5Y cells the downregulation was reduced.   Similarly, in M17 
cells the downregulation was reduced with the addition of zinc, resulting in an 
upregulation of hZnT2.   However, most of the Ct values for hZnT2 were relatively 
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higher than that of other transporters, and for the entire second set of experiments 
it did not produce any conclusive data.   Therefore, interpretation of hZnT2 results 
should be done with caution.   The large error bars seen in M17 cells treated with zinc 
is a result of these high Ct values.      
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Figure 2.4: hZnT1 expression levels following DHA treatment in different cell lines. 
Expression profile of hZnT1 in HaCaT, Sy5Y, M17 and NT2 cells in zinc deficient (A) 
and supplemented (B) media containing 0, 2.5, 5, 10 and 20 μg/mL of DHA, using 
QPCR analysis.  Fold differences above and beyond x5 is noted on the figure. 
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Figure 2.5: hZnT2 expression levels following DHA treatment in different cell lines. 
Expression profile of hZnT2 in HaCaT, Sy5Y, M17 and NT2 cells in zinc deficient (A) 
and supplemented (B) media containing 0, 2.5, 5, 10 and 20 μg/mL of DHA, using 
QPCR analysis.  Fold differences above and beyond x5 is noted on the figure. 
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2.3.2.3 hZnT3 
 
In HaCaT cells treated with DHA in the absence of zinc, the expression level of hZnT3 
was significantly downregulated as much as 73 fold difference compared to the DHA 
depleted cells.   This down regulation was also consistent in all DHA treatment groups 
(Figure 2.6A), where a dose dependent bell shaped curve could be seen, with the 10 
μg/mL DHA dose giving the largest downregulation.  Significant and dose dependent 
downregulation could also be seen in M17 cells (Figure 2.6A) with up to 12 fold 
difference in hZnT3 expression at the 40 μg/mL DHA dose.   In SY5Y cells (Figure 2.6A), 
the transporter expression level was not consistent or significant, except at the 
highest DHA doses where significant upregulation was detected.   In NT2 cells (Figure 
2.6A), the downregulation was very similar to M17 cells, and dose dependent when 
treated with DHA in the absence of zinc.  With higher DHA concentrations there was 
a significant downregulation in the expression levels of almost 16 fold difference.    
 
DHA plus zinc treatment (Figure 2.6B) of HaCaT cells did not give a reliable pattern 
for hZnT3 but a general upregulation trend could be seen across the triplicate 
experiments.   M17 cells followed a similar pattern (Figure 2.6B) to that of HaCaT 
cells, and addition of zinc impaired the original downregulation seen with no zinc 
treatment, to a significant upregulation with some DHA doses.   SY5Y cells showed a 
slight downregulation with the addition of zinc (Figure 2.6B), which is opposite to the 
upregulation seen in the absence of zinc (Figure 2.6A).   However, NT2 cells lost its 
consistency in the hZnT3 expression pattern when treated with both zinc and DHA 
(Figure 2.6B).  In these cells, the two middle DHA doses showed gradually decreasing 
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downregulation, which was then followed by and an upregulation at the highest 
dose.   When the four cell lines treated with DHA and zinc were compared, the 
expression patterns and levels of hZnT3 were not consistent.    However, when 
treated with DHA with no additional zinc, M17 and NT2 cells displayed a dose 
dependent significant downregulation (Figure 2.6A).   In contrast, HaCaT and SY5Y 
cells were not consistent even in the absence of zinc, suggesting that SY5Y cells may 
be behaving more like a keratinocyte cell line under these conditions with respect to 
this transporter.   
 
 
 
2.3.2.4 hZnT4 and hZnT5 
 
In HaCaT and M17 cells, hZnT4 expression was almost consistently downregulated in 
response to DHA treatment without zinc (Figure 2.7A).  In HaCaT cells, fold 
differences were significant only at 5 and 10 μg/mL DHA doses.   However, the 
downregulation seen in M17 cells were significant at 10, 20 and 40 μg/mL DHA doses 
(Figure 2.7A).   NT2 cells also showed a significant downregulation at 5, 10 and 20 
μg/mL DHA doses, but at the highest dose the fold difference could not be calculated 
due to the lack of consistency.  With zinc treatment, a downregulation pattern could 
still be seen in HaCaT cells, although the results lack a dose dependent pattern. In 
M17 cells, compared to the no zinc treatment, the level of hZnT4 downregulation was 
lower, which was closer to the non-significance threshold area in cells treated with 
most doses of DHA plus zinc (Figure 2.7B).   These changes were also seen in NT2 cells 
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apart from at one DHA dose (20 μg/mL), where a significant upregulation could be 
seen (Figure 2.7B).   SY5Y cells showed significant downregulation in hZnT4 
expression in response to all DHA doses, however these changes were not dose 
dependent (Figure 2.7B).  Moreover, all the Ct values for hZnT4 were around the mid-
twenties, indicating a positive and specific amplification pattern throughout all the 
three replicate experiments.   
 
In all the three experiment sets, no reasonable Ct values could be obtained for hZnT-
5 in any of the cell lines, so a graph is not shown for this transporter.   This may be 
due to the primers used for this transporter or very low transcript levels in the cell 
lines examined in this study. 
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Figure 2.6: hZnT3 expression levels following DHA treatment in different cell lines. 
Expression profile of hZnT3 in HaCaT, Sy5Y, M17 and NT2 cells in zinc deficient (A) 
and supplemented (B) media containing 0, 2.5, 5, 10 and 20 μg/mL of DHA, using 
QPCR analysis.  Fold differences above and beyond x5 is noted on the figure. 
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Figure 2.7: hZnT4 expression levels following DHA treatment in different cell lines. 
Expression profile of hZnT4 in HaCaT, Sy5Y, M17 and NT2 cells in zinc deficient (A) 
and supplemented (B) media containing 0, 2.5, 5, 10 and 20 μg/mL of DHA, using 
QPCR analysis.  Fold differences above and beyond x5 is noted on the figure. 
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2.3.2.5 hZnT6 
 
In HaCaT and SY5Y cells treated without zinc (Figure 2.8A), DHA doses did not cause 
much change in the expression level of hZnT6, with both cell lines being in the non-
significance zone.   In contrast, a staggering change was detected in M17 cells, where 
a significant downregulation was detected in a dose dependent manner, apart from 
at the 40 μg/mL concentration, which was the toxic level.   This downregulation was 
consistent in replicates and Ct values were again closer to mid-twenties indicating 
significance and accuracy.   NT2 cells also showed downregulation of hZnT6 at some 
DHA doses, although a consistent DHA dose dependent pattern could not be 
identified.    
 
Following zinc treatment (Figure 2.8B), downregulation of hZnT6 expression in M17 
cells was significantly reduced and this was consistent between the replicate 
experiments.   HaCaT, SY5Y and NT2 cells also did not show a significant change, 
though they showed a general downregulation pattern.  At the maximum DHA dose, 
NT2 cells reached significance where a 5 fold downregulation was observed (Figure 
2.8B). 
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2.3.2.6 hZnT7 
 
In HaCaT, M17 and SY5Y cell lines this transporter did not show a significant alteration 
in its expression in response to DHA and with or without zinc treatment (Figure 2.9A 
& 2.9B).   However, there was a significant upregulation of hZnT7 in SY5Y cells at the 
40 μg/mL DHA dose (without zinc), but this finding was disregarded as this dosage 
was toxic to some cells.   In contrast, in NT2 cells DHA treatment without zinc resulted 
in a consistent downregulation of hZnT7 (Figure 2.9A).   However, this 
downregulation was not significant.  When NT2 cells were treated with DHA plus zinc, 
a downregulation pattern was also observed, although this was not prominent or 
consistent as with the no zinc treatment group.  In all cell lines, Ct values obtained for 
this transporter were low, indicating significant and accurate amplification.    
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Figure 2.8: hZnT6 expression levels following DHA treatment in different cell lines. 
Expression profile of hZnT6 in HaCaT, Sy5Y, M17 and NT2 cells in zinc deficient (A) 
and supplemented (B) media containing 0, 2.5, 5, 10 and 20 μg/mL of DHA, using 
QPCR analysis.  Fold differences above and beyond x5 is noted on the figure. 
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Figure 2.9: hZnT7 expression levels following DHA treatment in different cell lines. 
Expression profile of hZnT7 in HaCaT, Sy5Y, M17 and NT2 cells in zinc deficient (A) 
and supplemented (B) media containing 0, 2.5, 5, 10 and 20 μg/mL of DHA, using 
QPCR analysis.  Fold differences above and beyond x5 is noted on the figure. 
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2.3.2.7 hZIP1  
 
In general, M17 cells showed an upregulation of hZIP1 expression levels with (Figure 
2.10A) and without zinc (Figure 2.10B) treatment.  Cells treated without zinc 
displayed a dose dependent pattern, although the results did not reach significance.  
NT2 cells showed a significant downregulation pattern when treated with DHA in the 
absence of zinc.  When zinc was present, the effect was reversed and the transporter 
showed an inconsistent upregulation pattern, but most of these values were not 
significant.  Likewise, HaCaT and SY5Y cells did not show any significant changes in 
hZIP1 expression with or without zinc treatment.  
 
 
2.3.2.8 hZIP2   
 
In the absence of zinc, HaCaT, M17 and SY5Y cell lines demonstrated a 
downregulation pattern for the expression of this transporter (Figure 2.11A).   Once 
again, M17 showed more significant downregulation than the other cell lines when 
treated without zinc (Figure 2.11A), and the same pattern could be seen to a lesser 
extent when treated with the combination of both zinc and DHA (Figure 2.11B).   
However, SY5Y cells treated with zinc and DHA showed an upregulation of hZip2 
(Figure 2.11B), which was the opposite of what was observed without zinc (Figure 
2.11A).  HaCaT cells did not show any significant difference in hZip2 expression in 
response to DHA and zinc.   
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Figure 2.10: hZip1 expression levels following DHA treatment in different cell lines. 
Expression profile of hZip1 in HaCaT, Sy5Y, M17 and NT2 cells in zinc deficient (A) and 
supplemented (B) media containing 0, 2.5, 5, 10 and 20 μg/mL of DHA, using QPCR 
analysis.  Fold differences above and beyond x5 is noted on the figure. 
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Figure 2.11: hZip2 expression levels following DHA treatment in different cell lines. 
Expression profile of hZip2 in HaCaT, Sy5Y, M17 and NT2 cells in zinc deficient (A) and 
supplemented (B) media containing 0, 2.5, 5, 10 and 20 μg/mL of DHA, using QPCR 
analysis.  Fold differences above and beyond x5 is noted on the figure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Chapter 2.3: Results 
72 | P a g e  
Moreover, the Ct values were substantially high for all these three cell lines indicating 
possible non-specific amplification.   
 
No reasonable Ct values could be obtained with the NT2 cell line for this transporter, 
therefore a graph is not shown.   This may be due to the absence or very low transcript 
levels of this transporter in the NT2 cells used in this study. 
 
 
2.2.9 hZIP3 and hZIP4  
 
In M17 cells, a significant downregulation of hZip3 (Figure 2.12A) was identified in 
two doses of DHA without zinc.  However, this was not dose dependent or consistent 
across all of the DHA doses.  This downregulation was more pronounced in the 
presence zinc (Figure 2.12B), and at the 20 μg/mL DHA dose a 2 fold downregulation 
was detected.   NT2 cells also showed a similar pattern to M17 cells in the DHA 
without zinc treatment groups.  However, this downregulation was more consistent 
and significant compared to M17 cells.  Results obtained for the zinc added treatment 
groups of NT2 cells were not consistent (Figure 2.12B).    
 
Although high error bars are present due to high Ct values, HaCaT cells showed an 
upregulation of hZip3 expression in DHA treatment groups without zinc (Figure 
2.12A). These error bars were much smaller in DHA plus zinc treatment groups (Figure 
2.12B).   SY5Y cells did not show any significant difference in hZip3 expression in 
response to DHA over time with or without zinc. 
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In contrast, changes in the hZIP4 expression without zinc were similar in HaCaT, M17 
and NT2 cell lines, with the exception of some DHA doses in M17 and NT2 cells (Figure 
2.13A).  In general, HaCaT, M17 and NT2 cell lines displayed downregulation without 
zinc treatment (Figure 2.13A).  With the combination of both zinc and DHA treatment 
(Figure 2.13B), HaCaT, SY5Y and NT2 cells showed upregulation in hZIP4 expression, 
but expression in M17 cells was consistently downregulated.  In the absence of added 
zinc SY5Y cells displayed an opposite trend to the other two cell lines, indicating a 
possible cell specific importance for this transporter.  However, in the presence of 
zinc it behaved more like HaCaT and NT2 cells showing an upregulation of hZIP4, 
though the values did not reach significance.   
 
Based on the results obtained from these experiments, hZnT3 was selected as the 
transporter of choice for further experiments. 
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Figure 2.12: hZip3 expression levels following DHA treatment in different cell lines. 
Expression profile of hZip3 in HaCaT, Sy5Y, M17 and NT2 cells in zinc deficient (A) and 
supplemented (B) media containing 0, 2.5, 5, 10 and 20 μg/mL of DHA, using QPCR 
analysis.  Fold differences above and beyond x5 is noted on the figure. 
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Figure 2.13: hZip4 expression levels following DHA treatment in different cell lines. 
Expression profile of hZip4 in HaCaT, Sy5Y, M17 and NT2 cells in zinc deficient (A) and 
supplemented (B) media containing 0, 2.5, 5, 10 and 20 μg/mL of DHA, using QPCR 
analysis.  Fold differences above and beyond x5 is noted on the figure. 
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2.3.3 DHA effect on cell survival 
 
The effect of DHA on cell survival was studied using four different DHA doses (0, 2.5, 
10, 40 μg/mL).   M17 cells were grown with or without supplements for 2 days and 
then tested for apoptosis end marker caspase-3 and an apoptosis regulator protein 
Bcl-2, using Western blotting.   
 
M17 cells exposed to 20 μg/mL DHA for 2 days demonstrated a marked reduction in 
caspase-3 protein levels when compared to untreated cells (Figure 2.14A).  Equal 
protein loading of the gel lanes was assessed by Western blot analysis for the 
housekeeping gene, β-actin (Figure 2.14B).   Caspase-3 protein levels were then 
normalised against the β-actin protein levels and densitometry analysis was 
performed to quantify the changes in the expression levels.  Following densitometry 
analysis, it was revealed that there was more than 66% reduction in caspase-3 protein 
levels with the 20 μg/mL DHA treatment when compared to untreated cells (Figure 
2.14C).  This reduction in the caspase-3 protein levels was significant and consistent 
across the replicates. 
 
In contrast, Bcl-2 protein levels were upregulated following DHA treatment (Figure 
2.15A) suggesting that DHA has initiated an apoptosis suppression mechanism in 
these cells.   Again, equal protein loading of the gel lanes was assessed by Western 
blot analysis for the β-actin housekeeper gene (Figure 2.15B).  Following 
normalization to the house keeping gene, densitometric analysis was performed.  
Densitometry analysis also confirmed the increase in Bcl-2 protein expression levels 
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(Figure 2.15C).   DHA treated cell lysates showed a significant increase in band 
intensity compared to untreated cells.  Quantification through densitometric analysis 
showed a 110% increase in Bcl-2 protein levels when subjected to 20 μg/mL DHA 
treatment in comparison to untreated cells.    
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Figure 2.14: Western blot analysis of Caspase-3 protein levels following DHA 
treatment in M17 cells. 
Caspase-3 protein (A) and the housekeeping gene β-actin protein (B) levels of M17 
cells cultured in the absence and presence (2.5, 10 and 40 μg/ml) of DHA were 
detected with specific antibodies. (C) Densitometric analysis of caspase-3 protein 
levels (normalised with the β -actin protein levels) are shown in arbitrary units (AU). 
Molecular mass protein markers (Mr) are indicated on the left of each gel. This result 
is representative of three similar independent experiments. 
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Figure 2.15: Western blot analysis of Bcl-2 protein levels following DHA treatment 
in M17 cells. 
Bcl-2 protein (A) and the housekeeping gene β-actin protein (B) levels of M17 cells 
cultured in the absence and presence (2.5, 10 and 40 μg/ml) of DHA were detected 
with specific antibodies. (C) Densitometric analysis of Bcl-2 protein levels (normalised 
with the β -actin protein levels) are shown in arbitrary units (AU). Molecular mass 
protein markers (Mr) are indicated on the left of each gel. This result is representative 
of three similar independent experiments. 
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2.3.4 Effects of DHA on ZnT3 protein levels 
 
The expression level of ZnT3 was analysed in extracts from HaCaT, M17, SY5Y and 
NT2 cells treated with different concentrations of DHA (0, 5, 10 and 20 μg/mL).  A 
ZnT3 transporter specific antibody was used to identify the proteins. The predicted 
band size of the proteins were identified from ExPASy database 
(http://au.expasy.org/) and by using the protein amino acid sequence from NCBI 
database (http://www.ncbi.nlm.nih.gov/).   
 
 
2.3.4.1 ZnT3 protein expression levels in M17 cells following DHA treatments 
 
ZnT3 expression was identified in the lysates of all treated M17 cells by the presence 
of a band of approximately 41.9 kDa in all lanes (Figure 2.16A).   Protein levels showed 
a dose dependent reduction when treated with DHA.  ZnT3 protein levels were 
markedly reduced in the cells exposed to 20 μg/ml DHA, when compared with the 
untreated cells.  To ensure equal lane protein loading of the gels, protein levels of the 
β-actin housekeeping gene were assessed (Figure 2.16B).   When the ZnT3 protein 
levels were normalised with the β-actin protein levels, densitometry analysis 
revealed more than 55% reduction in ZnT3 protein levels with the 20 μg/ml DHA 
treatment when compared with the untreated cells (Figure 2.16C).   
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Figure 2.16: ZnT3 protein levels following DHA treatment in M17 cells. 
ZnT3 protein (A) and the housekeeping gene β-actin protein (B) levels of M17 cells 
cultured in the absence and presence (2.5, 10 and 40 μg/ml) of DHA were detected 
with specific antibodies. (C) Densitometric analysis of ZnT3 protein levels (normalised 
with the β -actin protein levels) are shown in arbitrary units (AU). Molecular mass 
protein markers (Mr) are indicated on the left of each gel. This result is representative 
of three similar independent experiments. 
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2.3.4.2 ZnT3 protein expression levels in SY5Y cells following DHA treatments 
 
ZnT3 expression was identified by the presence of a band approximately 41.9 kDa in 
size in all lanes containing lysates of treated SY5Y cells (Figure 2.17A).  The β-actin 
housekeeping gene levels were assessed to ensure equal protein loading (Figure 
2.17B), followed by a densitometric analysis to quantify the changes (Figure 2.17C).  
Densitometric results obtained with SY5Y cells were not significant or consistent.  
These protein results were in line with the QPCR results for SY5Y cells. 
 
 
2.3.4.3 ZnT3 protein expression levels in HaCaT cells following DHA treatments 
 
All treated HaCaT cells were identified to express ZnT3 by the presence of a band of 
approximately 41.9 kDa in size (Figure 2.18A).  Following normalisation using β-actin 
as the housekeeping gene (Figure 2.18B), the results showed a decrease in ZnT3 
expression with some DHA doses.  Densitometric results also showed a decrease in 
ZnT3 protein levels (Figure 2.18C) at 5 & 10 μg/mL DHA doses.  However, this 
decrease was reversed at the 20 μg/mL DHA concentration, where a similar level of 
expression as the untreated cells was detected for ZnT3 protein.  Changes in ZnT3 
expression was not dose dependent between the replicates. 
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Figure 2.17: ZnT3 protein levels following DHA treatment in SY5Y cells. 
ZnT3 protein (A) and the housekeeping gene β-actin protein (B) levels of SY5Y cells 
cultured in the absence and presence (2.5, 10 and 40 μg/ml) of DHA were detected 
with specific antibodies. (C) Densitometric analysis of ZnT3 protein levels (normalised 
with the β -actin protein levels) are shown in arbitrary units (AU). Molecular mass 
protein markers (Mr) are indicated on the left of each gel. This result is representative 
of three similar independent experiments. 
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Figure 2.18: ZnT3 protein levels following DHA treatment in HaCaT cells. 
ZnT3 protein (A) and the housekeeping gene β-actin protein (B) levels of HaCaT cells 
cultured in the absence and presence (2.5, 10 and 40 μg/ml) of DHA were detected 
with specific antibodies. (C) Densitometric analysis of ZnT3 protein levels (normalised 
with the β -actin protein levels) are shown in arbitrary units (AU). Molecular mass 
protein markers (Mr) are indicated on the left of each gel. This result is representative 
of three similar independent experiments. 
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2.3.4.4 ZnT3 protein expression levels in NT2 cells following DHA treatments 
 
ZnT3 expression was also identified in lysates of NT2 cells.  All the lanes with different 
DHA doses displayed a band of approximately 41.9 kDa in size (Figure 2.19A).  A 
reduction in the band intensity was visible with increasing DHA dose.   The expression 
levels were normalized to the house keeping gene β-actin and lane loading was also 
normalized using the house keeper gene (Figure 2.19B).  Results were quantified 
using densitometric analysis (Figure 2.19C).   Approximately a 9 fold decrease was 
present in protein expression levels between untreated and 20 μg/mL DHA treated 
cells.  This decrease was significant and displayed a dose dependent pattern similar 
to M17 cells. 
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Figure 2.19: ZnT3 protein levels following DHA treatment in NT2 cells. 
ZnT3 protein (A) and the housekeeping gene β-actin protein (B) levels of NT2 cells 
cultured in the absence and presence (2.5, 10 and 40 μg/ml) of DHA were detected 
with specific antibodies. (C) Densitometric analysis of ZnT3 protein levels (normalised 
with the β -actin protein levels) are shown in arbitrary units (AU). Molecular mass 
protein markers (Mr) are indicated on the left of each gel. This result is representative 
of three similar independent experiments. 
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2.3.5 DHA effect with and without vitamin E on the ZnT3 transporter 
 
DHA is known to be a highly oxidative substance.   Thus, DHA effects on a culture 
system may not be effective for the entire incubation time.   In these instances, 
vitamin E can be used as a free radical scavenger to enhance the effects of DHA on 
cells.  
 
 
2.3.5.1 Vitamin E working concentration 
 
Firstly, three different vitamin E doses were tested to find the optimal working 
concentration of vitamin E for further studies.   M17 cells were incubated for 2 days 
with vitamin E (0, 0.5, 0.05, 0.005 mol/L) and DHA (20 μg/mL). Following treatments, 
QPCR was performed to test the influence on ZnT3 transporter levels.   When there 
was DHA present, ZnT3 expression was significantly downregulated at all three 
vitamin E doses (Figure 2.20).   However, at the 0.5 mol/L vitamin E concentration 
some cells started dying suggesting this dosage is closer to the toxic level.   Therefore, 
the middle dose of 0.05 mol/L vitamin E was selected for further experiments. 
 
 
2.3.5.2 ZnT3 mRNA expression levels with DHA and vitamin E 
 
Following DHA treatment with vitamin E, ZnT3 mRNA levels in M17 cells were 
analysed using QPCR.  M17 cells were treated with four different DHA concentrations 
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(0, 5, 10, 20 and 40 μg/mL) for 2 days with 0.05 mol/L vitamin E and then tested for 
changes in ZnT3 expression.   Results obtained were normalised using the internal 
control GAPDH and presented relative to expression level in untreated cells.   Both 5 
and 10 μg/mL DHA doses showed a significant downregulation of more than 80 fold 
in ZnT3 expression (Figure 2.21).   This downregulation was dose dependent apart 
from at the 40 μg/mL dose and the results were consistent among three individual 
sets of experiments. 
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Figure 2.20: Calculating vitamin E working concentration. 
Three different Vitamin E (0, 0.5, 0.05, 0.005 mol/L) doses were analysed using with 
QPCR to test optimal working concentration for vitamin E.  Fold differences above 
and beyond x5 is noted on the figure. 
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Figure 2.21: hZnT3 mRNA levels following DHA treatment in the presence of vitamin 
E in M17 cells. 
hZnT3 expression levels were analysed following DHA (0, 5, 10, 20 and 40 μg/mL) 
treatment in the presence of vitamin E (0.05 mol/L), using QPCR analysis.  Fold 
differences above and beyond x5 is noted on the figure. 
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2.3.5.3 ZnT3 protein levels with DHA and vitamin E 
 
Vitamin E (0.05 mol/L) and DHA (0, 5, 10,20 and 40 μg/mL) treated M17 cells were 
collected, lysed and the protein was analysed using Western blotting.   ZnT3 was 
expressed in treated M17 cells indicated by a band of approximately 41.9 kDa in all 
lanes (Figure 2.22A).   ZnT3 protein levels were markedly reduced in cells exposed to 
DHA and vitamin E, when compared to untreated cells.  To ensure equal protein 
loading across gel lanes, levels of the β-actin housekeeper gene was assessed (Figure 
2.22B).  Densitometric analysis also confirmed a significant reduction in ZnT3 protein 
when treated with vitamin E and DHA (Figure 2.22C).  
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Figure 2.22: ZnT3 protein levels following DHA treatment in the presence of vitamin 
E in M17 cells. 
ZnT3 protein (A) and the housekeeping gene β-actin protein (B) levels of M17 cells 
cultured in the absence and presence (0, 5, 10,20 and 40 μg/mL) of DHA and vitamin 
E (0.05 mol/L) were detected with specific antibodies. (C) Densitometric analysis of 
ZnT3 protein levels (normalised with the β -actin protein levels) are shown in arbitrary 
units (AU). Molecular mass protein markers (Mr) are indicated on the left of each gel. 
This result is representative of three similar independent experiments. 
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Chapter 2.4: Discussion 
 
 
Cellular zinc and omega-3 FA levels are both known to be vital in many biological and 
biochemical pathways in the human body.  Moreover, altered metabolism of zinc and 
omega-3 FAs are known to cause diverse health effects.  Thus, the human body 
contains specific yet complex mechanisms to closely regulate the absorption and 
excretion of these compounds.   Both zinc and omega-3 FAs are present abundantly 
in neuronal membranes and many neural cellular functions as well as the structural 
integrity of the cells are greatly reliant on the presence of zinc and omega-3 FAs.  
Thus, neurodegenerative disorders such as AD have been linked with their 
deficiencies.  Recent studies have revealed a link between DHA (an omega-3 FA) 
levels and zinc metabolism in rats, indicating possible synergistic effects at the 
cellular level (Jayasooriya et al., 2005b).  Combined with many epidemiological 
studies, this finding has opened up a new level of mental health research in regard to 
DHA and zinc.  However, there is a lack of studies conducted using human cell models 
to investigate this relationship between DHA and zinc homeostasis.  Thus, this study 
aimed to understand a possible relationship between DHA and zinc in cultured 
human neuronal cells.  This was carried out in three major steps; first to investigate 
the effects of DHA and zinc levels on zinc transporter gene expression levels in 
neuronal cells.  Then the zinc transporter protein levels were analysed in relation to 
different DHA and zinc levels. Thirdly, to understand the effect of vitamin E as a free 
radical scavenger and thus prevent oxidisation of DHA and increase the effects of 
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DHA at the cellular level. 
 
 
2.4.1 Effects of DHA and zinc on zinc transporter expression levels 
 
Cells treated with different doses of DHA (0, 5, 10, 20 and 40 μg/mL) in the presence 
or the absence of zinc were used to isolate total RNA, and then RNA was reverse 
transcribed to cDNA, and used in a QPCR assay to measure the changes in gene 
expression levels.  hZnT 1–7 and hZip 1–4 transporters along with GAPDH as the 
internal control were analysed for any changes in expression.  Overall, down 
regulation of zinc transporters was prominent at mRNA level in all four cell lines 
regardless of the treatment.  However, some significant changes could be seen in the 
expression levels of several transporters in response to different treatments.   
 
 
2.4.1.1 hZnT1 
   
Changes observed in hZnT1 expression levels were different between the control and 
the neuronal cell lines (Figure 2.4).  HaCaT, the control cell line showed an overall up-
regulation pattern in regard to hZnT1 expression levels (Figure 2.4A).  With zinc 
treatment NT2 cells also displayed some level of hZnT1 upregulation (Figure 2.4B).  In 
contrast, NT2 cells treated with DHA in the absence of zinc showed a significant 
downregulation.  However, these changes were not dose dependent.  In addition, in 
both neuronal cell lines SY5Y and M17, hZnT1 expression was mainly downregulated, 
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again more significant with zinc treatment than without. In general, hZnT 
transporters have been identified as facilitators of zinc efflux from the cytosol to the 
luminal compartments (Jayasooriya et al., 2005b).  hZnT1 was the first zinc 
transporter family member to be identified (Palmiter, 1995a) and it’s ubiquitously 
expressed in tissues, with the highest expression in the cerebral cortex and 
cerebellum (Sekler et al., 2002).  A rat neuronal cell line (PC12) study with 
overexpressed and negative dominant ZnT1 gene has shown that zinc induced 
apoptosis in neuronal cells is influenced by ZnT1 transporter (Kim et al., 2000).  
Another mouse study intended to knockout ZnT1 expression has failed due to the 
embryonic lethality of knockout mice (Andrews et al., 2004), thus indicating the 
importance of the ZnT1 transporter in cellular functions.   Moreover, hZnT1 is 
identified as one of the main zinc transporter proteins in human cells (Liuzzi et al., 
2004; Sekler et al., 2002).  Cells highly sensitive to extracellular zinc concentration 
normally have less hZnT1 expression levels (McMahon, 1998).   
 
As discussed above, higher expression of hZnT1 levels facilitate more efflux of zinc 
into extracellular matrix.  Thus, this decrease in hZnT1 expression level in response 
to high DHA doses can reduce internal zinc accumulation in extracellular matrix.  In 
neurodegenerative conditions such as AD a high level of zinc accumulation could be 
seen (Huang et al., 2000).  Moreover, zinc is closely related to the formation if 
neurofibrillary tangles (Bush et al., 1994b).  High levels of zinc have been linked with 
Aβ aggregation and induced amyloid plaque formation (Bush et al., 1994a; Bush et 
al., 1994b).  Amyloid plaque is one of the main pathological features in AD (Vickers et 
al., 2000).  Thereby, this finding indicates a possible mechanism of DHA in preventing 
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neurodegenerative diseases.   However, the dose dependent pattern could not be 
seen with DHA treatments in any of the cell lines indicating that hZnT1 might not be 
the most prominent or the most important pathway of DHA induced neuro-
protection in these cell lines. 
 
 
2.4.1.2 hZnT2 
 
hZnT2 mRNA levels were downregulated in all cell lines subjected to DHA treatment 
in the absence of added zinc (Figure 2.5).  In HaCaT cells this downregulation was not 
significant.  However, in the other three cell lines multiple DHA doses were able to 
downregulate hZnT2 levels beyond the significance threshold.  A similar 
downregulation pattern to a lesser extent was seen in zinc treated cells, suggesting 
the extra zinc availability has created a higher demand for this specific zinc 
transporter.  One study has shown a significant downregulation in hZnT2 levels in 
response to low zinc availability (Liuzzi et al., 2003), which was also confirmed in this 
study.  In M17 cells, an upregulation of hZnT2 was detected when treated with DHA 
and zinc. This suggests a possible specificity or importance of hZnT2 transporter in 
M17 cells.  
 
 
The ZnT2 transporter is known to be present in unique tissues where zinc 
requirement is high, such as in mammary and prostate glands (Lopez and Kelleher, 
2009).  Immunohistochemistry studies conducted with ZnT2 transporter has 
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identified its vesicular localisation pattern (Kelleher and Lonnerdal, 2002).  It has also 
been reported that ZnT2 transporters exhibits transient regulation (Lopez and 
Kelleher, 2009), localises to vesicles and functions in the sequestration of zinc into 
vesicles.  Studies performed with ZnT2 and mammary epithelial cells have shown a 
link between the ZnT2 availability and zinc exportation across the cell membrane 
(Chowanadisai et al., 2006).  Though the exact mechanism by which ZnT2 works to 
maintain the zinc homeostasis is yet unknown, intracellular localization and a positive 
correlation between zinc exposure and ZnT2 presence has led to the suggestion that 
this transporter participates in vesicular zinc sequestration and possible export or 
secretion from the tissues (Liuzzi and Cousins, 2004a). 
 
 
 
2.4.1.3 hZnT3 
 
ZnT3 expression, like that of ZnT2, also shows a restricted distribution pattern.  It has 
been identifies in both the rodent brain and testis (Palmiter, 1995a), and in the 
human breast epithelial cells (Michalczyk et al., 2002).  Distribution of this transporter 
in the rat brains is found to be limited to the synapses and axons of glutamatergic 
neurons, indicating a possible role for this transporters in neuronal health (Liuzzi et 
al., 2004).  Vascularisation of zinc and the triggered zinc release from synaptic vesicles 
is mainly controlled by ZnT3 transporters (Palmiter, 1995a).     
 
Changes in the hZnT3 expression at the mRNA level was one of the most interesting 
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and important findings of this study.  In response to DHA doses without zinc 
treatment, M17 and NT2 cells showed a significant and dose dependent 
downregulation in hZnT3 mRNA levels (Figure 2.6).  HaCaT cells also showed a bell 
shaped downregulation when treated with DHA in the absence of zinc, although this 
downregulation was not dose dependent.  hZnT3 mRNA expression levels in SY5Y 
cells were not significant in the presence of  DHA with no zinc treatment.  When 
treated with zinc and DHA, an upregulation pattern was prominent in HaCaT, M17 
and NT2 cells (Figure 2.6).  All four cell lines exhibited converse expression patterns 
with zinc and without zinc, indicating a possible zinc responsive mechanism in the 
expression of this transporter.  Protein studies done with the ZnT3 also confirmed the 
mRNA results in all the cell lines.  In M17 cells, ZnT3 protein levels were significantly 
downregulated in a dose dependent manner when treated with DHA and no zinc 
(Figure 2.16).  HaCaT cells and SY5Y cells displayed dissimilarities in the ZnT3 protein 
levels when treated with different DHA doses (Figure 2.17 & 2.18).  Protein results 
obtained with NT2 cells also correlate with mRNA results, where a significant dose 
dependent downregulation was seen (Figure 2.19).   Observations made in this study 
for this transporter expression was in line with the previous rat study done by 
Jayasooriya and colleagues (2005).  Altered ZnT3 expression levels in rat brains have 
been linked to abnormal zinc metabolism, and moreover, the same study has 
revealed a link between increased ZnT3 expression levels with the decrease DHA 
consumption (Jayasooriya et al., 2005b).  Thus, it can be postulated that this is the 
key transporter in both humans and rats, which links DHA, zinc and AD.  The human 
ZnT3 protein has 388 amino acids and shares more than 85% homology with rat and 
mouse ZnT3 proteins (Smidt and Rungby, 2012).  Hence, the correlation seen 
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between the two transporters when treated with DHA can be understood. Another 
study done with amyloid-β protein precursor (AβPP)/presenilin 1 (PS1) transgenic 
mice has shown elevated levels of ZnT3 protein in these mice (Zheng et al., 2010).  
These findings suggest a possible link between ZnT3 and amyloid-β at the cellular 
level.  Extracellular plaque deposits of the amyloid-β peptide are one of the hallmark 
pathologies required for the diagnosis of AD (Murphy and LeVine, 2010).  In addition, 
ZnT3 knock-out mice display reduced synaptic localization of amyloid-β 
oligomerization compared to its wild type counterpart (Deshpande et al., 2009).  A 
further study done with ZnT3 knock-out mice demonstrated a significant reduction in 
the quantity and size of plaque build-up compared to the wild type mice (Lee et al., 
2002).  Moreover, post-mortem AD brains has shown high expression of ZnT3 in the 
zinc containing plaques and amyloidangiopathy diseased vessels (Zhang et al., 2008).  
Collectively, these published data highlight the importance of the ZnT3 transporter, 
especially in relation to neurodegeneration.  Thus, an understanding of the decrease 
in expression of ZnT3 in such conditions will be of vital importance to at least mange 
if not cure these diseases.  The findings of this study shed light on such a pathway, 
where a DHA induced downregulation was prominent in two human cell lines.     
 
2.4.1.4 hZnT4 
 
Changes in hZnT4 expression levels were consistent in all cell lines (Figure 2.7), except 
for NT2 cells treated with zinc, which showed a slight upregulation.  However, the 
changes in mRNA levels for hZnT4 was not dose dependent in many cases.  In 
neuronal cells, hZnT4 is mainly localised on the Golgi apparatus and endoplasmic 
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reticulum, hence sequestrating zinc into intracellular compartments (Wang et al., 
2005).  Increased intercellular zinc accumulation is known to promote 
neurodegenerative conditions.  A study with mutant mice carrying pathogenic forms 
of the human APP and deficient in intracellular zinc has shown less severe AD 
pathological features than mice with normal zinc levels (Lee et al., 2002).  Therefore, 
the decrease in hZnT4 expression levels hZnT with high DHA doses again provides 
evidence for a possible link between omega-3 FA availability and AD conditions.  
 
 
2.4.1.5 hZnT6 
 
Cells from liver, brain and small intestine has shown the highest concentration of 
hZnT6 mRNA levels (Huang et al., 2002).  Immunofluorescence studies conducted 
with this transporter have identified a localisation, mainly concentrated in Golgi 
network and in the cell periphery (Huang et al., 2002).  hZnT6 transporter is known 
to be vital in allocating cytoplasmic zinc into trans-Golgi network.  In an experiment 
with AD and early AD brain subjects, it has been shown that a significant (P<0.05) 
increase in hZnT6 expression levels has occurred in hippocampus / parahippocampal 
gyrus regions (Smith et al., 2006).  Moreover, AD conditions are widely related to 
decrease DHA consumption (Connor and Connor, 2007; Horrocks and Yeo, 1999). 
 
Following the DHA treatment, a consistent downregulation at the mRNA level was 
observed for hZnT6 transporter in all four cell lines.  However, significance was only 
reached with M17 cells, indicating a potential specificity of the behaviour or a 
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functional importance for this zinc transporter in M17 cells.  No zinc treatment 
resulted in a significant downregulation compared with zinc treatment, suggesting a 
zinc dependent mechanism in gene regulation.  
 
 
2.4.1.6 hZnT5 and hZnT7  
 
With regard to hZnT7 expression levels, some changes could be observed when 
treated with DHA.   However, even with low Ct values most of the changes observed 
were under the 2 fold significance level for hZnT7 mRNA in all four cell lines.   
 
hZnT7 is mainly localised vascularly and found to have a function in accumulating zinc 
into Golgi apparatus and is predominantly expressed in the small intestine, liver and 
spleen and to a lesser extent in the kidney, lung and brain (Kirschke and Huang, 2003).  
Thus, hZnT7 may not have a significant role in either neuronal cells or skin cells.  The 
Ct values for hZnT5 were extremely low (data not shown), indicating non-specific, 
self-annealing or pair annealing of the primer had most likely occurred.       
 
 
2.4.1.7 hZip 1-4  
 
Analysis of hZip expression levels in general, did not produce significant or consisting 
regulation patterns.  However, in M17 cells a consistent downregulation was present 
and this was more prominent in NT2 cells (Figure 2.10).         
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Zip family facilitates zinc movement into the cytosol, either from the extracellular 
environment or intracellular compartments (Gaither and Eide, 2000).  Thus, it could 
be assumed that the expression levels would increase in the absence of zinc.  
However, this phenomenon could not be clearly visible with any of the Zip 
transporters during this study.  In most cases a higher degree of downregulation was 
seen without zinc than in the zinc treatment.  If DHA has a down-regulatory effect on 
Zip transporter family, this change could be interpreted as a zinc effect, which would 
be consistent with the previous assumption.  However, DHA effects on Zip 
transporter family expression levels has not been adequately studied. Therefore, 
there is a lack of information to support this observation. The changes in expression 
of hZip mRNA levels in regards to zinc levels have been shown to be more efficient in 
younger rats when compared with older rats (Wang et al., 2004a).  This suggests a 
possible age related discrepancy in zinc metabolism with this transporter.  The same 
phenomena of altered metabolism of zinc with the age is a common pathological 
feature with AD conditions as well.  
 
At the same time, the importance of the Zip family on zinc homeostasis is well 
documented.  Zip4 is the gene that is thought to be the most important for zinc 
homoeostasis since it is responsible for a rare recessive-lethal human genetic 
disorder Acrodermatitis enteropathica (Dufner-Beattie et al., 2003).  Patients with 
this genetic disease exhibit zinc malabsorption and suffer from a severe zinc 
deficiency due to a mutation of the Zip4 gene.  Moreover, translational and post-
translational modification processes are thought to affect Zip transporter expression 
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levels (Gaither and Eide, 2000).  Zip family members have been found to transit 
between the plasma membrane and intracellular compartments in zinc replete cells.  
However, with zinc deprivation, Zip family members have been found to be localised 
more on the plasma membrane, by decreasing their rate if endocytosis (Dufner-
Beattie et al., 2003; Wang et al., 2004a).  Therefore, a putative link between the post-
translational control and zinc levels with Zip family members exist.  However, this 
study was more focussed on mRNA and protein levels, and not the protein 
localisation patterns.  Therefore, it is possible that no significant expression changes 
had occurred, but the localisation patterns were different following the DHA 
treatment.  Such changes could not be deduced in this study.  A localisation study 
with different DHA and zinc levels would therefore, be beneficial to our 
understanding of the behaviour if these Zip proteins. 
 
 
2.4.2 Effects of DHA and zinc on neuronal cell survival 
 
As discussed in published data, DHA treated M17 cells were tested for apoptotic 
marker levels.  Caspase-3 and Bcl-2 were used to assess the apoptosis levels after 
treating the cells with relevant DHA doses for 48 hours.  Caspase-3 is a frequently 
activated death protease, and one of its main functions is to catalyse the specific 
cleavage of many key proteins at the cellular level (Porter and Janicke, 1999).  
Caspase-3 is also required in apoptotic chromatin condensation and DNA 
fragmentation, thus making it essential in the apoptotic process (Porter and Janicke, 
1999).   
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When treated with DHA, M17 cells display a clear reduction in caspase-3 protein 
levels (Figure 2.14).  More than a 60% reduction was seen at the 20 μg/mL DHA dose 
when compared with control cells.  On the other hand, a clear increase could be seen 
with Bcl-2 protein levels when treated with DHA (Figure 2.15).  The Bcl-2 family act 
as either anti- or pro-apoptotic regulators and are mainly responsible for determining 
whether a cell should live or die (Vaux et al., 1988).  Bcl-2 protein is a member of the 
Bcl-2 family of regulator proteins and is considered as an important anti-apoptotic 
protein in human cells (Cory et al., 2003).  Thus, the decrease seen in the Bcl-2 levels 
when treated with DHA indicates a protective mechanism at the cellular level against 
programmed cell death.  
 
 
2.4.3 Vitamin E and DHA effect on ZnT3 expression level 
 
DHA is well known for its susceptibility to spontaneous oxidation.  A long chain of 22 
carbons and 6 double bonds in its structure has given this extreme nature to DHA 
(Stillwell and Wassall, 2003).  Thus, many studies have shown the importance of using 
a free radical scavenger such as vitamin E with DHA to minimize oxidation and also to 
enhance the effects of PUFAs (Kubo et al., 1997; Piche et al., 1988; Wander et al., 
1996).  Thus, M17 cells were used to test vitamin E effect when treated with DHA.  
Firstly, the working concentration for vitamin E was established using three different 
doses and by assessing ZnT3 expression levels after 48 hours of treatment.  Though 
the highest difference observed was with 0.5 mol/L vitamin E, this was not used in 
subsequent experiments (Figure 2.20), due to some cells showing toxicity towards 
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the high vitamin E levels and undergoing cell death.  0.05 mol/L was selected as the 
optimal dose and used in the following experiments.  Use of vitamin E appeared to 
have further reduced the hZnT3 expression level up to almost 10 fold than the control 
where no vitamin E was used. 
 
When treated with different DHA doses in the presence of vitamin E, M17 cells 
showed a significant downregulation in hZnT3 at the mRNA levels.  The dose 
dependent pattern was similar to results obtained without vitamin E.  However, the 
downregulation appears to be greater than what was achieved without vitamin E 
(Figure 2.21).  When treated with only vitamin E, ZnT3 expression levels were 
upregulated, however introduction of DHA reversed the upregulation significantly.  
 
Both mRNA results and protein results (Figure 2.22) obtained from this study are in 
line with the previous reported data in literature.  In the presence of Vitamin E, DHA 
effect on ZnT3 was amplified, suggesting prolonged DHA availability and a slower 
depletion of DHA through oxidation, due to the presence of vitamin E. 
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CHAPTER 3.1: Introduction 
 
 
3.1.1 DHA effect on zinc fluxes  
 
Zinc is the second most abundant trace element in the human body, and considered 
as one of the most essential trace elements for life (Weiss et al., 2000).  Zinc serves 
as a structural and functional element at the cellular level, including as a component 
of over 300 different enzymes (Wallwork, 1987).  Zinc is also essential in many cellular 
functions such as growth, differentiation (Vallee and Falchuk, 1993), gene expression 
and DNA synthesis (Chai et al., 1999).  In addition to these functions, many cell types 
are known to have stored labile Zn2+ pools for proper cellular functions.  Relative 
concentrations of this labile Zn2+ pools can vary from 1 nM in the cytoplasm of some 
cell types to about 1 mM in some vesicles (Lippard, 1994).  In neuronal cells, these 
Zn2+ pools are believed to play an important role in synaptic plasticity (Li et al., 2001; 
Sensi et al., 2000).  Furthermore, the adult human brain has the highest concentration 
of zinc (150 μM) compared to the other organs (Wallwork, 1987).  This labile zinc in 
the human brain is very tightly regulated, and in normal conditions is believed to be 
around 10-20 nM (Frederickson et al., 2005b). 
 
Although zinc is vital for life, excessive amount of zinc is known to be toxic to cells. 
Under exposure to excessive amounts of zinc, neuronal cells exhibit neurotoxicity and 
neuro-degeneration (Sheline et al., 2000a).  The translocation of zinc from 
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presynaptic to postsynaptic neurons is the main mechanism suspected to be involved 
in neurotoxicity (Weiss et al., 2000).  This zinc translocation is responsible for inducing 
the cell injuries encountered in conditions such as brain trauma (Suh, 2000), epilepsy 
and transient global ischemia (Weiss et al., 2000).  Excessive zinc is also capable of 
inhibiting Ca2+ and Na+ voltage gated channels (Akaike, 1989; Ravindran et al., 1991; 
Winegar and Lansman, 1990) and upregulating the cellular levels of reactive oxygen 
species (ROS) (Kim et al., 1999b).  Elevated ROS levels can be directly detrimental to 
cell survival by damaging key macromolecules such as nucleic acids, proteins and 
lipids and cause rapid cell death.  Moreover, high levels of zinc is found in AD brains, 
indicating a possible zinc related neuro-degeneration (Weiss et al., 2000).  A study 
conducted using mouse neuronal cells has shown that exposure to high levels of zinc 
(40 μM) for just 24 hours is sufficient to degenerate the cells (Sheline et al., 2000b).  
Thus, it’s reasonable to conclude the importance of having a proper and detailed 
understanding of the localization and the availability of free zinc inside the cells.  
Moreover, in a therapeutic aspect, it will be beneficial to understand and develop a 
mechanism where the freely available zinc pool can be regulated.   
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3.1.2 DHA and zinc 
 
A link between zinc and PUFAs has been widely discussed in scientific literature.  Zinc 
deficient pregnant rats have shown a whole-body depletion of the maternal stores of 
both omega-3 and omega-6 PUFAs (Cunnane and Yang, 1995).  Furthermore, studies 
have shown DHA intake or absence can alter the zinc transporter expression levels, 
which in turn modulate cellular zinc levels.  Hence, a putative link between DHA and 
zinc is thought to exist.  For example, perinatal PUFA deficiency in rats resulted in 
upregulated levels of zinc transporter 3 (ZnT3) in the brain.  This was associated with 
increased hippocampal and decreased plasma levels of zinc (Jayasooriya et al., 
2005b).  Furthermore, DHA-treated human neuronal M17 cells showed a 
downregulation in ZnT3 levels compared to untreated cells (Suphioglu et al., 2010a).  
ZnT3 is a putative transporter of zinc into synaptic vesicles in human neuronal cells 
(Palmiter et al., 1996) and thus a reduction in its levels following DHA treatment 
allows for a reduction in free zinc levels in the cellular matrix. 
 
 
3.1.3 Zinc fluorophores 
 
As discussed above, due to the importance of zinc, especially labile zinc in cells and 
tissues, it is vital to study and understand the concentration, distribution, localization, 
kinetics and functions of free zinc.  However, unlike its counterparts Fe2+, Mn2+ or 
Cu2+, Zn2+ is not capable of producing many spectroscopic signals due to its 3d104s0 
configuration (Dai and Canary, 2007).  Thus, use of many spectral techniques such as 
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UV-vis or nuclear magnetic resonance (NMR) is either not possible or limited (Dai and 
Canary, 2007; Zhang et al., 2005).  Other techniques such as atomic absorption 
spectrometry, synchrotron radiation X-ray (SRXRF) spectrometry (R. Ishihara et al., 
2003) and microparticle-induced X-ray emission (micro-PIXE) (Lovell et al., 1998) may 
be useful in some applications, although they might be expensive and will require 
special instrumentation.  Thus, a more simple and economical fluorescent sensors of 
free zinc have become a more popular and widely used technique among 
researchers.  Much of this work has focused on the use of zinc fluorophores as the 
fluorescent sensor (Thompson, 2005).  6-methoxy-8-p-toluenesulfonamide-quinoline 
(TSQ) is the first reported zinc fluorophore to be used as it binds to Zn2+ selectively 
by the quinoline moiety (Frederickson et al., 1987).  Few other commonly used zinc 
fluorophores are Zinquin, Zinpyr, RhodZin and the ZnAF family (Thompson, 2005).  
There are two main families of zinc fluorophores, one is membrane permeable and 
the other is membrane impermeable. Membrane permeable fluorophores get 
modified into a membrane impermeable derivative through an enzymatic 
modification such as hydrolysis of an ethyl ester group by an esterase in the cell.  This 
modified derivative will then be able to bind the target cation, thus emitting its 
signalling (Kimber et al., 2000). 
 
This study was carried out to investigate the effects of DHA as a neuro-protective 
agent by analysing free zinc availability.  In the preliminary studies, four different zinc 
fluorophores (Zinquin, Zinpyr-1, RhodZin-3 and FluoZin-3) were tested for zinc fluxes 
in human neuronal cells and the compatibilities were evaluated under living and fixed 
conditions.  Following this, the most compatible fluorophore was used to measure 
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free zinc availability following DHA treatment. A time-point study was performed to 
gain a complete understanding of DHA effects and the specificity of DHA effects were 
verified using linoleic acid (LA).  
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CHAPTER 3.2: Materials & Methods 
 
 
3.2.1Cell culture 
 
The human neuroblastoma cell lines BE(2)-M17 and neuronally committed human 
teratocarcinoma cell line NT2 used in the present experimental study were obtained 
from Professor Leigh Ackland, Centre for Cellular and Molecular Biology, Deakin 
University, (VIC, Australia).   
 
NT2 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% 
heat inactivated foetal bovine serum (FBS), while BE(2)-M17 cells were cultured in 
OPTI-MEM (modified Eagles Minimum Essential Medium) with 2.5% heat inactivated 
FBS.  Both cell lines were grown as monolayers in 12 well disposable plates on glass 
cover slips and incubated at 37°C in a humidified atmosphere of 5% carbon dioxide.   
 
 
3.2.2Compatibility study of four different zinc fluorophores 
 
Free zinc availability was measured in M17 cells with four different fluorophores 
(Zinquin, Zinpyr-1, RhodZin-3 and FluoZin-3) to test their compatibility under fixed 
and non-fixed conditions.  All of the four fluorophores were maintained in DMSO 
stock solution (1–5 mM) and diluted down to a final concentration of 1–5 μM in 
appropriate culture media.  M17 cells were grown on glass coverslips until they 
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reached confluence.  Media was replaced every 2–3 days.  Once cells reached 
confluence, one set was used as it was and the second set was permeabilized before 
incubating with one of the fluorophores for 30 minutes. Fixing was performed 
following the protocol as previously described (Hardman et al., 2007).  Briefly, treated 
cells cultured on glass coverslips or coated filters were rinsed 3 times with PBS, fixed 
with 4% (w/v) paraformaldehyde (PFA/PBS) (Sigma-Aldrich, Sydney, Australia) for 5 
minutes at room temperature and rinsed again with PBS 3 times. The cells were 
permeabilised with 0.1% (v/v) Triton X-100/PBS (Amresco Inc. Solon, USA) for 10 
minutes at room temperature and rinsed 3 times with PBS.  Following the incubation, 
cells were washed 3 times with PBS and mounted with Bio-Rad FluoroGuardTM Anti-
fade Reagent (Bio-Rad, Hercules, USA). Confocal images were obtained as previously 
described (Hardman et al., 2007). 
 
 
 
3.2.3DHA effect on zinc fluxes across the cell membrane 
 
Cells were tested for the zinc fluxes following DHA treatment using Znpyr-1 as the 
zinc fluorophore.  DHA (20 μg/mL) and control (0 μg/mL) media were incubated at 
37oC overnight on an orbital rotator before treating the cells.  This was to allow DHA 
to conjugate with proteins in the media to ensure maximum delivery into the cells.  
When cells were about 100% confluent, old media was replaced by 2 mL of 
appropriate media per well and left for two days before harvesting, followed by 
further 30 minutes incubation with Znpyr-1 and subsequently checked under the 
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microscope.  Following the incubation, cells were washed 3 times with PBS and 
mounted with Bio-Rad FluoroGuardTM Anti-fade Reagent (Bio-Rad, Hercules, USA). 
Confocal images were obtained as previously described (Hardman et al., 2007). 
 
 
 
3.2.4LA effect on zinc fluxes across the cell membrane 
 
Cells were tested for the zinc fluxes following LA treatment using Znpyr-1 as the zinc 
fluorophore.  LA (20 μg/mL) and control (0 μg/mL) media were incubated at 37oC 
overnight on an orbital rotator before treating the cells.  This was to allow LA to 
conjugate with proteins in the media to ensure maximum delivery into the cells.  
When cells were about 100% confluent, old media was replaced by 2 mL of 
appropriate media per well and left for two days before harvesting, followed by 
further 30 minutes incubation with Znpyr-1 and subsequently checked under the 
microscope.  Following the incubation, cells were washed 3 times with PBS and 
mounted with Bio-Rad FluoroGuardTM Anti-fade Reagent (Bio-Rad, Hercules, USA). 
Confocal images were obtained as previously described (Hardman et al., 2007). 
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3.2.5DHA treatment - time point study   
 
Cells were treated with DHA (20 μg/mL) and control (0 μg/mL) and tested for the zinc 
fluxes using Znpyr-1 at different time points (0, 4, 8, 26, 24 & 48 hours) to identify 
DHA effects at different stages.  DHA (20 μg/mL) and control (0 μg/mL) media were 
incubated at 37oC overnight on an orbital rotator before treating the cells.  This was 
to allow DHA to conjugate with proteins in the media to ensure maximum delivery 
into the cells.  When cells were about 100% confluent, old media was replaced by 2 
mL of appropriate media per well and left for two days before harvesting, followed 
by further 30 minutes incubation with Znpyr-1 and subsequently checked under the 
microscope.  Following the incubation, cells were washed 3 times with PBS and 
mounted with Bio-Rad FluoroGuardTM Anti-fade Reagent (Bio-Rad, Hercules, USA). 
Confocal images were obtained as previously described (Hardman et al., 2007) 
 
 
 
3.2.6Serum starvation study with DHA enrichment 
 
Cells were cultured in serum free media (-FBS) for 48 hours, and then treated with 
one of the following combinations for another 48 hours followed by a 30-minute 
incubation with the zinc fluorophore Znpyr-1.  (a) –DHA and –FBS, (b) –DHA and +FBS, 
(c) 20 μg/mL DHA and –FBS, (d) 20 μg/mL DHA and +FBS.  Appropriate FBS 
concentrations were used according to the cell line as described on the Section 3.2.1.  
Treatment with –DHA and –FBS was just the relevant serum free media according to 
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the cell line.  All of the four treatment media were incubated at 37oC overnight on an 
orbital rotator before treating the cells.  This was to allow DHA to conjugate with 
proteins in the media to ensure maximum delivery into the cells.  When cells were 
about 100% confluent, old media was replaced by 2 mL of appropriate media per well 
and left for two days before harvesting, followed by further 30 minutes incubation 
with Znpyr-1 and subsequently checked under the microscope.  Following the 
incubation, cells were washed 3 times with PBS and mounted with Bio-Rad 
FluoroGuardTM Anti-fade Reagent (Bio-Rad, Hercules, USA). Confocal images were 
obtained as previously described (Hardman et al., 2007) 
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CHAPTER 3.3: Results 
 
 
3.3.1 Compatibility study of four different zinc fluorophores 
 
The purpose of this study was to evaluate the compatibility of four different 
fluorophores (Zinquin, Zinpyr-1, RhodZin-3 and FluoZin-3) in M17 cells.  Free zinc 
availability of M17 cells was tested using these fluorophores under live or fixed 
conditions and then samples were assessed by microscopy to determine the most 
compatible fluorophore under the given conditions.   
 
Cells were grown on cover slips for two days, then incubated with one of the 
fluorophores for 30 minutes.  Following incubation, one set was used as is and the 
second one was permeabilized, fixed and tested for fluorescence signals.   Live cells 
incubated with FluoZin-3 displayed scattered and very minimal fluorescence labelling 
(Figure 3.1.4-b).  Conversely, all the other three fluorophores produced strong signals 
in live M17 cells (Figure 3.1.b). Among these three fluorophores, Zinquin signalling 
was weaker than that of Zinpyr-1 and RhodZin-3.  However, fluorescence signalling 
with these three fluorophores showed a very similar and specific staining pattern.  
Signalling appeared to be confined mainly to the endoplasmic reticulum (ER), Golgi 
and the nucleus.  In contrast, the cytoplasmic region did not exhibit a strong 
fluorescence signalling with these three fluorophores in live cells.   Fluorescence 
signalling in dead and fixed M17 cells incubated with  Zinpyr-1, RhodZin-3 and Zinquin 
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appeared to be diffuse and weaker when compared to live cells, suggesting it is not 
specific or confined (Figure 3.1.a).  Cytoplasmic staining was also visible when 
incubated with fixed cells.  Interestingly, FluoZin-3 produced contrasting results with 
the fixed cells in comparison to the live cells (Figure 3.1.4-a).  Very strong ER and Golgi 
labelling was present and the signalling appeared to be specific and confined.  Three 
independent replicates were performed for this experiment and the results obtained 
were consistent across the three replicates.  Thus, based on the results, Zinpyr-1 was 
selected as the fluorophore of choice for non-permeabilized (live) cells.  FluoZin-3 
was selected as the fluorophore of choice for staining of permeabilized (dead) cells, 
as it gave the best zinc specific results. 
 
 
 
3.3.2 DHA effect on zinc fluxes across the cell membrane 
 
M17 cells were tested for zinc fluxes following DHA treatment using Znpyr-1 as the 
zinc fluorophore. M17 cells were incubated for 48hrs in the presence of DHA (20 
μg/mL) or in its absence as the control, followed by a further 30 minutes incubation 
with Znpyr-1, and subsequently assessed by microscopy.  Control M17 cells displayed 
very strong zinc labelling when incubated with Znpyr-1 (Figure 3.2.1-a).  Signalling 
was stronger close to the endoplasmic reticulum (ER) and the Golgi, and was 
consistent among all the cells present.  In contrast, DHA treated cells displayed 
minimal labelling indicating a very low levels of free zinc in the cytoplasm, thus 
producing low levels of fluorescence signalling compared to untreated cells. Bright 
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field imaging indicates the presence of cells, however, green fluorescence was almost 
negligible and was limited to a few insignificant scattered spots (Figure 3.2.1-b).  
These results were verified with three individual experimental sets and the results 
were highly consistent.  
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Figure 3.1: Fluorescence signalling from four different zinc fluorophores in M17 
cells. 
Free zinc availability of M17 cells was tested using four different fluorophores 
(Zinquin, Zinpyr-1, RhodZin-3 and FluoZin-3) to evaluate the compatibility of them 
under live (A) or fixed (B) conditions.   
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Figure 3.2: Comparison of zinc fluxes following DHA and LA treatments in M17 cells 
using Znpyr-1.  
M17 cells were tested for changes in free zinc levels using Znpyr-1 in the presence  
(1-b) and  absence (1-a) of DHA (20 μg/mL) treatments.  M17 cells were also tested 
for the fluorescence labelling in the presence (2-b) and absence (2-a) of LA to test the 
DHA specificity. 
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3.3.3 Linoleic acid effect on Zn fluxes across the cell membrane 
 
In this experiment, omega-3 fatty acid DHA was replaced by an omega-6 fatty acid LA 
to test the DHA-specific results obtained in the previous study.  M17 cells were 
treated for 48hrs with either 20 μg/mL LA as the test sample, or without LA as the 
control. Cells were then incubated for another 30 minutes with Znpyr-1 and 
subsequently checked under the microscope. 
 
Once again, the untreated control cells produced very strong green fluorescence 
signalling when incubated with Znpyr-1 (Figure 3.2.2-a).  This indicates the presence 
of free zinc in the untreated cells.  The red staining demonstrates ethidium bromide 
staining of the nucleus.  Green fluorescence signalling was mainly seen in the Golgi 
and ER regions, and the strong staining pattern was universal in all cells present.  In 
comparison to the control sample signal, there was no substantial difference in the 
staining pattern of cells treated with LA (Figure 3.2.2-b). The strong green 
fluorescence signalling prominent in the Golgi and cell membrane regions were in 
response to Znpyr-1 treatment, and the red signalling was from nuclear ethidium 
bromide staining.  This finding indicates that the free zinc availability in cells is not 
affected by LA, as it was with DHA, suggesting DHA specificity in this mechanism.  
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3.3.4 DHA treatment - timepoint study   
 
DHA treated M17 cells were tested for zinc fluxes using Znpyr-1 at different time 
points to identify DHA effects at different stages.  M17 cells were incubated with DHA 
(20 μg/mL), followed by a further 30 minutes incubation with Znpyr-1 and 
subsequently assessed under the microscope.  M17 cells were tested at 0, 4, 8, 16, 
24 and 48 hour timepoints to assess the effects of DHA.  
 
At 0 hours, cells showed a very high concentration of free zinc which was visualised 
by a strong green fluorescence signal (Figure 3.3.1-a).  The magnified image shows 
distinctive and specific labelling of free zinc around the ER and Golgi areas (Figure 
3.3.1-b).  This labelling pattern was consistent among experiment replicates and also 
consistent with previous observations made in the preliminary studies.  After 4 hours 
of DHA incubation, M17 cells still illuminated very high levels of green fluorescence 
when treated with Znpyr-1 (Figure 3.3.2-a).  This suggests that at this timepoint there 
is still a significant amount of free zinc available inside the cells, and the incubation 
time is not sufficient for DHA to act upon the cells.  The magnified image again shows 
more detail of the zinc localisation pattern, which was very similar to the 0 hour time 
point (Figure 3.3.2-b).  The next time point was at 8 hours, which again did not show 
any significant changes in the fluorescence labelling (Figure 3.3.3), or the labelling 
pattern.  However, after 16 hours of incubation the fluorescence signalling was 
slightly reduced compared to the first three time points (Figure 3.4.1).  Most of the 
cells still displayed fluorescence signalling but there were some cells with almost no 
specific or confined labelling pattern.  This tendency was more prominent after 24 
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hours of incubation with DHA (Figure 3.4.2). The strength of the Znpyr-1 labelling was 
reduced and more diffuse than the sharp and intense signalling patterns which were 
visible with previous time points.  By the 48 hour time point zinc signalling had almost 
disappeared indicating the absence of free zinc in DHA treated M17 cells (Figure 
3.4.3).  These results were consistent across the replicates and with previous 
observations.   
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Figure 3.3: Timepoint (0 – 8 hours) analysis of M17 cells with DHA treatment.   
DHA (20 μg/mL) treated M17 cells were tested for free zinc availability using Znpyr-1 
at different time points to identify DHA effects at different stages.  M17 cells were 
tested at 0 hour (1-a), 4 hours (2-a), 8 hours (3-a) for the green fluorescence labelling 
by Znpyr-1 treatment, and the red signalling was from nuclear ethidium bromide 
staining.  Magnified image is presented next to the corresponding image to gain 
better understanding of the zinc localisation pattern (1-b, 2-b & 3b).  
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Figure 3.4: Timepoint (16 – 48 hours) analysis of M17 cells with DHA treatment.  
DHA (20 μg/mL) treated M17 cells were tested for free zinc availability using Znpyr-1 
at different time points to identify DHA effects at different stages.  M17 cells were 
tested at 16 hour (1-a), 24 hours (2-a), 48 hours (3-a) for the green fluorescence 
labelling by Znpyr-1 treatment, and the red signalling was from nuclear ethidium 
bromide staining.  Magnified image is presented next to the corresponding image to 
gain better understanding of the zinc localisation pattern (1-b, 2-b & 3b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Chapter 3.3: Results 
126 | P a g e  
3.3.5 Serum starvation study with DHA enrichment  
 
M17 cells were cultured in serum free media (-FBS) for 48 hours, and treated with 
one of the following combinations for another 48 hours followed by a 30-minute 
incubation with the zinc fluorophore Znpyr-1.  (a) –DHA and –FBS, (b) -DHA and +FBS, 
(c) 20 μg/mL DHA and –FBS, (d) 20 μg/mL DHA and +FBS. 
 
When assessed under the microscope, M17 cells showed very strong zinc labelling 
within the no zinc and no FBS treated cells (Figure 3.5-a).  However, most of the cells 
appeared to be dying and unhealthy after a total of 4 days of serum starvation.  Zinc 
labelling was also strong in the second treatment condition of FBS with no added 
DHA, following 2 days of serum starvation (Figure 3.5-b).  With this condition, cells 
were healthier compared to the previous “no FBS and no DHA” treatment.  More 
specific localization patterns of zinc could be seen with this condition.  The most 
interesting results were produced with the next combination where cells were 
treated with 20μg/mL of DHA but no FBS, after 2 days of serum starvation (Figure 3.5-
c).  Even though there was no FBS present, cells appeared to be healthier compared 
to the first experimental set with no FBS and no DHA.  This suggests DHA alone can 
promote cell survival, which validates our previous (Chapter 2) results obtained with 
DHA treatment and caspase-3 and Bcl-2 studies.  Green fluorescence signalling was 
also very low in this experimental condition (Figure 3.5-c), suggesting lack of free zinc.  
When cells were treated with both DHA and FBS after the serum starvation period, 
once again the cells did not produce any green fluorescence labelling when incubated 
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with the zinc fluorophore (Figure 3.5-d).  These results were consistent across the 
replicates and validate previous studies done with DHA and zinc fluorophores.    
 
 
3.3.6 DHA effects on zinc fluxes across the cell membrane in NT2 cells 
 
NT2 cells were tested for zinc fluxes following DHA treatment using Znpyr-1 as the 
zinc fluorophore.  NT2 cells were incubated with DHA (20 μg/mL) for 48 hours 
followed by a further 30 minute incubation with Znpyr-1, and then examined under 
the microscope. NT2 cells displayed a very similar fluorescence signalling pattern to 
M17 cells following DHA treatment.  Cells treated with no DHA showed strong 
signalling with the fluorophores (Figure 3.6.1-a), indicating high levels of free zinc 
present in the cells.  DHA treated NT2 cells had a lesser amount of free zinc, hence 
produced a significantly less fluorescence signal in comparison to untreated cells 
(Figure 3.6.1-b). This experiment was repeated independently three times and the 
results were consistent. 
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Figure 3.5: Serum starvation study with DHA enrichment.  
48 hour serum starved (-FBS) M17 cells were tested for free zinc levels in the cells 
following DHA treatment  with one of the following combinations for another 48 
hours followed by a 30-minute incubation with the zinc fluorophore Znpyr-1.                 
(a) –DHA and –FBS, (b) -DHA and +FBS, (c) 20 μg/mL DHA and –FBS, (d) 20 μg/mL DHA 
and +FBS. 
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3.3.7 Linoleic acid effect on zinc fluxes across the cell membrane in NT2 cells 
 
When NT2 cells were treated with 20 μg/mL LA instead of DHA, no significant 
difference could be seen compared to the control sample.  Untreated control cells 
produced strong green fluorescence signalling in response to incubation with Znpyr-
1 (Figure 3.6.2-a).  This result was in line with the observations made with M17 cells.  
Strong green florescence labelling indicates the presence of free zinc in untreated 
NT2 cells.  Ethidium bromide was used as the nuclear stain and red fluorescence 
signalling corresponds to this nuclear staining.  Green fluorescence signalling was 
mainly seen in the Golgi and ER regions and the strong staining pattern was universal 
to all cells present.  When cells were treated with LA there was no visible difference 
in the staining pattern in comparison to the control sample (Figure 3.6.2-b).  Strong 
green fluorescence signalling was still present after LA treatment and was mainly 
confined to the Golgi and cell membrane regions.  The lack of change in fluorescence 
labelling patterns following LA confirms that free zinc levels were not altered by the 
treatment, and that the changes observed on zinc availability with DHA treatment 
are DHA specific.  
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Figure 3.6: Comparison of zinc fluxes following DHA and LA treatment in NT2 cells 
using fluorophores.  
NT2 cells were tested for changes in free zinc levels using Znpyr-1 in the presence    
(1-b) and absence (1-a) of DHA (20 μg/mL) treatments.  NT2 cells were also tested for 
the fluorescence labelling in the presence (2-b) and absence (2-a) of LA to test the 
DHA specificity. 
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3.3.8 DHA treatment - timepoint study with NT2 cells  
 
NT2 cells were tested at different timepoints following DHA treatment for zinc fluxes 
using the zinc fluorophore Znpyr-1. NT2 cells were incubated with DHA (20 μg/mL) 
and its effects on NT2 cells were tested at 0, 4, 8, 16, 24 and 48 hours with use of the 
Znpyr-1 zinc fluorophore.  
 
Similar to M17 cells, NT2 cells also showed a high fluorescence labelling with Znpyr-
1 at 0 hours indicating a high concentration of labile zinc (Figure 3.7.1).  The 
localisation patterns are visible on the magnified image, where a strong signal is seen 
in the ER and Golgi areas (Figure 3.7.1-b).  No significant changes could be seen after 
the first 4 hours of DHA incubation, NT2 cells still illuminated very high levels of green 
fluorescence when treated with Znpyr-1 (Figure 3.7.2-a).  The magnified image 
highlights the zinc location pattern and is also very similar to the 0 hour image (Figure 
3.7.2-b).  After 8 hours of DHA treatment NT2 cells showed a similar strength in 
fluorescence labelling (Figure 3.7.3).  No real changes could be seen with regard to 
the signal strength or localisation at this time point.  Other than a slight decrease in 
fluorescence signalling, no significant changes were visible at the 16-hour (Figure 
3.8.1) and 24-hour (Figure 3.8.2) timepoints either.  This suggest that at these 
timepoints there is still a significant amount of free zinc available inside the cells, and 
the incubation time is not sufficient for DHA to act upon the cells.  Following 48 hours 
of DHA treatment, a significant change in the zinc fluorescence labelling could be 
seen.  At the 48 hour timepoint zinc signalling had almost disappeared indicating the 
absence of free zinc in NT2 cells (Figure 3.8.3).  Observations made in NT2 cells were 
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the same as with M17 cells, indicating a strong similarity between both cell types in 
relation to the effect of DHA treatment on labile zinc.   
 
 
3.3.9 DHA and serum starvation study with NT2 cells 
 
The effect of DHA on NT2 cell survival was tested by a serum starvation study. In this 
study, NT2 cells were cultured in serum free media (-FBS) for 48 hours, and then 
treated with one of the following combinations for another 48 hours followed by a 
30 minute incubation with the zinc fluorophore Znpyr-1:  (a) –DHA and –FBS, (b) -DHA 
and +FBS, (c) 20 μg/mL DHA and –FBS, (d) 20 μg/mL DHA and +FBS.  
 
Though many cells were distressed and dying following the no zinc and no FBS 
treatment, a strong zinc fluorescence labelling could still be seen (Figure 3.9-a).  Zinc 
labelling was also strong in NT2 cells with the second experimental condition, which 
was treatment with FBS in the absence of DHA, following 2 days of serum starvation 
(Figure 3.9-b).  Following this treatment, cells appeared healthier compared to the 
previous “no FBS and no DHA treatment”.  In addition, a more specific localization 
pattern for zinc could be seen with this second experimental condition.  The most 
interesting results were produced with the third condition, where cells were treated 
with 20 μg/mL of DHA without FBS, after serum starvation for 2 days (Figure 3.9-c).  
Even though there was no FBS present, cells appeared to be healthier compared to 
the first experimental condition of no FBS and no DHA.  This suggests DHA alone can 
promote cell survival, which validates our previous (Chapter 2) results obtained with 
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DHA treatment and caspase-3 and Bcl-2 studies.  Green fluorescence signalling was 
also very low in cells exposed to the third experimental condition (Figure 3.9-c), 
suggesting the lack of free zinc.  When cells were treated with both DHA and FBS after 
the serum starvation period, once again the cells did not produce any green 
fluorescence labelling when incubated with the zinc fluorophore (Figure 3.9-d).  
These results were consistent among the replicates and validate the results of 
previous studies done with DHA and zinc fluorophores.   Moreover, both M17 and 
NT2 cells produced similar results with the serum starvation study.  
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Figure 3.7: Timepoint (0 – 8 hours) analysis of NT2 cells with DHA treatment.   
DHA (20 μg/mL) treated NT2 cells were tested for free zinc availability using Znpyr-1 
at different time points to identify DHA effects at different stages.  NT2 cells were 
tested at 0 hour (1-a), 4 hours (2-a), 8 hours (3-a) for the green fluorescence labelling 
by Znpyr-1 treatment, and the red signalling was from nuclear ethidium bromide 
staining.  Magnified image is presented next to the corresponding image to gain 
better understanding of the zinc localisation pattern (1-b, 2-b & 3b). 
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Figure 3.8: Timepoint (16 – 48 hours) analysis of NT2 cells with DHA treatment.  
DHA (20 μg/mL) treated NT2 cells were tested for free zinc availability using Znpyr-1 
at different time points to identify DHA effects at different stages.  NT2 cells were 
tested at 16 hour (1-a), 24 hours (2-a), 48 hours (3-a) for the green fluorescence 
labelling by Znpyr-1 treatment, and the red signalling was from nuclear ethidium 
bromide staining. Magnified image is presented next to the corresponding image to 
gain better understanding of the zinc localisation pattern (1-b, 2-b & 3b). 
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Figure 3.9: Serum starvation study with DHA enrichment.  
48 hour serum starved (-FBS) NT2 cells were tested for free zinc levels in the cells 
following DHA treatment  with one of the following combinations for another 48 
hours followed by a 30-minute incubation with the zinc fluorophore Znpyr-1.                 
(a) –DHA and –FBS, (b) -DHA and +FBS, (c) 20 μg/mL DHA and –FBS, (d) 20 μg/mL DHA 
and +FBS. 
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CHAPTER 3.4: Discussion 
 
 
Zinc is considered as an indispensable element in the molecular economy of 
mammalian cells.  Gene transcription and metalloenzyme activity is highly dependent 
on zinc availability (Berg and Shi, 1996; Vallee and Falchuk, 1993).  In addition, cell-
cell signalling in the CNS is mediated by zinc (Frederickson, 1989). The glutamategic 
terminal in mammalian brains are known to contain high levels of labile zinc 
(Danscher, 1984).  Zinc exists as three main forms in the human brain.  Firstly, as 
vesicular pools localized in synaptic vesicles of nerve ends.  Zinc also exists as 
metalloproteins or protein-metal complexes, and thirdly as ionic pools of free or 
loosely bound zinc in the cell cytoplasm (Frederickson, 1989).  Independent from the 
dietary zinc availability, cerebral zinc is maintained at a steady level, highlighting the 
importance of zinc in brain function (O'Neal et al., 1970; Wallwork et al., 1983).  
 
Despite the importance of zinc in neuronal cells, neurons only have a very narrow 
window of zinc tolerability compared to other cell types.  In vivo and in vitro studies 
have shown excessive amounts of zinc can induce both necrotic and apoptotic death 
in neuronal cells (Choi et al., 1988; Chuah et al., 1995; Cuajungco and Lees, 1997b; 
Duncan et al., 1992; Yokoyama et al., 1986).  Labile zinc in the cytosol is considered 
as an apoptotic marker in neuronal cells (Lee et al., 2006).  Many neurodegenerative 
conditions including AD, is linked with altered zinc homeostasis (Cuajungco and Lees, 
1997a; Cuajungco and Lees, 1997b; Joseph et al., 2009; Mizuno and Kawahara, 2013; 
Chapter 3.4: Discussion 
138 | P a g e  
Mocchegiani et al., 2005; Weiss et al., 2000).  However, the exact intracellular 
mechanism(s) of zinc induced toxicity in neuronal cells are not yet known.  
 
Therefore, this study was done to examine the possible protective mechanism of DHA 
through decreasing the amount of labile zinc in human neuronal cells. Generally, DHA 
is known as a neuro-protective agent (Akbar et al., 2005a; Cole et al., 2005; Horrocks 
and Yeo, 1999; Treen et al., 1992).  Studies conducted have also shown anti-apoptotic 
properties of DHA in many cell types (Akbar and Kim, 2002; German et al., 2006).  
When treated with DHA, serum starved Neuro 2 cells showed increase in anti-
apoptotic markers (Kim et al., 2000) indicating a possible protective mechanism over 
programmed cell death.  These reported observations were re-tested using human 
M17 and NT2 cells to identify a link between DHA and cellular levels of free zinc. 
 
 
3.4.1 Compatibility study of four different zinc fluorophores 
 
The first part of this study was to analyse four different free zinc markers to assess 
the usability of those markers under specific conditions.  There are two main families 
of zinc fluorophores, membrane permeable and membrane impermeable.  Once 
inside the cell, membrane permeable fluorophores undergo an esterase modification 
and is converted into membrane impermeable derivatives (Kimber et al., 2000), thus 
enabling the modified derivative to bind free zinc. 
 
Chapter 3.4: Discussion 
139 | P a g e  
When incubated with fluorophores for 30 minutes, cultures of M17 cells exhibit 
specific results under fixed or live conditions (Figure 3.1).  Fluozin-3, the only 
membrane impermeable fluorophore tested displayed very weak signalling when 
examined under live conditions.  In contrast, in fixed cells Fluozin-3 was the only 
fluorophore which produced specific signalling.  In permeabilized cells, the other 
three fluorophores exhibit non-specific signalling which was more diffuse across the 
entire cell.  These results confirm that there are specific conditions ideally suited for 
the use of different zinc fluorophores.     
 
 
3.4.2 DHA effect on zinc fluxes across the cell membrane 
 
M17 and NT2 cells were used to assess the effect of DHA on zinc fluxes across the cell 
membrane.  Cells were treated with 20 μg/mL or 0 μg/mL of DHA for 48 hours and 
subsequently incubated with the zinc fluorophore for an additional 30 minutes.  
Interestingly, both cell types showed similar results when incubated with Zinpyr-1, 
following DHA treatment.  The strong zinc labelling seen in cells not exposed to DHA 
(Figure 3.2.1-a & 3.6.1-a) almost disappeared following the DHA treatment (Figure 
3.2.1-b & 3.6.1-b), indicating a possible effect of DHA on free zinc availability.  As 
indicted in our published data, 65Zn studies showed a decrease in cellular zinc 
accumulation following DHA treatment in M17 cells (Suphioglu et al., 2010a).  The 
significantly reduced florescence labelling observed in both cell lines following Zinpyr-
1 incubation also confirms the above findings.  As evident in the findings of Chapter 
2, ZnT3 transporter levels were also downregulated in both these cell lines following 
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DHA treatment, suggesting the high likelihood of a link between DHA, labile zinc and 
ZnT3 transporter expression levels in these two cell lines.  However, the exact 
mechanism or the order in which DHA acts on these cells is not yet confirmed. 
 
 
3.4.3 Linoleic acid effect on zinc fluxes across the cell membrane  
 
The specificity of the results obtained with DHA treatment on zinc flux was tested 
using LA as a substitute for DHA.  Cells were incubated with LA (0 or 20 μg/mL) for 48 
hours, followed by 30 minutes incubation of Zinpyr-1 and examined under the 
microscope.  Control cells incubated in the absence of LA displayed strong zinc 
labelling following exposure to zinc fluorophores (Figure 3.2.2-a & 3.6.2-a).  
Interestingly, no significant changes could be seen following the LA treatment in both 
M17 and NT2 cells (Figure 3.2.2-b & 3.6.2-b).  The results observed in LA treated cells 
were contrary to what was observed when treated with DHA, where following LA 
treatment strong zinc labelling was still visible, as same as the control cells.  LA (18:2n-
6) is a polyunsaturated omega-6 FA with a18 carbon chain and two cis double bonds. 
The main structural difference between omega-3 FAs and omega-6 FAs is the position 
of the first double bond.  In omega-3 FAs it’s on the third carbon atom and in omega-
6 FAs it’s on the sixth carbon atom, counting from the methyl end.  Omega-6 FAs are 
considered to be essential in maintaining biochemical functions in the human body 
(Simopoulos, 2002).  At the cellular level, omega-6 FAs tend to have an opposing 
effect when compared to omega-3 FAs.  As an example, at high concentrations 
omega-6 FAs can increase the formation of prostaglandins and thereby increase 
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inflammatory processes.  In contrast, the reverse can be seen with increased omega-
3 FAs in the body.  Many biochemical factors such as thromboxane A2 (TXA2), 
leukotriene B4 (LTB4), IL-1, IL-6, tumour necrosis factor (TNF), and C-reactive protein, 
which are related to various health conditions have been shown to increase with high 
levels omega-6 FAs.  Thus, suggesting a clear difference between omega-3 and 
omega-6 FAs at the cellular level.  The difference in the results obtained from this 
study could be due to the functional differences between these two FAs, and 
therefore, the changes seen in cellular free zinc levels can be classified as DHA-
specific.  A previous study done with mouse Neuro 2A cells have shown a DHA specific 
decrease in apoptotic cell death, induced by serum starvation.  In contrast, oleic acid 
was unable to illicit similar anti-apoptotic properties in serum starved Neuro 2A cells 
(Kim et al., 2000).  In another study where Neuro 2A cells were treated with 
docosapentaenoic acid, was less effective in inducing 
phosphatidylserine accumulation and Akt translocation, and therefore was less 
effective as an anti-apoptotic agent when compared to DHA.  Oleic and arachidonic 
acids were also less effective in reducing the caspase-3 activity, DNA strand breaking 
and laddering in mouse cells compared to DHA (Akbar and Kim, 2002).  Hence, 
observations made in our study also falls in line with these previously reported 
findings, re-establishing the specificity of DHA in preventing apoptosis.   
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3.4.4 DHA treatment - timepoint study   
 
In this study, the effect of DHA on both M17 and NT2 cells were studied at different 
timepoints to gain a better understanding of the mechanism involved.  The 
timepoints selected for this study were 0, 4, 8, 16, 24 and 48 hours after DHA 
treatment.  As predicted, both cell lines showed the maximum intensity in 
fluorescence labelling at 0 hours, and the lowest at 48 hours.  No notable changes 
were seen during the first three timepoints. However, from the fourth timepoint 
onwards, a slight decrease was visible.  These observations provide an insight into 
DHA effects at the functional level in M17 and NT2 cells.  A time course study done 
with rat pheochromocytoma PC12 cells have shown that DHA effects were visible 
only after 24 hours and was at the highest at 48 hours (Kim et al., 2000).  In PC12 
cells, DNA fragmentation induced by serum starvation was reduced when the cells 
were enriched with DHA for a longer period of up to 48 hours.  In addition in HL-60 
cells, sphingosine-induced apoptosis was only reduced following a pre-incubation of 
cells with DHA for at least 24 hours (Kishida et al., 1998).   
 
The changes in zinc levels following DHA treatment can be due to the direct influence 
DHA has on membrane composition and fluidity.  DHA is able to readily incorporate 
into membrane phospholipids and esterified into phospholipids.  DHA can influence 
many basic membrane properties such as acyl chain order, phase behaviour, 
membrane elasticity, membrane permeability, flip-flop and protein activity (Stillwell 
and Wassall, 2003).  DHA’s ability to interact with cholesterol and other membrane 
lipids may have an important role in its ability to modify the structure and functions 
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of the cell membrane (Stillwell and Wassall, 2003).  In addition to the changes in the 
lipid profile of the cell membrane, DHA has a shown tendency to alter gene 
transcription levels in many cells (Kim et al., 2000; Sadli et al., 2012; Suphioglu et al., 
2010b).  In fact, during our study we have also observed this in regard to the ZnT3 
expression levels (Chapter 2). 
 
 
3.4.5 Serum starvation study with DHA enrichment  
 
M17 and NT2 cells were cultured in serum free media (-FBS) for 48 hours, and then 
treated with one of the following combinations for another 48 hrs followed by a 30 
minute incubation with the zinc fluorophore Znpyr-1:  (a) –DHA and –FBS, (b) -DHA 
and +FBS, (c) 20 μg/mL DHA and –FBS, (d) 20 μg/mL DHA and +FBS.  Following 
incubation with Znpyr-1, both cell lines showed a very similar zinc labelling pattern in 
response to different treatments.  With –DHA and –FBS treatment, both cell lines 
indicated significant zinc labelling (Figure 3.5-a & 3.9-a).  However, with this 
treatment cells were distressed and dying.  When treated with –DHA and +FBS cells 
were healthier than the previous treatment and a strong zinc labelling pattern was 
still present (Figure 3.5-b & 3.9-b).  When treated with both DHA and FBS cells 
appeared healthier, but zinc labelling was not present indicating a possible DHA 
modulation of free zinc availability (Figure 3.5-d & 3.9-d).  However, the most 
significant results came with the +DHA and –FBS treatment.  With this treatment 
regime both the cell lines displayed minimum zinc labelling, which is in line with 
previous observations.  Despite the absence of FBS, cells looked healthier when 
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treated with only DHA (Figure 3.5-c & 3.9-c), indicating the anti-apoptotic effects of 
DHA.  Many studies done with DHA have also reported similar anti-apoptotic 
properties of DHA.  In cultured mouse Neuro 2A cells, DHA increased phosophatidyl 
serine levels resulting in membrane translocation/activation of Akt through its 
capacity to increase phosphatidylserine, thus promoting cell survival (Akbar et al., 
2005b).  DHA enrichment of Neuro 2A cells prior to serum starvation has shown a 
protective effect against apoptotic death (Kim et al., 2000).  In addition, DHA 
enrichment has also elicited a protective effect on staurosporine (ST) induced 
apoptosis in Neuro 2A cells (Akbar and Kim, 2002).  Thus, observations made during 
this study are well in line with the reported literature linking DHA, zinc levels and 
apoptosis.  
 
 
 
3.5.6 Conclusion 
 
Zinc fluxes across the membrane in both M17 and NT2 cells displayed interesting 
changes in response to DHA treatment.  A significant decrease in free zinc levels was 
visible following 48 hours of DHA treatment.  Changes in labile zinc levels were only 
seen upon incubation of cells with DHA.  LA showed no effect on labile zinc levels in 
both M17 and NT2 cell lines.  In general, elevated levels of free zinc is associated with 
neurodegeneration and apoptosis.  Thus, the reported depletion in free zinc levels 
following DHA treatment could potentially be linked with the well-known anti-
apoptotic properties of DHA.  In the second chapter of my study, I was able to               
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re-establish the anti-apoptotic nature of DHA.  The current study provides strong 
evidence for a DHA mediated zinc-dependent pathway of neuroprotection. 
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CHAPTER 4.1: Introduction 
 
 
4.1.1 Cell culture models in neuro-research 
 
Neurosciences have advanced significantly over the last few decades with the 
development in molecular biology, electron microscopy and computer technology.  
However, the key limitation of neuroscience, aside from its high cost, is the lack of 
relevant in vitro models which can mimic the structure, function and expression of 
the proteins present in mature human neurons.  With the increase in the incidence 
of neurodegenerative diseases such as AD (Hebert et al., 2001), there is a greater 
need for high-throughput neuroscience research.  Neuroscience research, especially 
research into AD use animal models or rodent neurons or other immortalized cells 
such as neuroblastoma cells as a substitute, due to the lack of live mature human 
neuronal cells.   
 
Animal models can be a good in vivo substitute for the human system, although 
immortalized human cell lines can be more advantageous due to their homogenous 
nature and also because cellular mechanisms such as cell death can be more easily 
and closely studied using a specific cell line rather than an animal system.  
Immortalized human cell lines also allow investigations into species specific effects of 
drugs. Using an animal model instead of a human cell line may restrict obtaining 
similar results due to the species or environmental specificity of certain drugs (Allen 
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et al., 2014).  In addition, study of mutations through genetic manipulation is much 
easier to conduct in cell lines compared to animal models.  
 
Thus, there is a high demand to develop a system to grow human neuronal cells in 
vitro.  If such a system can be developed, it will deliver experimental material for 
studying cell therapies for central nervous system (CNS) disorders and may ultimately 
assist as a source for neural transplantation and brain repair.  Many research groups 
have attempted to address this need in the past using different approaches. One of 
the most popular methods used is to differentiate neuroblastoma cell lines into a 
more neuronal-like state.   
 
Neuroblastoma is one of the most common solid tumours in children which accounts 
for more than 9% of all childhood cancers. It is known to have a neural crest origin, 
with over half the incidences arising within or near the adrenal gland (Beckwith and 
Perrin, 1963; Imashuku et al., 1976).  Originally, short term in vitro culture of 
neuroblastoma tumours was used as a tool for diagnosis (Murray and Stout, 1947), 
and they found that explants of neuroblastoma tumours grown in plasma-clot 
cultures readily expressed axons. The long term culture of neuroblastoma cells and 
their propensity to differentiate in vivo and in vitro under special culture conditions 
have attracted the interest of many researchers (Goldstein, 1968). 
 
However, under normal culture conditions most of the neuroblastoma cell lines do 
not demonstrate many neuronal features such as neuronal morphology, inhibited cell 
division and expression of neuron-specific markers. More importantly, expression of 
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neuron-specific proteins such as β-III tubulin and mature tau isoforms are 
significantly lower in neuroblastoma cells in comparison to mature neurons (Agholme 
et al., 2010).  Previous studies have shown that M17 cells are resistant to retinoic acid 
(RA) differentiation, and M17 cells continued to proliferate after RA treatment 
(Draoui et al., 1997).  However, one published study has successfully demonstrated 
differentiation of SY5Y cells using RA (Simpson et al., 2001). 
 
A likely alternative to neuroblastoma cells is the well-characterized neuronally 
committed teratocarcinoma cell line Ntera2 (NT2).  NT2 cells were derived from a 
human testicular cancer (Andrews, 1984).  According to published literature, NT2 
cells can be induced to differentiate into fully functional, post-mitotic neurons and 
other cell types of the neuronal lineage which display a variety of neurotransmitter 
phenotypes when treated with RA (Guillemain et al., 2000).  NT2 cells have been used 
extensively in neuroscience studies in the past few decades (Paquet-Durand and 
Bicker, 2007).  Published work by Nelson et al. reveal that terminally differentiated 
NT2 cells were successfully transplanted into a human stroke patient (Nelson et al., 
2002).    
 
 
 
4.1.2 Differentiation agents 
 
Differentiation of neuroblastoma and teratocarcinoma cells can be induced using a 
few different differentiation agents.  These agents can be classified under three 
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groups according to their biological functions: growth factors, kinase 
activators/inhibitors and serum withdrawal.  RA, insulin, insulin like growth factors 
(IGF), brain derived neurotrophic factors (BDNF) and nerve growth factors (NGF) are 
the most widely used growth factors (Pahlman et al., 1984; Recio-Pinto et al., 1984; 
Sidell, 1982; Sonnenfeld and Ishii, 1982).  Protein kinase C activators such as 12-O-
tetradecanolyphorbol-13-acetate (TPA) is a widely used kinase activator to induce 
differentiation (Pahlman et al., 1981; Spinelli et al., 1982).  Non-specific protein 
kinase inhibitors such as staurosporine are also used extensively to induce 
differentiation in many neuroblastoma cell lines (Jalava et al., 1992; Leli et al., 1992).  
Serum withdrawal is also widely used to differentiate many neuroblastoma cell lines 
(Diaz-Nido et al., 1991; Evangelopoulos et al., 2005; Wang et al., 2004b).  However, 
none of the methods are considered to be more effective than the other.  
Effectiveness can vary with the cell line and the conditions used.  Many researchers 
tend to use at least a combination of these methods to maximise the outcome of the 
differentiation process.  
 
 
 
4.1.3 Traditional culture system versus 3D system 
 
The traditional method of culturing cell lines is in monolayers in cell culture vessels, 
flasks or petri dishes.  Flat and hard plastic or glass substrate is used in this method 
as the adherent material for the cells.  However, many have questioned the use of 
this 2 dimensional (2D) method of cell culture, especially in neuroscience research.  It 
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is generally accepted that a 2D cell culture method is not capable of mimicking the 
cellular environment found in organisms.  Growth, cell expansion, cell to cell 
interaction and cell to drug interaction are hindered in traditional 2D culture systems, 
thus the accuracy of many studies can be embattled (Abbott, 2003).  
 
In contrast to the traditional 2D method, cells grown in a 3 dimensional (3D) matrix 
has many advantages.  Firstly, it’s a better representation of the cell’s growth 
patterns and interactions in vivo. The 3D system allows cells to form more natural cell 
to cell attachments including gap junctions.  The native configuration of cells and their 
tissue-like flexibility and pliability can be achieved using the 3D culture method.  The 
microenvironment of the 3D culture system promotes many natural cellular 
characteristics such as cell morphology, polarity, motility, differentiation, gene 
expression, cellular migration and many other biochemical activities compared to the 
2D system (Pampaloni et al., 2007).  Studies done using cancer cells have shown 
decreased chemo-sensitivity (Loessner et al., 2010) and decreased radiation-induced 
cytotoxicity (Sowa et al., 2010) in the 3D culture system relative to the 2D monolayer 
system.  Thus, these studies highlight the importance of a 3D culture system to gain 
a better understanding of the pathophysiological events seen in patients. 
 
However, as with any system the 3D culture system has its own disadvantages.  The 
high costs associated with 3D culture is a key limitation in its infrequent use in a 
majority of academic research settings.  Variations between 3D matrix to matrix, over 
time structural changes of the matrix and difficulty in harvesting cells from the matrix 
are a few other limitations.  In addition to these disadvantages, one of the basic 
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difficulties with many differentiation attempts is the prolonged cell culture and 
treatment period.  In particular, the time consuming process of NT2 cell 
differentiation has been widely reported (Pleasure et al., 1992).  
 
 
4.1.4 Outline of the study 
 
Thus, this study was conducted with several aims. The main focus of this study was 
to differentiate three different human cell lines including two neuroblastoma cell 
lines (SY5Y, M17) and a teratocarcinoma cell line (NT-2).  The second main focus was 
to test egg white as a low cost alternative to ECM matrigel using M17 cells.  Thirdly, 
to develop a differentiation method with a shorter culture/treatment period in order 
to maximise economical out turn and productivity.  Differentiation achieved by these 
three improved methods was tested for neuronal-specific markers using 
immunocytochemistry and Western blotting techniques.  
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CHAPTER 4.2: Materials & Methods 
 
 
 
4.2.1 Cell culture 
 
The human neuroblastoma cell lines BE(2)-M17, SH-SY5Y and neuronally committed 
human teratocarcinoma cell line NT2 used in the present experimental study were 
obtained from Professor Leigh Ackland, Centre for Cellular and Molecular Biology, 
Deakin University, (VIC, Australia).   
 
NT2 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% 
heat inactivated foetal bovine serum (FBS).   SH-SY5Y cells were grown in Roswell Park 
Memorial institute 1640 (RPMI) medium supplemented with 20% heat inactivated 
FBS, while BE(2)-M17 cells were cultured in OPTI-MEM (modified Eagles Minimum 
Essential Medium) with 2.5% heat inactivated FBS.  All three cell lines were grown as 
monolayers in 75 cm2 disposable culture flasks (NuncTM, Roskilde, Denmark) and 
incubated at 37°C in a humidified atmosphere of 5% carbon dioxide.  At ~90% 
confluence, cells were harvested or passaged using 0.025% trypsin/EDTA. 
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4.2.2 M17 differentiation using a conventional 2D cell culture system 
 
M17 cells were grown on glass coverslips or in a culture flask in the presence of 10 
μM retinoic acid [all-trans-retinoic acid (RA); Sigma, St. Louis, MO] for a period of 14 
days. Media was replaced every 2–3 days. Cells grown in flasks were harvested for 
Western blot analysis and the coverslips were processed for immunocytochemistry 
studies.  
 
 
4.2.3 M17 differentiation using 3D culture system 
 
Following primary culture, cells were cultured onto Costar Transwell Clear Insert 
(Costar, Cambridge, MA). Four inserts were coated with 200μl of matrigel and egg 
white.  Briefly, thawed egg white or matrigel was pipetted directly into the middle of 
6-well plate wells and spread using a 25 mL pipette.  The coated filters were left to 
set at 37°C for approximately 2-3 hours. Any excess liquid was aspirated before 
seeding of cells. From the following day, two egg white coated filters and two 
matrigel coated filters were treated with 10 μM RA for 14 days.  Media was replaced 
every 2–3 days. Concurrently, control filters were treated with media in the absence 
of RA. Subsequently, cells were either processed for immunocytochemistry or 
harvested for Western blot analysis. 
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4.2.4 Modified 3D culture system for differentiation 
 
The protocol developed for this study was performed by modifying and shortening 
previously reported cell aggregation methods (Paquet-Durand et al., 2003, Jain P et 
al., 2007). A summary of the method employed is exhibited in Figure 4.1.  Cells (1–
1.5 × 106) were grown in corresponding medium (as described previously) on 
bacteriological plates or on filers coated with matrigel to induce neurosphere 
formation.  On day 2, 10 μM RA was added, and medium was replaced every 2-3 days 
for 14 days.  One set of cells grown on bacteriological plates were divided into culture 
flasks and glass coverslips.  The second set was transferred onto filters coated with 
matrigel. All three sets were then treated with corresponding medium containing 
either 5% FBS (SY5Y & NT2 cells) or 1% FBS (M17 cells) and mitotic inhibitors (10 lM 
FUdR, 10 lM Urd, 10 lM araC) for 7 days.  Low FBS and mitotic inhibitors were used 
to reduce non-neuronal cell proliferation.  Neurons were maintained in culture media 
with 5% FBS and mitotic inhibitors, and media was replaced twice a week. Neurons 
could be maintained for approximately 2 months. 
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Figure 4.1: Schematic diagram of the modified 3D cell culture system developed for 
cellular differentiation. 
A summary of the method employed during the study for 3D cellular differentiation. 
Filter Æ Filter method (A), Suspension culture Æ Filter method (B) and Suspension 
culture Æ Flask method were the tree different methods used.  
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4.2.5 Protein isolation and Western blot analysis 
 
Harvested cells were re-suspended in 500 μL lysis buffer (1% sodium dodecyl sulfate 
(SDS) in 10 mM Tris-hydrochloric acid (HCl), pH 6.8).  To prevent protein degradation, 
a mini EDTA-free protease inhibitor cocktail tablet (Roche Applied Science, Castle Hill, 
NSW, Australia) was added to every 10 mL of lysis buffer prior to pipetting onto cell 
pellet.  Cells were placed on ice and homogenized by passing through a 21-gauge 
needle ~10 times and sonicated (40% power output, 30% duty cycle) three times for 
15 seconds with a 30 second break between each sonication, using a Microsone 
ultrasonic cell disrupter (Misonix Incorporated, NY, USA). The homogenate was 
centrifuged at 16,000 X g at room temperature for 10 minutes and the supernatant 
was collected and stored at -80°C until further analysis. Quantification of protein 
concentration was performed using the Pierce BCA Protein Assay Reagent Kit (Perbio, 
Rockford, USA), according to the manufacturer’s Microplate Procedure instructions, 
adapted from Smith et al. (Smith, 1985).   
 
For Western blot analysis, cell lysates (described above) were resolved on 12% SDS-
PAGE gels, transferred onto a nitrocellulose membrane (Pall, Life Sciences, Pensacola, 
Florida, USA) and blocked with 1% (w/v) casein in TBS. Membranes were incubated 
with either  rabbit anti-Beta III tubulin, mouse anti-Tau, mouse anti-DBH or mouse 
anti-MAP antibodies overnight at 4°C. After washing, antibody binding was detected 
with anti-mouse or anti-rabbit (HRP) horseradish-peroxidase conjugated (Chemicon 
International, CA, USA) secondary antibodies (diluted 1:10,000 in TBS), as previously 
described (Suphioglu et al., 2010b).  Proteins were detected using Immobilan 
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Western chemiluminesence HRP substrate (Millipore Corporation, CA, USA) following 
the manufacturer’s instructions.  Membranes were developed using a Fujifilm 
Luminescent Image Analyser LAS-3000.   
 
Developed membranes were stripped for 10 mins at room temperature using 1 mL 
Re-blot Plus-strong (Chemicon International, Temecula, CA, USA) diluted 1:10 in 
MilliQ water. In order to confirm equal protein loading, membranes were re-probed 
for β-actin using a mouse anti-β-actin (Sigma-Aldrich) primary antibody (diluted 
1:5000 in TBS), followed by an anti-mouse HRP antibody (Chemicon International), 
and developed as described above.  Densitometry to quantify results was performed 
using Fujifilm Multi Gauge V2.3 computer software.   
 
 
 
4.2.6 Immunocytochemistry experiments 
 
Immunocytochemistry was performed as previously described (Hardman et al., 
2007). Briefly, treated cells cultured on glass coverslips or coated filters were rinsed 
3 times with PBS, fixed with 4% (w/v) paraformaldehyde (PFA/PBS) (Sigma-Aldrich, 
Sydney, Australia) for 5 minutes at room temperature and rinsed again with PBS 3 
times. The cells were permeabilised with 0.1% (v/v) Triton X-100/PBS (Amresco Inc. 
Solon, USA) for 10 minutes at room temperature, rinsed 3 times with PBS and blocked 
with 1% (w/v) BSA for 10 minutes at room temperature.  Cells were incubated 
overnight at 4°C with either rabbit anti-Beta III tubulin, mouse anti-Tau, mouse anti-
Chapter 4.2: Materials & Methods 
158 | P a g e  
DBH or mouse anti-MAP primary antibodies at a 1:1000 dilution in 1% (w/v) BSA/PBS.  
Samples were then rinsed with PBS 3 times, incubated with either Alexa Flour 488 
anti-mouse (1:10,000) or Alexa Flour 488 anti-rabbit (1:10,000) antibody for 2 hours 
at room temperature, washed 3 times with PBS and mounted with Bio-Rad 
FluoroGuard anti-fade reagent (Bio-Rad, Hercules, USA). Confocal images were 
obtained as previously described (Hardman et al., 2007). 
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CHAPTER 4.3: Results 
 
 
4.3.1  M17 cells are resistant to retinoic acid in a conventional 2D cell culture 
system 
 
Previous studies conducted with the M17 cell line and RA suggest that it is resistant 
to RA and continue to proliferate even after treatment with RA (Draoui et al., 1997).  
These observations were re-tested in a study where M17 cells were cultured in a 
conventional 2D cell culture system. After 14 days of RA treatment, cells were tested 
for cellular differentiation by assessing the expression levels of neuronal markers β-
tubulin III, Tau, DBH and MAP2 using immunocytochemistry and Western blotting 
techniques.    
 
Immunocytochemistry analysis of these RA treated M17 cells demonstrated low 
levels of neuronal markers β-tubulin III (Figure 4.2.1a), Tau (Figure 4.2.2a), DBH 
(Figure 4.2.3a) and MAP2 (Figure 4.2.3a) as visualized by green fluorescence labelling.  
Magnified cell images are also shown to give a more detailed understanding of the 
neuronal marker labelling patterns (Figure 4.2.1b), (Figure 4.2.2b), (Figure 4.2.3b), 
(Figure 4.2.4b).  Green fluorescence labelling was lowest with the DBH antibody and 
the rest displayed very minimal levels of labelling, indicating possible low levels of 
these markers within the M17 cells under these conditions.  
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Immunocytochemistry results were verified by Western blot analysis using the four 
neuronal marker antibodies.  M17 cells treated with RA under the conventional 2D 
cell culture method did not demonstrate a significant difference in neuronal marker 
levels compared to untreated cells (Figure 4.3A).  Equal protein loading of the gel 
lanes was assessed by Western blot analysis for the housekeeping gene, β-actin 
(Figure 4.3B).   Neuronal marker protein levels were then normalized against the 
corresponding β-actin protein levels and densitometry analysis was performed to 
quantify the changes in expression.  Following densitometry analysis, it was 
confirmed that there was no significant changes in the levels of any neuronal markers 
in RA-treated cells compared to untreated control cells (Figure 4.3C) in the 2D culture 
system.   These results were consistent across the three individual experimental sets 
and the findings corroborated published literature regarding differentiation of M17 
cells using RA under a conventional 2D cell culture method. 
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Figure 4.2: Immunocytochemistry analysis of M17 cell differentiation using the 
traditional 2D culture system. 
Immunocytochemistry analysis of RA treated M17 cells for neuronal markers β-
tubulin III (1-a), Tau (2-a), DBH (3-a) and MAP2 (4-a) as visualized by green 
fluorescence labelling.  Magnified cell images are also shown next to the 
corresponding image to give a more detailed understanding of the neuronal marker 
labelling patterns (Figure 4.2-b).  Red signalling was from nuclear ethidium bromide 
staining 
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Figure 4.3: Western blotting analysis of M17 cell differentiation using traditional 
2D culture system. 
Neuronal markers, β-tubulin III, Tau, DBH and MAP2 (A) and the housekeeping β-
actin (B) protein levels of M17 cells cultured in 2D system in the presence of RA 
were measured with specific antibodies. (C) Densitometric analysis of neuronal 
marker protein levels (normalised with the β-actin protein levels) are shown in 
arbitrary units (AU). Molecular mass protein markers (Mr) are indicated on the left 
of each gel. This result is representative of three similar independent experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Chapter 4.3: Results 
163 | P a g e  
4.3.2 M17 cells acquire expression of neuronal markers when cultured in the 
presence of RA in a 3D cell culture system 
 
Since M17 showed resistance to RA in a 2D cell culture, a novel method was 
developed to culture cells in a 3D matrix to promote RA induced differentiation. The 
3D culture system was developed using cell culture filters and coating them with 
matrigel or the cheaper alternative egg white, as the 3D cell adhesive media.  Cells 
cultured using the 3D system were treated with 10 μM RA for 14 days.  Following 
treatment, cells were harvested and analysed for expression levels of neuronal 
markers β-tubulin III, Tau, DBH and MAP2 using immunocytochemistry and Western 
blotting techniques.   
 
 
4.3.2.1 Immunocytochemistry results revealed a clear difference between 2D and 
3D culture systems 
 
The dichotomy between 2D and 3D cell culture systems was clearly demonstrated by 
the immunocytochemistry results.  A dramatic increase was clearly visible in all four 
neuronal markers tested (Figure 4.4).  Green fluorescence labelling in RA treated 
experimental groups under 3D conditions showed a marked increase in fluorescence 
labelling compared to the 2D culture system.  Under the microscope, most of the cells 
showed neuronal morphology, including elongated axons and dendrites.  With the 
3D culture system, labelling of neuronal markers was stronger and unanimous among 
the cells.  Also importantly, despite of the cell adhesive media used, both matrigel 
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and the cheaper alternative egg white produced strong labelling with all four 
neuronal markers with only a slight difference in the labelling intensity.  Nuclear 
labelling is indicated in red by ethidium bromide staining.  β-tubulin III labelling of 
differentiated M17 cells showed very strong signalling with the matrigel system 
(Figure 4.4.1-a) compared to the egg white system (Figure 4.4.1-b).  Elongated and 
fluorescence labelled axons were visible in both matrigel and egg white grown cells. 
A similar pattern was observed with the tau antibody as well, where cells grown on 
matrigel (Figure 4.4.2-a) showed a slight increase in antibody labelling compared to 
cells grown on egg white (Figure 4.4.2-b).  β-tubulin III is mainly present in 
microtubules and tau is a microtubule-associated protein.  Thus, an elongated 
labelling pattern was visible with antibody binding.  However, fluorescence labelling 
with DBH was more intracellular in its localisation pattern.  Matrigel grown cells 
(Figure 4.4.3-a) still produced stronger signalling with the antibody labelling 
compared to cells grown on egg white (Figure 4.4.3-b).  An antibody specific to MAP2 
proteins also produced similar results as the other three antibodies.  Strong and well-
defined antibody staining was visible with cells grown on matrigel (Figure 4.4.4-a), 
and a slightly reduced but still well defined antibody labelling was present with cells 
grown on egg white (Figure 4.4.4-b). 
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Figure 4.4: Immunohistochemistry analysis of M17 cells differentiated on matrigel 
and egg white matrixes.  
M17 cell were grown in either matrigel (a) or egg white (b) and Immunocytochemistry 
analysis of RA treated cells were done to test the neuronal marker levels.  β-tubulin 
III (1), Tau (2), DBH (3) and MAP2 (4) antibody labelling are visualized by green 
fluorescence signals.  Red signalling was from nuclear ethidium bromide staining 
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4.3.2.2 Analysis of protein expression levels in RA treated M17 cells using a 3D 
culture system 
 
M17 cells from both matrigel and egg white matrixes were collected and lysed to 
extract protein, and then analysed by Western blotting.  Four antibodies were used 
to assess changes in the protein expression levels of neuronal cell markers.  The 
experiment was repeated three times and the results were consistent among the 
three independent replicates. 
 
β-tubulin III expression was significantly increased in lysates of all RA treated M17 
cells compared to untreated cells, which was demonstrated by a strong band of 
approximately 50-55 kDa by Western blot analysis.  This strong band was visible in 
both egg white and matrigel systems (Figure 4.5-A).  The band corresponding to 
untreated cell lysates was very faint suggesting low levels of β-Tubulin-III.  Protein 
loading was normalized using β-actin levels (Figure 4.5-B), and densitometric analysis 
was performed to quantify changes in the expression levels (Figure 4.5-C).  
Densitometry results demonstrated an approximately 7-fold increase in β-tubulin III 
protein levels in cells grown on matrigel compared to control cells. In cells grown on 
egg white, the fold difference was lower (3-fold) but still significant similar to the cells 
grown on matrigel. 
 
A second Western blot incubated with antibodies specific for tau protein displayed a 
band of approximately 80 kDa in all lanes confirming expression of the protein.  Band 
intensity was much weaker in untreated control cells compared to RA-treated cells 
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(Figure 4.5-A).  This suggested that tau protein levels have increased following RA 
treatment in the 3D culture method.  Both egg white and matrigel showed very 
similar results, with tau signalling having only about 1-fold difference between the 
two adhesive media.  β-actin levels were then tested to ensure equal protein loading 
across all the lanes (Figure 4.5-B), followed by quantification using densitometry 
analysis (Figure 4.5-C), which showed approximately a 9-fold increase in tau 
expression in response to RA treatment compared to untreated cells in the matrigel 
system.  
 
When incubated with an antibody specific for DBH, a band of approximately 70 kDa 
was visible in all lanes confirming expression of the protein.  Moreover, an increase 
in band intensity was noticeable in RA treated cells compared to untreated cells 
(Figure 4.5-A).  Band intensity was highest with the matrigel system followed by the 
egg white system, with very faint signalling visible in control samples using both 
systems.  This suggests that DBH protein expression levels have increased following 
RA treatment using the 3D culture method.  β-actin levels were then tested to ensure 
equal protein loading across all the lanes (Figure 4.5-B), followed by the densitometry 
analysis (Figure 4.5-C).  Quantification analysis revealed that using the matrigel 
system, over 7-fold increase in DBH expression was seen at the protein level in RA-
treated cells compared to the control M17 cells.  With the egg white system, a 5-fold 
increase in DBH protein levels was detected than in control cells.  
 
MAP2 also displayed a similar trend to the other three neuronal markers.  When 
treated with RA, M17 cells showed an increase in MAP2 band intensity when cultured 
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in a 3D culture model.  Expression of the MAP2 protein was confirmed by the 
presence of an approximately 75 kDa band in all lanes (Figure 4.5-A).  Once again, the 
band intensity was highest with the matrigel system (approximately 4-fold increase) 
compared to the control sample.  Cells grown on egg white also showed an increase 
of about 2.5-fold than the control M17 cells.  β-actin levels were then tested to 
ensure equal protein loading across all lanes (Figure 4.5-B), followed by the 
densitometry analysis (Figure 4.5-C).   
 
The increase observed in the protein expression levels of neuronal markers with the 
3D culture system was contradictory to findings from the 2D culture system and the 
reported observations in published literature.  These findings are significantly 
important considering the level of differentiation achieved with the novel 3D culture 
method.  Findings made in this study reiterate the importance of a 3D culture system 
in achieving a better differentiation, at least in M17 cells.  
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Figure 4.5: Changes in protein expression levels in M17 cells following 3D culture 
differentiation. 
Neuronal markers, β-tubulin III, Tau, DBH and MAP2 (A) and the housekeeping β-
actin (B) protein levels of M17 cells grown in 3D culture system in the presence of 
RA were measured with specific antibodies. (C) Densitometric analysis of neuronal 
marker protein levels (normalised with the β-actin protein levels) are shown in 
arbitrary units (AU). Molecular mass protein markers (Mr) are indicated on the left 
of each gel. This result is representative of three similar independent experiments. 
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4.3.3  Modified 3D culture method with reduced differentiation time 
 
The following modified 3D culture method was used to differentiate neuronal cell 
lines, and consequently develop a differentiation method with a reduced treatment 
period. 
 
METHOD 1: Cells grown on matrigel with RA (for 2weeks) Æ Cells grown on 
matrigel for 1 week with anti-mitotic agents, no RA.  
METHOD 2: Suspension culture of cells with RA (for 2weeks) Æ Cells grown on 
matrigel for 1 week with anti-mitotic agents, no RA.  
METHOD 3: Suspension culture of cells with RA (for 2weeks) Æ Normal cell culture 
flasks for 1 week with anti-mitotic agents, no RA.  
 
Immunocytochemistry was performed to assess the neuronal marker protein levels 
using antibodies specific for β-tubulin III, tau, DBH and MAP proteins.  MAP2 and DBH 
are classified as markers of later stages of differentiation, while β-tubulin III is 
classified as a more early stage differentiation marker in neuronal cells (Gingras et 
al., 2007).   The cells used for these experiments were cultured using the three 
different cell culture methods (detailed above) for three weeks in the presence of RA.  
Cells were cultured in 10 μM RA for the first two weeks followed by one week of 
treatment with mitotic inhibitors.  Three different human cell lines, which include the 
neuroblastoma M17 and SY5Y cells, and the teratocarcinoma NT2 cells, were cultured 
using these three different culture methods.  Therefore, there were 9 different 
treatment regimens and with four neuronal markers, 36 samples per set in total.    
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4.3.3.1 Filter method 
 
This was the most basic method out of the three methods tested.  Cells were grown 
on filters which were coated with matrigel as the culture media, and after three 
weeks of treatment, filter pieces were cut out to be used in immunocytochemistry, 
and the rest of the cells were used to perform Western blotting. 
 
 
4.3.3.1.1 M17 cells 
 
M17 cells, which were cultured on filters, produced a strong fluorescence signal for 
all four neuronal markers (Figure 4.6.1-a, 4.6.2-a, 4.6.3-a & 4.6.4-a,).  This was 
consistent with the previous study done with M17 cells cultured on a basic 3D system 
using RA.  Red ethidium bromide labelling was used as the nuclear marker and green 
Alexa 488 labelling corresponds to the neuronal marker primary antibody.  
 
β-tubulin III protein expression was seen in M17 cells with very strong green 
fluorescence labelling present in both the cytoplasm and nucleus (Figure 4.6.1-a). 
This labelling was seen in almost all and was consistent across the three individual 
experimental sets. Tau labelling was also very strong (Figure 4.6.2-a) in M17 cells 
grown on filters with RA.  Tau protein is predominantly found in the axons of neurons, 
in the cytosol and in association with plasma membrane components.  DBH also 
produced strong cytoplasmic fluorescence labelling in differentiated M17 cells 
(Figure 4.6.3-a).  This is an indication of late stage differentiation of these particular 
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cells.  Strong MAP2 labelling was present in M17 cells (Figure 4.6.4-a), indicating that 
the cells have reached a later stage of differentiation.  With the tested samples, 
almost all the cells unanimously produced positive fluorescence labelling suggesting 
universal expression of these specific neuronal marker proteins.   
 
 
4.3.3.1.2 SY5Y cells 
 
All four antibodies for neuronal markers produced strong fluorescence labelling in 
SY5Y cells (Figure 4.6.1-b, 4.6.2-b, 4.6.3-b & 4.6.4-b,).  Specific neuronal marker 
signals are identified by green labelling, while the red labelling indicates nuclear 
staining by ethidium bromide.  DBH green labelling visible was more concentrated in 
the cytoplasmic area, and with other antibodies they were detected more towards 
the neurites.  Differentiated SY5Y cells were more elongated compared to normal 
undifferentiated cells. Tau and MAP2 labelling was especially distinctive in neurite 
projections in RA treated cells.  Both DBH and MAP2 labelling were once again very 
strong in RA treated SY5Y cells, suggesting full differentiation of the cells. The 
antibody staining of these cells were consistent indicating complete differentiation 
of the systems as a whole.  Results obtained were consistent among the replicates 
demonstrating convincing differentiation of SY5Y cells under these conditions.   
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4.3.3.1.3 NT2 cells 
 
Strong fluorescence labelling was visible with all four antibodies when NT2 cells were 
treated with RA (Figure 4.6.1-c, 4.6.2-c, 4.6.3-c & 4.6.4-c,).  Similar with other cells 
discussed above, red fluorescence staining indicates ethidium bromide labelling of 
the nucleus and green staining corresponds to the neuronal marker primary 
antibody.  In general, using the filter method, NT2 cells had a tendency to grow as 
cluster-like formations, which made it difficult to identify individual cells. 
Nevertheless, fluorescence labelling was present abundantly with all neuronal 
marker antibodies.  Published literature suggests that at least 5-6 weeks of RA 
treatment of NT2 cells can achieve their complete differentiation (Jain et al., 2007).  
However, the presence of DBH and MAP2 after just 3 weeks of RA treatment using 
the new method employed in this study suggests otherwise.  Following RA treatment, 
neurite bearing cells were clearly visible, while non-neuronal cells had almost 
disappeared, thus producing ubiquitous labelling of the cells with all four antibodies. 
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Figure 4.6: 3D Cell differentiation – filter method.    
Immunocytochemistry analysis of cells cultures with 3D filter method and treated 
with RA.  Fluorescence signalling from neuronal markers β-tubulin III (1), Tau (2), DBH 
(3) and MAP2 (4) were present in all the three cell lines, M17 (a), SY5Y (b) and NT2 
(c).  Red signalling was from nuclear ethidium bromide staining 
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4.3.3.2 Suspension Æ filter method 
 
Cells were grown in a suspension culture with RA for two weeks, then transferred 
onto filters coated with matrigel and then cultured for another week with mitotic 
inhibitors prior to use in immunocytochemistry. 
 
 
4.3.3.2.1 M17 cells 
 
Antibody specific labelling was detected with all four neuronal markers in RA treated 
M17 cells (Figure 4.7).  Green fluorescence signifies labelling by neuronal marker 
antibodies and red labelling indicates nuclear staining by ethidium bromide. 
M17 cells displayed a more cluster forming tendency with this method compared to 
the filter only method used previously.  However, clear neurite outgrowth was 
present and the cells were more elongated under RA treatment compared to the 
normal spindle shape (Figure 4.7).  
 
Strong green labelling was visible with β-tubulin III antibodies suggesting expression 
of this neuronal marker protein (Figure 4.7.1.a).  This labelling was present in almost 
90-95% cells grown on coverslips.  The same expression pattern was seen with tau, 
which also produced strong green fluorescence labelling (Figure 4.7.2.a).  Since most 
of the cells were in a cluster formation, a defined labelling pattern in terms of protein 
localisation could not be identified.   
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Both MAP2 (Figure 4.7.3.a) and DBH (Figure 4.7.4.a) neuronal markers were present 
in RA treated M17 cells as shown by green fluorescence labelling.  Presence of these 
two neuronal markers suggests cells have reached the final stages of differentiation.  
The majority of M17 cells were positive for green fluorescence labelling.   
 
 
4.3.3.2.2 SY5Y cells 
 
SY5Y cells treated with RA demonstrated positive fluorescence labelling for the four 
neuronal marker antibodies tested (Figure 4.7.1.b, Figure 4.7.2.b, Figure 4.7.3.b, 
Figure 4.7.4.b).  Signals from the neuronal specific marker are shown by green 
fluorescence and red labelling indicates nuclear staining by ethidium bromide.  
Neuronal projections from SY5Y cells can be clearly identified using antibodies 
specific for β-tubulin III (Figure 4.7.1.b), tau (Figure 4.7.2.b) and MAP2 (Figure 
4.7.3.b).  However, more prominent elongations were seen with the later neuronal 
marker.  DBH (Figure 4.7.4.b) was more confined to the cytoplasmic area, which was 
consistent with previous experiments.  Once again, by the presence of fluorescence 
labelling for DBH and MAP2, it can be concluded that the cells are at a more end stage 
of differentiation. All cells on the slide were universally fluorescent labelled and this 
was consistent among the individual experimental sets. 
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4.3.3.2.3 NT2 cells 
 
All four neuronal marker antibodies produced strong fluorescence labelling in NT2 
cells cultured using the suspension and filter method and treated with RA (Figure 
4.7.1.c, Figure 4.7.2.c, Figure 4.7.3.c, Figure 4.7.4.c).  As mentioned previously, red 
labelling signifies nuclear labelling from ethidium bromide and green labelling 
corresponds to the neuronal marker primary antibody. NT2 cells still exhibited a 
cluster formation tendency, however the tendency was decreased compared to the 
Filter method. Both end stage neuronal markers were also present, as highlighted by 
green labelling indicating the cells are fully differentiated.  Specific labelling 
localisations or patterns were again hard to identify due to the cluster like formations 
displayed by NT2 cells. 
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Figure 4.7: 3D Cell differentiation – Suspension Æ filter method.  
Immunocytochemistry analysis of cells cultures with suspension culture Æ filter 
method and treated with RA.  Fluorescence signalling from neuronal markers β-
tubulin III (1), Tau (2), DBH (3) and MAP2 (4) were present in all the three cell lines, 
M17 (a), SY5Y (b) and NT2 (c).  Red signalling was from nuclear ethidium bromide 
staining 
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4.3.3.3 Suspension Æ flask method 
 
Cells were grown in a suspension culture for two weeks in the presence of RA, then 
transferred into cell culture flasks and cultured for another week with mitotic 
inhibitors prior to use in immunocytochemistry. 
 
 
4.3.3.3.1 M17 cells 
 
When cultured using this method, M17 cells produced specific fluorescence labelling 
for all four neuronal markers tested.  Green fluorescence labelling corresponded to 
specific neuronal marker antibodies and red labelling represented nuclear staining 
from ethidium bromide.  This method promoted cell growth in a monolayer enabling 
easier detection by immunocytochemistry compared to the other two culture 
methods.   
 
The β-tubulin III antibody produced strong green labelling indicating a very high 
expression level of the protein in M17 cells (Figure 4.8.1.a).  This protein was 
expressed by all of the cells present on the coverslip.  A similar expression pattern 
was seen with the tau antibody, which produced strong green fluorescence labelling 
(Figure 4.8.2.a) in M17 cells.  Cell elongation and the presence of neurites were 
identified when M17 cells were cultured using this method.  MAP2 (Figure 4.8.3.a) 
and DBH (Figure 4.8.4.a) neuronal markers were also present in RA treated M17 cells, 
which were identified by green fluorescence labelling.  Positive labelling for MAP2 
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and DBH neuronal markers suggests these cells have reached the final stages of 
differentiation.   
 
 
4.3.3.3.2 SY5Y cells 
 
Strong green fluorescence labelling detected in SY5Y cells demonstrated positive 
expression of the four neuronal marker antibodies tested (Figure 4.8.1.b, Figure 
4.8.2.b, Figure 4.8.3.b, Figure 4.8.4.b).  Red labelling present in the images are nuclear 
staining by ethidium bromide.  As seen with M17 cells, the presence of fluorescence 
labelling for both DBH and MAP2 suggests that the cells are in a later stage of 
differentiation.  Florescent-labelled cells comprised almost 100% of cells present on 
the slide and this phenomenon was consistent across the individual experimental 
sets. 
 
 
4.3.3.3.3 NT2 cells 
 
When cultured using the suspension and flask method in the presence of RA, NT2 
cells indicated positive labelling for all four neuronal marker antibodies used (Figure 
4.8.1.c, Figure 4.8.2.c, Figure 4.8.3.c, Figure 4.8.4.c).  Even with this culture method, 
NT2 cells displayed a cluster-forming tendency although this was almost negligible 
when compared with the previous two methods.  Neuronal projections and cell 
elongations could be clearly identified as the morphological changes the cells have 
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undergone when cultured using this method.  NT2 cells produced green fluorescence 
labelling for both DBH and MAP2 end stage neuronal markers, indicating the cells 
were fully differentiated.   
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Figure 4.8: 3D Cell differentiation – suspension Æ flask method.  
Immunocytochemistry analysis of cells cultures with suspension culture Æ flask 
method and treated with RA.  Fluorescence signalling from neuronal markers β-
tubulin III (1), Tau (2), DBH (3) and MAP2 (4) were present in all the three cell lines, 
M17 (a), SY5Y (b) and NT2 (c).  Red signalling was from nuclear ethidium bromide 
staining 
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4.3.4 Analysis of protein expression levels in RA treated cells using the modified 3D  
culture systems 
 
Cells cultured with RA using three different 3D culture systems were collected and 
lysed to extract proteins.  Extracted proteins were then analysed using Western 
blotting.  The same four antibodies (β-tubulin III, tau, DBH and MAP2) used in 
immunocytochemistry were used in Western blotting to assess changes in protein 
expression levels of neuronal markers.  
 
A strong band of approximately 50 kDa was visible in all the lanes indicating the 
presence of β-tubulin III protein (Figure 4.9.A). The intensity of the bands 
corresponding to β-tubulin III was lower in the 1st, 5th and the 9th lanes where proteins 
were from the untreated M17, SY5Y and NT2 cells, respectively.  Furthermore, 
Western blotting of M17 cell proteins showed the largest increase in band intensity 
between control cells and RA treated lanes (Figure 4.9.A), followed by NT2 and SY5Y 
cells.  Protein loading was normalized using β-Actin levels (Figure 4.9.B), which 
verified consistent loading across all lanes.  Densitometric analysis was performed to 
quantify protein levels and the results are presented as a graph (Figure 4.9.C).  
Suspension culture followed by culture in filters showed the highest increase in the 
levels of β-tubulin III protein in both M17 and NT2 cells.  The increase in the levels of 
this neuronal marker was relatively lower in SY5Y cells compared to the other two 
cell lines.  However, the increase in β-tubulin III protein levels in RA treated cells was 
still significant when compared to untreated control SY5Y cells. 
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A band of approximately 80 kDa in size was visible when incubated with antibodies 
specific for tau protein (Figure 4.10.A).  Once again, the lanes corresponding to 
untreated control cells displayed the weakest band relative to RA treated lanes.  This 
observation suggests that tau protein levels have increased following RA treatment.  
The most significant increase in tau protein was displayed in SY5Y cells.  Increase in 
the tau levels following the RA treatment was consistent and verified the previous 
observations made with M17 cells in the basic 3D culture system.  Equal protein 
loading across all lanes were evaluated using the housekeeper gene β-actin (Figure 
4.10B), followed by quantification using densitometry analysis (Figure 4.10.C).  
Similar to β-tubulin III expression levels, tau expression was highest with the 
suspension Æ filter method.   
 
Western blots incubated with an antibody specific for DBH also produced a strong 
band of approximately 70 -75 kDa in all lanes (Figure 4.11.A), revealing the presence 
of this neuronal marker in all samples. The intensity of the band was lower in the 1st, 
5th and 9th untreated samples compared to the RA treated protein samples.  Increase 
in the band intensity of this neuronal marker with RA treatment suggests the 
acquisition of neuronal cell-like properties following RA treatment.   Blots were re-
probed with β-actin to ensure equal protein loading across all lanes (Figure 4.11.B).  
Subsequently, densitometric analysis was performed to quantify the changes 
observed (Figure 4.11.C).  All 3 cell lines showed a significant increase in DBH 
expression in response to RA, and of these M17 cells exhibited the most prominent 
change.  
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MAP2 expression was significantly increased in lysates of all RA treated cells 
compared to untreated cells (Lanes 1, 8 and 15), which was demonstrated by a strong 
band of approximately 70 kDa by Western blot analysis (Figure 4.12.A).  Presence of 
these strong bands suggests high expression of this neuronal specific marker in RA 
treated samples compared to untreated cells.  Protein loading was normalized using 
β-actin (Figure 4.12.B) and densitometric analysis was done to quantify the findings 
(Figure 4.12.C).  SY5Y cells showed the largest increase in MAP2 expression.   Both 
NT2 and M17 cells showed similar levels of change in MAP2 levels following RA 
treatment.  All three cell lines showed the highest change in expression using the 
suspension Æ filter method when treated with RA. 
 
This increase in MAP2 and DBH levels when treated with RA using these 3D culture 
systems demonstrates that the cells have progressed to a later stage of neuronal 
differentiation.  
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Figure 4.9: Changes in β-tubulin III protein expression levels in cells following 3D 
culture differentiation. 
Western blot analysis of β-tubulin III protein levels in cells cultures with novel 3D 
culture methods and treated with RA.  The housekeeping β-actin (B) protein levels of 
cells were also analysed using Western blotting.  Densitometric analysis (C) of β-
tubulin III protein levels (normalised with the β-actin protein levels) are shown in 
arbitrary units (AU). Molecular mass protein markers (Mr) are indicated on the left of 
each gel. Corresponding control cells (WT) were used to analyse the difference in the 
expression levels (lanes 1, 5 & 9). This result is representative of three similar 
independent experiments. 
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Figure 4.10: Changes in tau protein expression levels in cells following 3D culture 
differentiation. 
Western blot analysis of tau levels in cells cultures with novel 3D culture methods 
and treated with RA.  The housekeeping β-actin (B) protein levels of cells were also 
analysed using Western blotting.  Densitometric analysis (C) of tau protein levels 
(normalised with the β-actin protein levels) are shown in arbitrary units (AU). 
Molecular mass protein markers (Mr) are indicated on the left of each gel. 
Corresponding control cells (WT) were used to analyse the difference in the 
expression levels (lanes 1, 5 & 9). This result is representative of three similar 
independent experiments. 
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Figure 4.11: Changes in DBH protein expression levels in cells following 3D culture 
differentiation. 
Western blot analysis of DBH levels in cells cultures with novel 3D culture methods 
and treated with RA.  The housekeeping β-actin (B) protein levels of cells were also 
analysed using Western blotting.  Densitometric analysis (C) of DBH protein levels 
(normalised with the β-actin protein levels) are shown in arbitrary units (AU). 
Molecular mass protein markers (Mr) are indicated on the left of each gel. 
Corresponding control cells (WT) were used to analyse the difference in the 
expression levels (lanes 1, 5 & 9). This result is representative of three similar 
independent experiments. 
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Figure 4.12: Changes in MAP2 protein expression levels in cells following 3D 
culture differentiation. 
Western blot analysis of MAP2 levels in cells cultures with novel 3D culture methods 
and treated with RA.  The housekeeping β-actin (B) protein levels of cells were also 
analysed using Western blotting.  Densitometric analysis (C) of MAP2 protein levels 
(normalised with the β-actin protein levels) are shown in arbitrary units (AU). 
Molecular mass protein markers (Mr) are indicated on the left of each gel. 
Corresponding control cells (WT) were used to analyse the difference in the 
expression levels (lanes 1, 5 & 9). This result is representative of three similar 
independent experiments. 
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CHAPTER 4.4: Discussion 
 
 
RA induced cellular differentiation is one of the most common and widely used 
methods in differentiating cells, including neuronal cell lines.  Currently, the 
neuroscience field is lacking a successful and economical method to differentiate 
neuronal cells into the primary neuronal stage.  Many studies reported in the 
literature with different cell lines have been unable to develop a successful, 
economical and universal method to differentiate human neuronal cells.  In this 
study, we were able to compare and further develop the current methods used into 
a more economical and efficient method.  This study also obtained very conclusive 
evidence to elucidate the importance of a 3D cell culture system in neuronal cell 
differentiation. 
 
  
4.4.1 M17 cells are resistant to retinoic acid in a conventional 2D cell culture system 
 
When M17 cells were cultured using a conventional 2D system, they showed 
resistance towards RA treatment.  This was concluded by both immunocytochemistry 
and Western blotting techniques.  With both methods, M17 cells showed no 
significant increase in neuronal marker levels (Figure 4.2 and Figure 4.3) following a 
14-day RA treatment. 
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Green fluorescence labelling indicative of neuronal marker expression (Figure 4.2) 
was very limited for all four tested neuronal marker antibodies (β-tubulin III, tau, DBH 
& MAP2).  Western blotting results also showed (Figure 4.3) no significant increase 
when quantified using densitometric analysis.  These findings are in agreement with 
literature where it has been reported that following RA treatment, proliferation 
rather than differentiation or apoptosis occurs (Draoui et al., 1997; Ramkumar and 
Adler, 1999).  Although RA resistance of M17 cells with the conventional 2D culture 
method has been widely reported, the mechanism involved in RA resistance remains 
to be investigated (Melino et al., 1996).  Nevertheless, cell-cell interaction is well 
known to be important in neuronal development.  Cell-cell interaction is crucial 
during neural development.  Many aspects of neuronal development, including 
migration of neural cells and the establishment of functional interactions between 
axons and their target cells are highly dependent on cell-cell interactions (Cole et al., 
1986).  Cellular interaction and the environment has also been directly linked with 
neuronal cell differentiation and cellular morphogenesis (Letourneau et al., 1994).  
Moreover, the ECM and neuronal cell interaction has also been linked to neuronal 
cell migration, cell shape, cytoskeletal architecture and neurite growth (Damsky and 
Werb, 1992; Strittmatter and Fishman, 1991).  Both cell-cell interaction and cell-ECM 
interaction are limited in a conventional 2D cell culture model.  This may be the 
underlying reason for the limited cellular differentiation observed with M17 cells in a 
2D culture. 
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4.4.2 M17 cells acquire expression of neuronal markers when cultured in the 
presence of RA in a 3D cell culture system 
 
The conventional method of cell culture involves growing cells on a flat 2D substrate, 
hence far different from the physiological environment of the in vivo state.   Under 
physiological conditions, cells acquire their natural 3D structure where it is supported 
by a complex ECM, which facilitates the cells to function in their optimal condition.  
However, the widely used 2D cell culture models does not allow for such support or 
cell-cell interactions and contacts thus, failing to provide the sufficient physical and 
chemical cues which underlie their characteristics and functions in vivo (Ben-Ze'ev, 
1991).  As a consequence, there has been widespread concern and discussion 
regarding the validity and resemblance of the data obtained from 2D cell culture 
models to a 3D culture model (Geckil et al., 2010). 
 
As mentioned previously, M17 cells have been reported to be RA resistant in a normal 
2D culture system.  Thus, a novel method was developed in my PhD studies to culture 
cells in a 3D matrix to promote RA-induced cell differentiation. A 3D culture system 
was developed using cell culture filters and coating them with matrigel or the cheaper 
alternative, egg white as the 3D cell adhesive media. Cells cultured on the 3D systems 
were treated with either 10 μM RA as the experimental group or without RA as the 
control group. After 14 days, cells were harvested and analysed for the expression 
levels of neuronal markers using immunocytochemistry and Western blotting.   
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The dichotomy between a 2D and 3D cell culture system was clearly demonstrated 
by the immunocytochemistry results alone. A dramatic increase was clearly evident 
in all the neuronal marker protein levels (Figure 4.4), compared to the 2D culture 
method (Figure 4.2).  With 2D differentiation, neuronal marker labelling of M17 cells 
was very limited and could not be seen in all the cells present. However, with the 3D 
culture system, RA treated cells displayed strong and unanimous labelling of the 
neuronal markers.  Most importantly, despite the type of cell adhesive media used, 
both matrigel and the cheaper alternative egg white produced strong labelling for the 
tested neuronal markers. However, signals produced with egg white were slightly 
weaker than with the matrigel system.  After 14 days of RA treatment, the matrigel 
matrix was holding marginally better than the egg white matrix.  Considering the 
prolonged time (3-4 weeks) of the next study, matrigel was selected as the preferred 
matrix for further studies.   However, after considering the results obtained during 
the current study and given its cost effectiveness and readily availability, egg white 
can be classified as a very cost effective alternative for matrigel.    
 
The immunocytochemistry results were re-confirmed by Western blotting results 
where there was a significant increase in neuronal marker protein levels in 3D 
cultured cells when compared to that in control M17 cells (Figure 4.5).  Only a minor 
and almost negligible difference could be seen in the expression levels of the 
neuronal marker proteins between matrigel and egg white matrixes.  
 
This increase in neuronal marker levels observed in M17 cells was contradictory from 
the results obtained with the 2D method and also with the reported literature where 
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conventional 2D culture method and RA was used on M17 cells (Draoui et al., 1997).  
Though this observation is novel and not previously reported in the literature, similar 
kind of differences in the expression levels have been reported in relation to 2D and 
3D cell culture methods.  Studies done with PMC4 cells have shown an increase in 
milk-specific gene expression when treated with hormone in a 3D matrix system 
compared to the flat 2D system (Ackland et al., 2001).  Extensive studies done with 
human endothelial cells have also shown the importance of a 3D cell culture system 
over a 2D method.   A study conducted by Davis and colleague have shown that when 
cultured in a 3D system, human endothelial cells develop intracellular vacuoles that 
coalesce to form capillary lumens and tubes (Davis and Camarillo, 1996).  In another 
study, Sacharidou and colleagues have shown the importance of a 3D culture over a 
2D system where they reported a 3D culture specific endothelial lumen signalling 
complexes involved in the formation of lumen and tube structures of endothelial cells 
(Sacharidou et al., 2010).  Culture of human skin cells have also shown marked 
increase in their ability to withstand cytotoxic agents when cultured in a 3D method.  
This study reported up to 50% increase in resistance and a difference in the way cells 
respond to small molecules under a 3D culture method (Sun et al., 2006).   
 
There are more compelling evidence highlighting the difference in the way cells react 
and interact when grown in a 3D culture system rather than using the conventional 
method.  Thus, the observations made by the current study re-iterate the importance 
of a 3D culture system over a conventional 2D system.  Though many publications 
have reported M17 cells as RA resistant and not differentiable, this study 
demonstrates that under the correct conditions it can be induced to differentiate into 
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a more neuronal cell-like stage.  Thus, the current study allows the usage of a cell 
culture model that is more readily available for neuronal research.  
 
 
4.4.3 Modified 3D culture methods 
 
NT2 cells in general are considered to have a rather prolonged differentiation 
process.  Published literature reports that they can take between 42 and 54 days to 
differentiate into post-mitotic neurons (Andrews, 1984).  Another study has 
suggested the use of suspension cultures to reduce the differentiation time of NT2 
cells (Jain et al., 2007; Paquet-Durand and Bicker, 2007; Paquet-Durand et al., 2003).  
One of the disadvantages of suspension cultures is their susceptibility for infections.  
Suspension cultures need regular agitation to keep cells in suspension and 
centrifuging to passage cells (Mustafa et al., 2011).  The absence of an ECM and cell 
interactions may be a limiting factor with this method in achieving terminal 
differentiation with some cell types.  Hence, the following modified 3D culture 
methods were used to differentiate neuronal cell lines with a reduced treatment 
period and a better 3D model of cellular matrix: 
1. Cells grown on matrigel with RA (for 2weeks) Æ Cells grown on matrigel for 1 
week with anti-mitotic agents, no RA;  
2. Suspension culture of cells with RA (for 2weeks) Æ Cells grown on matrigel 
for 1 week with anti-mitotic agents, no RA; 
3. Suspension culture of cells with RA (for 2weeks) Æ Normal cell culture flasks 
for 1 week with anti-mitotic agents, no RA.  
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Immunocytochemistry and Western blotting were performed to assess neuronal 
marker protein levels using antibodies for β-tubulin III, tau, DBH and MAP proteins 
following the treatment periods.   MAP2 and DBH are classified as markers of late 
stage differentiation, while β-tubulin III is classified as an early stage marker of 
neuronal cell differentiation (Gingras et al., 2007). 
 
Immunocytochemistry analysis of the three cell lines displayed positive and specific 
labelling with the four neuronal marker antibodies tested (Figure 4.6, 4.7 and 4.8) , 
and Western blotting confirmed the findings of immunocytochemistry analysis 
(Figure 4.9, 4.10, 4.11 & 4.12).  Western blotting and densitometry analysis confirmed 
that the increase in neuronal marker protein levels were significant in all three cell 
lines with all three different methods tested.  In summary, cells grown in suspension 
with RA followed by the filter method demonstrated the highest level of significance.  
However, cells grown on the filter for the entire period also showed similar results to 
the suspension Æ filter method.  Cells grown on suspension culture and transferred 
onto cell culture flasks also showed an increase in neuronal marker protein levels.  
However, compared to the other two methods the increase in expression of the 
neuronal markers was considerably low.  This observation suggests that the extra one 
week of 3D culture can promote cellular differentiation even further.  As discussed 
above, this might be due to the cell-cell interaction and ECM-cell interaction, which 
is more conceivable with the 3D matrix than with monolayer flasks. 
 
The positive labelling, which was seen with both MAP2 and DBH neuronal markers, 
signifies that the cells have reached the final stages of neuronal differentiation 
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(Dehmelt and Halpain, 2005; Gingras et al., 2007).   Published literature reports the 
necessity for longer RA treatment periods to achieve terminal differentiation 
(Pleasure et al., 1992).  However, one study that used a simple suspension method 
to achieve neuronal differentiation has reported a shorter turnover period, although 
the yield of post-mitotic neurons was considerably reduced with this method (Cheung 
et al., 1999).  Immunocytochemistry results obtained from our study failed to identify 
any non-stained cells, suggesting that the majority of cells have reached the terminal 
stages of differentiation.  After 3 weeks of RA treatment, cells appeared healthy and 
very little dead cells were present, confirming the suitability of these methods to 
differentiate cells for further studies.    
 
 
 
4.4.4 Conclusion 
 
In conclusion, the findings of this study have successfully identified a novel method 
to differentiate M17 cells in vitro, which has previously been reported as RA resistant.  
In contrast to the conventional 2D culture method, a 3D cell culture model in 
conjunction with RA has resulted in a significant overexpression of neuronal marker 
levels in M17 cells, making this the most significant discovery of this study.  This 
finding also reiterates the importance of the cell culture media and culture 
environment used in experiments. As a well-established and widely used cell line in 
neuroscience research, the current findings allows M17 cells to be used in a wide 
variety of studies and experiments.  Their ability to terminally differentiate into a 
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more neuronal state means better access to cheaper and widely available culture 
models in the future. 
 
The modified 3D differentiation culture model, which was tested during this study, 
enables a shorter, efficient and more economical approach to generate terminally 
differentiated neurons.  This novel method with a shorter period of RA treatment will 
facilitate all studies involving primary neurons and will enable study and greater 
understanding of the bio-mechanisms involved in cell differentiation and 
pathophysiology.   
 
In summary, the findings of the current study will be valuable in developing a cell 
culture model, which can be used as an alternative to animal models in neuroscience 
research and drug screening studies.  
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CHAPTER 5: General Discussion 
 
 
A diet high in PUFAs, mainly omega-3 FAs, have been reported to reduce the risk of 
some common cancers, notably those of breast, colon, and perhaps, prostate cancer 
(Berquin et al., 2007; Brasky et al., 2010; Hall et al., 2008; Wolk et al., 2006).  It has 
also been reported that omega-3 FAs can inhibit the growth of tumours in animal 
models (Kato et al., 2007; Zhang et al., 2013), and increase the rate of apoptosis in 
cancer cells (Abdi et al., 2014; Serini et al., 2008).  Epidemiological and pre-clinical 
studies have shown that a diet rich in omega-3 FAs, such as DHA, inhibits colon 
tumours by modulating signalling pathways that alter gene expression related to 
tumour growth and inducing apoptosis (Chapkin et al., 2008; Reddy, 2002; Skender 
et al., 2014).  Anti-inflammatory properties have also been observed in diets rich in 
omega-3 acids. In vitro studies have revealed an ability of omega-3 FAs to promote 
apoptotic death of pro-inflammatory T helper cell-1 lymphocytes through 
incorporating into the cell membrane (Switzer et al., 2004).  Thus, many protective 
effects of omega-3 FAs have been reported over the years.  The importance of DHA 
in neuronal cells has also been reported widely.  One of the most important findings 
to support the effect of DHA in neuronal cells is the binding affinity DHA has to these 
cells.  DHA has the highest reported fatty acid-binding protein/ligand interaction ratio 
in human neuronal cells.  The binding affinity of DHA has a Kd value of approximately 
10 nM, which is even greater than the RA affinity towards its binding proteins (Xu et 
al., 1996). 
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 Similarly, zinc is considered to be one of the most important trace elements for 
cellular and biochemical functions (Bitanihirwe and Cunningham, 2009; Takeda, 
2000).  However, excessive amounts of zinc is considered to be cytotoxic (Szewczyk, 
2013).  Many neurodegenerative conditions such as AD has been linked to excessive 
amounts of free zinc (Watt et al., 2010).  Thus, the homeostasis of zinc is very 
important at the cellular level.  Two main groups of proteins are involved in 
maintaining the zinc balance at the cellular level. The  ZnT family that mediates zinc 
efflux from cells to ECM or into cellular compartments or organelles (Cousins and 
McMahon, 2000), and the Zip family that transport zinc from the ECM or from 
intracellular vesicles into the cytosol (Cousins et al., 2006). 
 
The main focus of the current PhD project was to evaluate the effect of DHA on 
neuronal cell survival and zinc homeostasis.  In summary, the current study was able 
to demonstrate a link between DHA and free zinc availability, and also link DHA with 
zinc transporter expression levels.  Importantly, the current study was able to confirm 
the link between DHA and apoptosis, which has been discussed above. 
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5.1  DHA effect on neuronal cell survival and zinc homeostasis 
 
5.1.1 DHA effect on apoptosis levels 
 
To establish the role of DHA as a neuro-protector, apoptosis marker levels were 
tested in DHA-treated neuronal cells using Western blotting (Figure 1.14 & Figure 
1.15).  When treated with 20 μg/ml DHA for 48 hours, M17 cells demonstrated a 
marked reduction in caspase-3 protein levels compared to untreated cells (Figure 
1.14).  Densitometry analysis revealed a significant decrease in caspase-3 protein 
levels (66%) with the DHA treatment, when compared with untreated cells.  In 
contrast, Bcl2 levels were upregulated following DHA treatment (Figure 1.15).  Bcl2 
is known to promote cell survival by inhibiting apoptotic death and by regulating 
programmed cell death (Miyashita et al., 1994; Oltvai et al., 1993; Reed, 1994).     
Caspase-3 on the other hand is a well-known end stage marker of apoptosis (Gown 
and Willingham, 2002; Jeruc et al., 2006).  Therefore, the findings of this study 
corroborate published literature, where DHA has been reported as a regulator for 
apoptosis. 
 
 
5.1.2 DHA and zinc transporter levels 
 
When tested for zinc transporter expression levels following the DHA treatment, 
ZnT3 expression exhibited a significant downregulation at both the mRNA (Figure 2.6) 
and protein levels in M17 and NT2 cells (Figure 2.16 & Figure 2.19).  ZnT3 is prominent 
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in the human brain and testis, and within the brain it’s more pronounced in the 
hippocampus and cerebral cortex (Palmiter et al., 1996).  Zinc accumulation in 
synaptic vesicles are known to be facilitated by the ZnT3 transporter (Palmiter et al., 
1996), highlighting the importance of the ZnT3 transporter in neuronal cells.  In the 
current study, we demonstrated a significant downregulation of ZnT3 mRNA levels 
when grown in DHA enriched culture medium compared to the control cells (Figure 
2.6).  These findings suggest a possible DHA dependent regulation of cellular zinc 
levels in these tested human cells.  To test this theory further, cellular levels of “free 
zinc” availability was tested using zinc fluorophores and these results are reported in 
Chapter 3 of this thesis. 
 
 
5.1.3 DHA and free zinc availability  
 
M17 and NT2 cells were grown in a culture medium enriched with DHA (20 μg/mL) 
prior to exposure to Zinpyr-1 for a period of 30 minutes.  DHA treated cells showed a 
marked reduction in fluorescence labelling compared to untreated cells at the 48 
hour timepoint (Figure 3.3, Figure 3.4, Figure 3.7 & Figure 8).  At the 0, 4, 8, 16 & 24 
hour timepoints there were no significant changes observed in fluorescence labelling 
patterns, apart from a minor decrease in the intensity at later timepoints.  Results 
observed were tested for DHA specificity using LA, where no differences were visible 
in fluorescence signalling (Figure 3.2 & (Figure 3.6).  Similarly, DHA specific cellular 
responses have been reported with many different cell types.  When treated with 
metabolites derived from omega-6 arachidonic acid (epoxyeicosatrienoic acid) 
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angiogenesis and tumour progression was increased in mice. In contrast, when 
treated with DHA, more than 70% reduction in primary tumour growth and 
metastasis was observed (Zhang et al., 2013).  In a study performed with using U937 
cells, DHA induced a rapid increase in Ca2+, suggesting an ability of DHA to mobilise 
Ca2+ from intracellular pools. However, when tested with other structural analogues 
of DHA, this same effect was not visible (Aires et al., 2007). Many other studies also 
have shown similar DHA-specific effects on cellular apoptosis in cancer cells. (Iigo et 
al., 1997; Merendino et al., 2003; Rahman et al., 2013; Suzuki et al., 1997). 
 
The ability of DHA to regulate apoptosis was also established in the present serum 
starved study conducted using M17 and NT2 cells.  DHA alone was sufficient to rescue 
cells, which were serum starved for 48 hours (Figure 3.5 & Figure 3.9).  As discussed 
above, both pro and anti-apoptotic effects of DHA have been reported in literature.  
The combination of results obtained in both Chapters 2 and 3 suggest possible DHA 
regulation of apoptosis.  Results obtained in Chapter 3 also reveal a significant 
decrease in cellular free zinc levels with DHA treatment.  Elevated levels of free zinc 
have been linked to both necrotic and apoptotic death in neuronal cells (Choi et al., 
1988; Chuah et al., 1995; Cuajungco and Lees, 1997b; Duncan et al., 1992; Yokoyama 
et al., 1986).  Taken together, these results indicate a potential link between DHA, 
free zinc availability and apoptosis.   
   
Following analysis of the results, we propose that the apoptotic regulatory effects of 
DHA are mediated through control of cellular zinc homeostasis. In neuronal cells, this 
mechanism may contribute to the positive effects of DHA as a neuro-protector by 
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reducing neuronal cell death and neurodegenerative diseases such as AD (Figure 5.1), 
whose incidence is reduced in populations with a high omega-3 FA diet.  
 
 
5.2 Cellular differentiation  
 
Scientific research into cellular, molecular and pharmaceutical aspects is in desperate 
need of improved in vitro models to aid the identification and assessment of many 
biological functions and reactions. The widely used traditional cell culture models 
involve growing cells on a 2D substrate.  Though this practice is common, easy and 
economical than any complex cell culture model, there are certain flaws attached to 
this system.  With the 2D method, cells adapt to a synthetic 2D environment, thus 
changing the characteristics of normal cells and becoming flattened.  Cell-cell 
interaction becomes hindered and ultimately cells fail to express and perform at the 
peak level.  Therefore, the demand for a more efficient and economical 3D cell culture 
model has grown over the years.  A 3D culture model will allow cells to grow in an 
environment which is closer to the native physiological conditions.  In a 3D cell 
culture, cells are able to acquire a natural 3D phenotype, thus favouring improved 
cell proliferation, differentiation and function. In the current study, we succeeded in 
overcoming M17 cell resistance to RA by using a 3D model, thus enabling cells to 
acquire a more neuronal phenotype.   
 
In the second part of the study, we also managed to develop a shorter and more 
efficient 3D culture model to use with cellular differentiation. 
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Figure 5.1: Schematic diagram of the proposed apoptotic regulatory effect of DHA. 
Following the analysis of the key findings of this study, we propose that the apoptotic 
regulatory effects of DHA are mediated through control of cellular zinc homeostasis. 
In turn this mechanism may contribute to the positive effects of DHA as a neuro-
protector by reducing neuronal cell death and neurodegenerative diseases such as 
AD.  The key findings of this study are represented by the solid (black) arrows. Empty 
(white) arrows represent possible benefits of DHA in neuroprotection (NP) and 
therefore contributing to lower incidence of neurodegenerative diseases (ND), such 
as Alzheimer’s disease (AD). 
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5.2.1 Differentiating M17 cells 
  
M17 cells are a subclone of the parental cell line SK-N-BE(2).  The parental cell line 
was originally isolated in 1972 from the bone marrow of a two year old Caucasian 
male suffering from disseminated neuroblastoma (Ciccarone et al., 1989).  M17 cells 
have been long reported as a RA resistant cell line, thus been deemed not suitable 
for differentiation (Carvalho et al., 1993; Draoui et al., 1997; Melino et al., 1993).  
During the current study we managed to differentiate M17 cells to acquire mature 
neuronal cell properties by using a 3D culture model instead of the traditional 2D 
monolayer model.   
 
Immunocytochemistry performed on M17 cells which were grown on 3D culture and 
treated with RA, showed a clear increase in all neuronal marker protein levels (Figure 
4.3) compared with M17 cells grown on 2D culture flasks (Figure 4.2).  In M17 cells 
grown on 2D flasks, neuronal marker labelling was very limited and not ubiquitous 
among all the cells present.  However, RA treated cells grown under a 3D culture 
system displayed strong and universal labelling of the neuronal markers.  
 
This study yet again establishes the importance of a 3D culture model over the 
conventional 2D model.  Due to its versatility and availability, M17 cells have become 
a widely used cell culture model.  However, many attempts to differentiate M17 cells 
have failed in the past.  As discussed above, 3D differentiated cells allow a closer 
resemblance to the structure and function of their in situ counterparts.  Having a 
greater resemblance to the actual physiological conditions allows researchers to 
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carry out more accurate in vitro investigations of complex biological processes.  
Studies have shown a clear difference in cell-cell interactions, drug delivery methods 
and cellular responses in neuroblastoma cells and primary neuronal cells (Haghighat 
et al., 2000; LePage et al., 2005; Storch et al., 2000).  Therefore, the current M17 cell 
differentiation protocol we have developed has the potential to provide substantial 
benefits for further neuroscience studies.   
 
 
5.2.2 Novel differentiation method 
 
One of the disadvantages of the current differentiation methods are the lengthy 
periods of RA treatment.  As an example, NT2 cells take between 42 and 54 days to 
differentiate into post-mitotic neurons (Andrews, 1984).  Shorter RA treatment 
periods have resulted in a reduced yield of post-mitotic neurons (Cheung et al., 1999).  
During this study, we were able to develop a novel differentiation method with a 
reduced RA treatment time, without compromising the yield or the quality of cells.  
Cells grown in suspension culture followed by the filter method showed the highest 
increase in neuronal marker levels compared to the other two methods tested.  This 
novel combination of suspension culture and filter enables cells to have a better cell-
cell and cell-matrix interaction than the suspension culture alone.  Moreover, this 
method cuts down the differentiation period in half to just 21 days, making the entire 
differentiation process more economical and efficient.  The simplicity of the method 
and the quick turnaround period allows this method to be used easily and routinely 
in laboratory experiments. 
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A readily available method of producing human neurons in the lab has many 
advantages.  Due to the lack of availability and ethical complications linked with 
primary human neuronal cells, many scientists rely on using animal models or other 
substitutions for neuronal studies.  Thus, the current model provides an easy and 
cheaper alternative for obtaining pure post mitotic neuronal cells.  Ultimately, a 
similar method of producing human neuronal cells can be used in gene therapy, 
neurogenesis and neural transplantation.  This will greatly facilitate in combating the 
increasing incidence of neurodegenerative cases and treating other brain related 
injuries (Paquet-Durand and Bicker, 2007; Trojanowski et al., 1997). 
 
 
 
5.3 Limitations of the present study  
 
One of the main aims of this study was to identify any possible link between DHA and 
zinc homeostasis.  Human cells treated with different doses of DHA in the presence 
or absence of zinc displayed several important patterns in the expression levels of 
zinc transporters and the availability of free zinc.  The ZnT3 transporter exhibited the 
most significant change in expression following DHA treatment.  Labile zinc levels 
were also significantly altered following DHA treatment.  Moreover, the apoptosis 
marker caspase-2, was downregulated in M17 and NT2 cells following DHA 
treatment.  
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The cells used in Chapters 2 and 3 of the current study were not differentiated cells, 
thus were not a true and accurate representation of primary neuronal cells.  
Therefore, more work needs to be carried out before proposing an overall model for 
ZnT or ZIP transporter expression.  It will be interesting to ascertain the outcome if 
the experiments were conducted using differentiated cells. However, studies have 
shown that both undifferentiated M17 and SY5Y cell lines express neuronal markers 
to a certain extent (Ciccarone et al., 1989).  In general, SY5Y cells are more 
predisposed to environmental parameter induced variations in gene expression, and 
are influenced by factors such as the health of the culture media, nutrient 
composition and the growth substrates utilized (Buttiglione et al., 2007).  A study 
conducted using SY5Y cells and different types of growth media and substrates 
suggests that the expression of neuronal differentiation markers can be reduced by 
the use of FBS on carboxylic group containing surfaces (Buttiglione et al., 2007).  
Therefore, fewer neuronal characteristics exhibited by SY5Y cells in some cases can 
be attributed to this reason.   
 
 
 
5.4 Future directions 
 
To ascertain a better understanding of the effect of DHA on neuronal survival and 
zinc homeostasis under natural physiological conditions, it will be beneficial to repeat 
the Chapter 2 & 3 studies with differentiated cells using the methods proposed in 
Chapter 4.  As discussed extensively, differentiated cells can mimic actual 
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physiological conditions better than undifferentiated cells.  Thus, their cellular 
responses will be more accurate and similar to in situ conditions.  Though the cells 
used in Chapters 2 and 3 have many neuronal properties, as reported extensively in 
literature, they are very different to primary neuronal cells.  Therefore, it will be 
interesting to find out whether differentiated cells possessing more neuronal 
properties will respond likewise when treated with DHA.  A study conducted in mice 
have reported similar results to that obtained in this study (Jayasooriya et al., 2005b; 
Kitajka et al., 2004).  If differentiated cells respond to DHA in the same way, this will 
provide conclusive evidence to establish the effect of DHA on neuronal survival and 
zinc homeostasis.  
 
It will also be beneficial to study the importance of the ZnT3 transporter in neuronal 
cells.  One of the most resourceful and widely used techniques to study its 
importance will be to manipulate the gene expression of ZnT3 at the cellular level.  
Overexpression and most importantly silencing of the ZnT3 gene will provide greater 
knowledge of the importance of this transporter in neuronal cells.  To study gene 
manipulation effects, cell lines with silenced or overexpressed ZnT3 will need to be 
established, and subsequently analysed for transporter expression levels using QPCR.  
Zinc fluorophore studies can assist in the understanding of zinc trafficking in the 
silenced and overexpressed cell lines.  The effects of both silencing and 
overexpression on cell survival must be investigated by analysis of caspase-3 and Bcl2 
levels.  It will also be interesting to determine whether there is a direct link between 
DHA, APP and β-amyloid levels.  Both APP and β-amyloid are hallmark proteins in AD 
pathophysiology.  DHA treated-differentiated neuronal cells can be tested using 
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Western blotting or QPCR techniques to determine if there are any changes to APP 
and β-amyloid expression levels.  Collectively, these additional studies will benefit in 
understanding the importance of these zinc transporters to human cells even further. 
 
 
 
5.5 Significance of the current findings 
 
As discussed extensively throughout this thesis, neurodegenerative disorders 
including AD are considered a huge health threat and a burden to individuals, and to 
the world as a whole.  With the rapid increase in rate and no effective cure, 
neuroscience research has become a national priority for many countries.   
 
The current study provides a few significant contributions towards the advancement 
of neuroscience research, to ultimately find a cure for many neurodegenerative 
conditions. There is a significant amount of data that has been reported linking excess 
amounts of free zinc to AD.  Moreover, many other studies have reported 
neuroprotective effects of DHA, especially in relation to AD.  However, the exact 
mechanism of DHA or zinc involvement in such conditions was not clear until now.  
During this study, we successfully elucidated a link between free zinc availability, DHA 
levels and apoptosis, thus we are able to suggest a pathway of neuroprotection 
following DHA treatment at the cellular level.  Understanding the ability of DHA to 
regulate apoptosis via altering zinc homeostasis provides a possible platform and a 
mechanism for further studies in both cellular and animal models.   
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The other major contribution of this study was to develop a better cell culture model 
for neuronal differentiation.  Due to the practical difficulties in obtaining primary 
neuronal cells for experiments, much research is done with alternatives such as 
neuroblastoma cells or animal models.  Though, both alternatives share similarities 
at the structural and functional level with primary neurons, there are many major 
dissimilarities as well.  Thus, the validity of the observations seen with alternative 
models are somewhat questionable.  Therefore, the current PhD project provides an 
economical, effective and simple method of differentiating neuronally committed 
cells into primary neuronal cells.  This method allows quick and easy access to 
terminally differentiated neuronal cells for neuroscience research.  Therefore, 
increasing the productivity and specificity of the research conducted.  More 
importantly, by further improvement of this method, it can ultimately be used as a 
method for producing human neuronal cells, which in turn can be used in gene 
therapy, neurogenesis and neural transplantation.  This will greatly facilitate 
combating the increasing incidence of neurodegenerative cases and treating other 
brain related injuries. 
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5.6 Conclusion 
 
In conclusion, the experimental findings of this thesis provide novel information 
about DHA involvement in zinc uptake and apoptosis in human cells.  Following a 
comprehensive analysis of the molecular events in DHA treated M17 and NT2 cell 
lines, we conclude that zinc uptake was significantly lowered and ZnT3 mRNA and 
protein levels were downregulated in comparison to DHA-depleted cells.  Moreover, 
the end apoptosis marker caspase-3 displayed a marked reduction in protein levels 
when compared with untreated cells.  Furthermore, anti- apoptotic Bcl-2 protein 
levels were increased following the DHA treatment in both M17 and NT2 cells.  In 
combination, these observations infer a link between DHA and free zinc availability, 
which ultimately can regulate programmed cell death in neuronal cells.   However, 
with both SY5Y cells and the human keratinocyte cell line HaCaT we did not observe 
this same response to DHA, highlighting the neuronal specificity of the findings made 
during this study.   
 
The outcomes presented in this thesis re-establish the importance of 3D cell culture 
models.  M17 cells which were previously reported as RA resistant, when cultured on 
3D models responded to RA and expressed neuronal markers. The current study also 
presents a novel method with shorter treatment periods for cellular differentiation.  
This unique method combining suspension culture and 3D culture facilitate terminal 
cellular differentiation of both M17 and NT2 cells to neuronal cells within 21 days, 
which is almost half the time of most widely used methods.  This novel method 
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provides an efficient, economical and simple method for cellular differentiation in 
neuroscience research.    
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